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Abstract 
 
During development, vascular networks expand following a process known as sprouting 
angiogenesis. New vascular branches arise from pre-existing vessels through the 
coordinated migration and proliferation of endothelial cells, and eventually connect to 
form new vascular loops. The functionality of these new vessel segments is dependent 
on the opening of a central lumen to allow perfusion. While mechanisms of lumen 
formation during the establishment of the primary vasculature by vasculogenesis have 
been well characterised, the mechanisms underlying lumen formation during sprouting 
angiogenesis in vivo are still poorly understood and subject to debate. 
In this work, I established high spatial and temporal imaging of apical membrane 
dynamics during sprouting angiogenesis in vivo, both in the zebrafish trunk vasculature 
and the mouse retina primary inner plexus. By doing so, I identified a novel mechanism 
of lumen formation, where blood flow expands luminal compartments by driving 
spherical deformations reminiscent of membrane blebs at the apical membrane of 
sprouting endothelial cells. Additionally, I show that this process, that I chose to term 
inverse membrane blebbing, is tightly controlled through local and transient recruitment 
and contraction of actomyosin at the surface of growing blebs. This mechanism 
eventually leads to the selective retraction of inverse blebs along the apical membrane, 
allowing unidirectional lumen expansion. When endothelial cells ability to retract is 
inhibited through expression of a dominant-negative form of myosin II, cells fail to 
lumenise or show dilated lumens with multiple unresolved side blebs and branches. 
Together, this work provides a mechanism for lumen expansion within sprouting 
endothelial cells in vivo, and identifies for the first time inverse blebbing as a reaction of 
membranes to high external pressure. In the context of sprouting endothelial cells, I 
show that a tight equilibrium between the forces exerted by the blood and the contractile 
responses from the cells is required for lumen expansion within angiogenic sprouts. 
  4 
Acknowledgements 
 
To my thesis supervisor, Holger Gerhardt. Thank you for the freedom you gave me to 
follow my scientific curiosity and explore my own ideas, I could not have dreamt of 
better circumstances to grow as a scientist. Your enthusiasm, kindness and support 
made working with you the most enjoyable experience. Thank you for always 
challenging me and trusting me. 
 
To Li-Kun Phng. I learnt so much by working with you. Thank you for always 
providing great input and support, and for welcoming me in Leuven when I was 
desperate to play with more microscopes! 
 
To my PhD sister, Filipa Neto. I was so lucky to share this journey with you. Thank you 
for having taken such good care of me, and for all the amazing memories I keep from 
our time in London. 
 
To all the VBL/iVBL/VPL extended family: 
To the past members of the London Vascular Biology Lab. To my British English and 
Physics tutor, running coach, and digestives supplier, Martin Jones; to Benedetta 
“Cookie Monster” Ubezio; to Claudio Franco, Raquel Blanco, Irene Aspalter, Anan 
Ragab, Andrea Taddei, Katie Bentley, Eleonora Lapi, Jane Babbage, Giovanni Mariggi, 
and Dominique Sauvaget. 
To our new team in Berlin: Anne-Clémence Vion, Russell Collins, André Rosa, Irene 
Hollfinger, Baptiste Coxam, Anna Szymborska, Santiago Andrade, Elena Cano-Rincon, 
Marta Bastos de Oliveira, Eireen Bartels-Klein, Ines Uhlenhut, Iris Unterweger, and 
Alexandra Klaus. 
To past and present members of the Vascular Patterning Lab in Leuven: Fabio Stanchi, 
Ilse Geudens, Thomas Mathivet, Claire Bouleti, Marly Balcer, Pavel Nedvetsky, Petya 
Georgieva, Ken Matsumoto, Xiaocheng Zhao, and Andrin Wacker. 
To our short-term but fondly remembered visitors: Helena Serra, Julia Schopp and Tuyu 
Zheng. 
  5 
Working with you all was such a rewarding experience. Thank you for the daily support, 
helpful discussions, and most of all for the unique entertainment you provided every 
single day of my PhD! 
 
To my classmates of the London Research Institute PhD programme: Martina, 
Marianne, Sakshi, Nil, Ichha, Yaiza, Mauro, Steffi, Aldona, Molly, Pavel, Kristyna. 
Thank you for your friendship, the parties, and the invaluable support! 
 
To friends from the 6th floor and beyond: Solène, Florent, Lars, Delphine, Justin, Eyal. 
 
To everyone at the LRI and Cancer Research UK. Your dedication to the fight against 
cancer is inspirational and made the LRI a very special place to be. 
 
To Cancer Research UK and all its generous donators for funding my PhD, and 
allowing us scientists to work towards a better understanding of the disease, even in its 
most fundamental aspects. 
 
To everyone at the LRI PhD programme and to my thesis committee members, Barry 
Thompson and Thomas Surrey, for making sure the journey was as smooth as possible. 
 
To all the staff at the Animal and Fish Facilities of the LRI, Max Delbrück Center and 
Vesalius Research Center. A special thank you to Sue Watling, Caroline Zverev and 
Claire Darnbrough at Clare Hall, and to our fish whisperers, Chris Sergeant and Darren 
Martin at Lincoln’s Inn Fields, and Robby Fechner at the MDC. 
 
To Thomas Surrey and Nicholas Cade at the LRI for granting me access to their 3i 
spinning disk microscope, and Peter Vanden Berghe for letting me use the Andor 
spinning disk confocal of the Cell Imaging Core Facility at KU Leuven. 
 
 
 
 
  6 
To my friends and family back home, for their incredible support: 
 
To Virginie, ma Ninou, for being the most supportive and inspirational friend. You kept 
me sane and hopeful throughout this whole journey. I look forward to our reunion and 
the many adventures awaiting for us on this planet. 
 
To my friends from Ginette: the one-and-only Caroline Bailleux, Guigui, and my “co”s 
Cha and Pierrick. Thank you for visiting me everywhere I ended up and for staying the 
same crazy bunch over the years! To Buchette, and my friend-without-borders Maï, I 
am so lucky to have you by my side. 
 
Finally: 
 
To the Feest family, for having welcomed us, “the kids”, in Berlin with the greatest 
kindness. 
 
To Jianni, for having made Berlin feel like home. 
 
And last but not least: 
 
To my brother and best friend, Nicolas. For having been there every step of the way, 
every single day. For having come to my rescue when I needed it the most, and for 
being up for anything, always. You are the best. 
 
À Maman et Papa, pour votre soutien et votre amour inconditionnels. 
  7 
Table of Contents 
 
Abstract  ...................................................................................................................... 3	
Acknowledgements ............................................................................................................ 4	
Table of Contents ............................................................................................................... 7	
Table of figures ................................................................................................................ 11	
List of tables  .................................................................................................................... 14	
Abbreviations ................................................................................................................... 15	
Chapter 1.	 Introduction ............................................................................................... 20	
1.1	 The cardiovascular system: structure, development and associated diseases20	
1.1.1	 Organisation and function of the cardiovascular system ............................... 20	
1.1.2	 Blood vessel formation during embryonic development ............................... 21	
1.1.3	 Associated diseases and therapeutic perspectives ......................................... 22	
1.2	 Cellular and molecular mechanisms of sprouting angiogenesis ..................... 27	
1.2.1	 Hypoxia and secretion of pro-angiogenic factors .......................................... 29	
1.2.2	 Exit from quiescence ..................................................................................... 31	
1.2.3	 Tip and stalk cell selection ............................................................................ 31	
1.2.3.1	 Cellular behaviours within angiogenic sprouts ...................................... 31	
1.2.3.2	 Molecular regulation of endothelial cell specification ........................... 32	
1.2.4	 Anastomosis and lumen formation ................................................................ 36	
1.2.5	 Vessel maturation .......................................................................................... 38	
1.2.6	 Arterial-venous specification ......................................................................... 38	
1.2.7	 Vascular remodelling ..................................................................................... 39	
1.2.8	 Concluding remarks ....................................................................................... 40	
1.3	 Working models for the study of vascular lumen formation ......................... 41	
1.3.1	 In vitro models ............................................................................................... 41	
1.3.2	 In vivo models ............................................................................................... 45	
1.3.2.1	 Mouse retina ........................................................................................... 45	
1.3.2.2	 Zebrafish ................................................................................................. 48	
1.4	 Lumen formation during vascular development ............................................. 53	
1.4.1	 General principles of apical-basal polarity establishment and lumen 
formation in epithelial tissues .................................................................................... 53	
  8 
1.4.2	 Mechanisms of apical-basal polarity establishment and lumen formation in 
epithelial tissues ......................................................................................................... 54	
1.4.2.1	 Lumen formation from already polarised tissues ................................... 54	
1.4.2.1.1	 Wrapping ......................................................................................... 54	
1.4.2.1.2	 Budding ........................................................................................... 56	
1.4.2.1.3	 Mechanisms of apical constriction .................................................. 56	
1.4.2.2	 Lumen formation from non-polarised tissues ......................................... 58	
1.4.2.2.1	 Cavitation ........................................................................................ 58	
1.4.2.2.2	 Cord hollowing ................................................................................ 59	
1.4.2.2.2.1	 Madin-Darby canine kidney (MDCK) cyst model ................... 59	
1.4.2.2.2.2	 Drosophila fusion cells ............................................................. 64	
1.4.2.2.3	 Cell hollowing ................................................................................. 65	
1.4.2.2.4	 Membrane invagination ................................................................... 66	
1.4.2.3	 Concluding remarks ................................................................................ 67	
1.4.3	 Vascular lumen formation ............................................................................. 69	
1.4.3.1	 Lumen formation during blood vessel formation in vitro ...................... 69	
1.4.3.1.1	 Cellular mechanisms ....................................................................... 69	
1.4.3.1.2	 Molecular mechanisms .................................................................... 69	
1.4.3.1.3	 Concluding remarks ......................................................................... 72	
1.4.3.2	 Lumen formation during vasculogenesis in vivo ................................... 74	
1.4.3.3	 Lumen formation during sprouting angiogenesis in vivo ....................... 79	
1.5	 Objectives ............................................................................................................ 84	
Chapter 2.	 Materials & Methods ................................................................................ 86	
2.1	 Zebrafish experiments ........................................................................................ 86	
2.1.1	 Zebrafish care and procedures ....................................................................... 86	
2.1.2	 Transgenic lines ............................................................................................. 86	
2.1.3	 Transgenesis .................................................................................................. 87	
2.1.4	 Cloning and constructs .................................................................................. 87	
2.1.5	 Embryo preparation for imaging ................................................................... 91	
2.1.6	 Live imaging .................................................................................................. 91	
2.1.7	 Laser ablations ............................................................................................... 92	
2.1.8	 Image analysis ............................................................................................... 92	
  9 
2.1.9	 Statistical analysis ......................................................................................... 93	
2.2	 Mouse experiments ............................................................................................. 93	
2.2.1	 Mouse care and procedures ........................................................................... 93	
2.2.2	 Retina dissection ............................................................................................ 93	
2.2.3	 Immunofluorescence staining of mouse retinas ............................................ 94	
2.2.4	 Imaging and image analysis .......................................................................... 95	
Chapter 3.	 Lumen does not form through vacuole formation and fusion during 
sprouting angiogenesis in vivo ........................................................................................ 98	
3.1	 Introduction ........................................................................................................ 98	
3.2	 Establishment of high resolution imaging of the apical membrane in in vivo 
models of sprouting angiogenesis ............................................................................... 98	
3.2.1	 Choice of apical membrane markers ............................................................. 99	
3.2.2	 Choice of imaging systems .......................................................................... 101	
3.3	 Lumen does not expand by vacuole formation and fusion in angiogenic 
sprouts in vivo ............................................................................................................ 104	
3.4	 Lumen expansion is dependent on blood pressure ........................................ 105	
3.5	 Conclusions ....................................................................................................... 105	
Chapter 4.	 Blood pressure drives lumen formation by inverse membrane 
blebbing during sprouting angiogenesis in vivo .......................................................... 110	
4.1	 Introduction ...................................................................................................... 110	
4.2	 Angiogenic sprouts expand both unicellular and multicellular lumens in 
vivo  ............................................................................................................................ 110	
4.3	 Apical membranes expand by inverse membrane blebbing during 
angiogenesis ................................................................................................................ 112	
4.3.1	 Apical membranes undergo inverse blebbing during unicellular and 
multicellular lumen expansion ................................................................................ 112	
4.3.2	 Inverse blebbing is driven by blood pressure .............................................. 118	
4.3.3	 Apical membrane shows constricted patterns in mouse retinas suggestive of 
lumen expansion by inverse blebbing ..................................................................... 119	
4.4	 Conclusions ....................................................................................................... 119	
Chapter 5.	 Endothelial cells regulate inverse blebbing and lumen expansion by 
local and transient recruitment and contraction of actomyosin ............................... 122	
  10 
5.1	 Introduction ...................................................................................................... 122	
5.2	 Endothelial cells retract inverse blebs by recruiting and contracting 
actomyosin at the apical membrane ........................................................................ 122	
5.2.1	 F-actin polymerises around inverse blebs during phases of retraction ........ 122	
5.2.2	 Myosin II is recruited around inverse blebs during phases of retraction .... 123	
5.2.3	 Bleb retraction requires actomyosin contraction ......................................... 124	
5.2.4	 A contractile actomyosin cortex underlines the apical membrane in 
angiogenic sprouts in mouse retinas ........................................................................ 126	
5.3	 Weakening of the actomyosin cortex at the apical membrane triggers 
inverse blebbing ......................................................................................................... 134	
5.4	 Apical membrane contractility is required for lumen formation and 
maintenance ............................................................................................................... 136	
5.5	 Conclusions ....................................................................................................... 137	
Chapter 6.	 Discussion ................................................................................................. 141	
6.1	 Summary of the findings .................................................................................. 141	
6.2	 Cellular mechanisms of vascular lumen formation ....................................... 143	
6.2.1	 Revisiting previous models of lumen formation during sprouting 
angiogenesis in vivo ................................................................................................. 143	
6.2.2	 Relevance of in vitro models of vascular lumen formation ........................ 144	
6.2.3	 Lumen formation during vasculogenesis and angiogenesis in vivo: different 
contexts call for specific mechanisms ..................................................................... 146	
6.3	 Molecular mechanisms of vascular lumen formation ................................... 147	
6.3.1	 Establishment of apical-basal polarity ......................................................... 147	
6.3.2	 The role of the actin cytoskeleton during vascular lumen formation .......... 148	
6.3.2.1	 Cell shape changes during lumen formation ........................................ 148	
6.3.2.2	 Regulation of inverse blebbing at the apical membrane ...................... 150	
6.4	 Conclusion ......................................................................................................... 155	
Chapter 7.	 Appendix .................................................................................................. 156	
7.1	 Movie legends .................................................................................................... 156	
7.2	 Plasmid maps .................................................................................................... 159	
Reference List ................................................................................................................ 163	
  11 
Table of figures 
 
Figure 1.1. The vertebrates cardiovascular system ........................................................ 24	
Figure 1.2. Cross-sections of arteries, veins, and capillaries .......................................... 25	
Figure 1.4. Sprouting angiogenesis: overview of a multistep process ........................... 28	
Figure 1.5. Molecular regulation of pro-angiogenic factors secretion under hypoxia ... 30	
Figure 1.6. Notch signalling pathway ............................................................................. 34	
Figure 1.7. VEGF/Notch signalling positive feedback loop .......................................... 35	
Figure 1.8. Sequence of cellular events leading to anastomosis .................................... 37	
Figure 1.9. In vitro models of vasculogenesis and sprouting angiogenesis, as developed 
by Davis and colleagues ................................................................................................. 44	
Figure 1.10. Post-natal development of the mouse retina vasculature ........................... 46	
Figure 1.11. The development of the mouse retina primary inner plexus: a model for 
high resolution imaging of sprouting angiogenesis ........................................................ 47	
Figure 1.12. Anatomy of the zebrafish vasculature at 1.5 and 2.5 dpf ........................... 51	
Figure 1.13. Formation of the trunk vasculature in the zebrafish embryo ..................... 52	
Figure 1.14. Mechanisms of lumen formation ............................................................... 55	
Figure 1.15. Mechanism of lumen formation by cord hollowing in MDCK cysts ........ 63	
Figure 1.16. Lumen formation by membrane invagination during trachea formation in 
Drosophila ...................................................................................................................... 68	
Figure 1.17. Cellular mechanisms of vascular lumen formation in vitro ....................... 73	
Figure 1.18. Molecular mechanisms of vascular lumen formation in vitro ................... 73	
Figure 1.19. Mechanisms of lumen formation in the mouse dorsal aorta ...................... 75	
Figure 1.20. Endothelial tubes assemble from intracellular vacuoles in vivo ................ 80	
Figure 2.1. Experimental procedure for live imaging of fluorescent reporters in single 
cells in zebrafish embryos .............................................................................................. 89	
Figure 2.2. LexOP/LexPR inducible expression system ................................................ 90	
Figure 3.1. ICAM-2 is a specific marker for the apical membrane in mouse retinas .. 103	
Figure 3.2. mCherry-CAAX and EGFP-CAAX localise to the apical membrane and cell 
junctions in sprouting ISVs .......................................................................................... 103	
Figure 3.4. Disconnected lumen fragments arise from the collapse of pre-existing 
lumens ........................................................................................................................... 108	
  12 
Figure 3.5. Blood pressure is required for lumen expansion in angiogenic sprouts .... 109	
Figure 4.1. Endothelial sprouts undergo both unicellular and multicellular lumen 
formation in zebrafish ISVs (continued on next page) ................................................. 111	
Figure 4.2. Apical membrane undergoes inverse membrane blebbing during lumen 
expansion in sprouting ISVs ......................................................................................... 114	
Figure 4.3. Membrane blebbing: cellular and molecular mechanisms ......................... 115	
Figure 4.4. Measurement of expansion time, retraction time, expansion speed, and 
retraction speed of inverse blebs .................................................................................. 116	
Figure 4.5. Lumens expanding in multicellular sprouts undergo inverse membrane 
blebbing ........................................................................................................................ 117	
Figure 4.6. Ablation of the connection of ISVs to the dorsal aorta abrogates inverse 
blebbing at the apical membrane of lumenising cells .................................................. 120	
Figure 4.7. Transient treatment with 4x tricaine leads to transient loss of inverse blebs at 
the apical membrane of lumenising cells ..................................................................... 121	
Figure 5.1. F-actin and myosin II reporters co-localise at cell junctions, at the apical 
membrane, and at the base of filopodia in zebrafish ISVs ........................................... 127	
Figure 5.2. F-actin polymerises at the surface of inverse blebs during phases of 
retraction ....................................................................................................................... 128	
Figure 5.3. Structure and regulation of actomyosin filament assembly and contraction
 ...................................................................................................................................... 129	
Figure 5.4. Myosin II is recruited at the surface of inverse blebs during phases of 
retraction ....................................................................................................................... 130	
Figure 5.5. F-actin polymerisation precedes myosin II recruitment at the surface of 
inverse blebs ................................................................................................................. 131	
Figure 5.6. Actomyosin contraction drives bleb retraction .......................................... 132	
Figure 5.7. The apical membrane of angiogenic sprouts is lined with a contractile 
actomyosin cortex in mouse retinas ............................................................................. 133	
Figure 5.8. Local ablation of the cortex at the apical membrane of sprouting cells 
induces inverse blebbing .............................................................................................. 135	
Figure 5.9. Inverse blebbing: molecular mechanisms .................................................. 135	
Figure 5.10. Expression of Myl9bAA from 30 hpf leads to lumen defects in ISVs at 2 
dpf ................................................................................................................................. 138	
  13 
Figure 5.11. ISVs expressing Myl9bAA show dilated or no lumen at 2 dpf ............... 139	
Figure 5.12. Myl9bAA-expressing endothelial cells lacking lumens at 2 dpf fail to 
expand lumens .............................................................................................................. 140	
Figure 6.1. Model of lumen formation by inverse membrane blebbing during sprouting 
angiogenesis in vivo ..................................................................................................... 142	
Figure 7.1. Map of the pTol2-fli1ep:EGFP-CAAX plasmid ......................................... 159	
Figure 7.2. Map of the pTol2-fli1ep:Lifeact-mCherry plasmid .................................... 160	
Figure 7.3. Map of the pTol2-fli1ep:LexPR plasmid .................................................... 161	
Figure 7.4. Map of the pTol2-lexOP:myl9b-EGFP plasmid ........................................ 162	
 
  14 
List of tables 
 
Table 1.1. Composition of collagen gels and media used for in vitro models of 
vasculogenesis and sprouting angiogenesis .................................................................... 43	
Table 2.1. List of antibodies used for immunofluorescence staining in mouse retinas .. 97	
Table 3.1. Quantitative analysis of lumen conformations in endothelial sprouts in P6 
mouse retinas ................................................................................................................ 106	
 
  15 
Abbreviations 
 
ADAM  A disintegrin and metalloprotease 
ADP   Adenosine diphosphate 
aISV   Arterial intersegmental vessel 
ALPS   Amphipathic lipid-packing sensor 
AMIS   Apical membrane initiation site 
AmotL2  Angiomotin-like protein 2 
Ang-1   Angiopoietin 1 
Ang-2   Angiopoietin 2 
Anx2   Annexin 2 
AQP-8   Aquaporin 8 
ATPase  Adenosine triphosphatase 
aPKC   Atypical protein kinase C 
BAR   Bin-Amphiphysin-Rvs 
Bcl-2   B-cell lymphoma 2 
BSA   Bovine serum albumin 
bFGF   Basic fibroblast growth factor 
CA   Caudal artery 
CAAX Cystein, aliphatic amino acid, aliphatic amino acid, any amino 
acid 
cAMP   Cyclic adenosine monophosphate 
CBP   Creb-binding protein 
CCM1   Cerebral cavernous malformation protein 1 
CDS   Coding DNA sequence 
CFTR   Cystic fibrosis transmembrane conductance receptor 
CoR   Co-repressor complex 
COUP-TFII  Chicken ovalbumin upstream promoter-transcription factor II 
CRISPR  Clustered regularly-interspaced short palindromic repeats 
CV   Caudal vein 
DA   Dorsal aorta 
DAPI    4’,6-diamidino-2-phenylindole 
  16 
DE-Cadherin  Drosophila epithelial cadherin 
DIAPH3  Diaphanous related formin 3 
DLAV   Dorsal longitudinal anastomotic vessel 
Dll4   Delta-like ligand 4 
DNA   Deoxyribonucleic acid 
Dpf    Days post-fertilisation 
E(x)   Embryonic day (x) 
EBP-50  Ezrin radixin moesin-binding phosphoprotein 50 
ECM   Extracellular matrix 
EGFP    Enhanced green fluorescent protein 
EGFP-F  Farnesylated enhanced green fluorescent protein 
EGFR   Epidermal growth factor receptor 
ELC    Essential light chain 
ERM   Ezrin radixin moesin 
F-actin   Filamentous actin 
FAK   Focal adhesion kinase 
FCS   Fetal calf serum 
FGF-2   Fibroblast growth factor 2 
FHOD1  Formin homology 2 domain-containing protein 1 
FIP5   Rab11 family interacting protein 5 
FMNL2/3  Formin-like protein 2/3 
FRET   Fluorescence resonance energy transfer 
GEF   Guanine nucleotide exchange factor 
GSK-3β  Glycogen synthase kinase 3β 
GTP   Guanosine triphosphate 
HDAc   Histone deacetylase 
HGF   Hepatocyte growth factor 
Hes   Hairy/enhancer of split 
HIF   Hypoxia-inducible factor 
Hpf    Hours post-fertilisation 
hPR-LBD  Human progesterone receptor ligand binding domain 
HRE   Hypoxia-response element 
  17 
HUVEC  Human umbilical vein endothelial cell 
IAP   Inhibitor of apoptosis 
ICAM-2   Intercellular adhesion molecule 2 
IFB-1   Intermediate filament protein 1 
IL-3   Interleukin 3 
INF2   Inverted formin 2 
INL   Inner nuclear layer 
ISV    Intersegmental vessel 
LDA   Lateral dorsal aorta 
LexA-DBD  LexA DNA binding domain 
LexOP   LexA operon promoter 
LexPR   LexA progesterone receptor 
LFA-1   Lymphocyte function-associated protein 1 
LPM   Lateral plate mesoderm 
MAML  Mastermind-like 
MDCK  Madin-Darby canine kidney 
mDia1/2  Mammalian Diaphanous 1/2 
MMP   Matrix metalloprotease 
MT-MMP  Membrane-type matrix metalloprotease 
MLCK   Myosin light chain kinase 
mRFP-F  Farnesylated monomeric red fluorescent protein 
mRNA   Messenger ribonucleic acid 
NA   Numerical aperture 
Nck1/2  Tyrosine kinase adaptor proteins 1/2 
NF-κB   Nuclear factor kappa-light-chain-enhancer of activated B cells 
NHERF-1  Na+/H+-exchange regulatory factor 1 
nmMyosin IIA  Non-muscle myosin IIA 
NICD   Notch intracellular domain 
OIR   Oxygen-induced retinopathy 
p65-AD  p65 activation domain 
P(x)   Post-natal day (x) 
PAP   Pre-apical patch 
  18 
PCP   Planar cell polarity 
PCV   Posterior cardinal vein 
PDGF   Platelet-derived growth factor 
PDGFR  Platelet-derived growth factor receptor 
PH   Pleckstrin homology 
PHD   Prolyl-hydroxylase domain-containing enzyme 
Pi   Inorganic phosphate 
PKC   Protein kinase C 
pMLC2   Phospho-myosin light chain 2 
PIP2    Phosphatidylinositol (4,5)-biphosphate 
PIP3   Phosphatidylinositol (3,4,5)-trisphosphate 
PLC∂    Phospholipase C, ∂ isoform 
PKC    Protein kinase C 
PTEN   Phosphatase and tensin homolog 
pVHL   Von Hippel-Lindau tumor suppressor protein 
RBP-Jκ Recombination signal-binding protein for immunoglobulin-kappa 
J region 
RFP   Red fluorescent protein 
RhoGAP  Rho GTPase activating protein 
RIP   Receptor interacting protein 
RLC    Regulatory light chain 
ROCK   Rho-associated protein kinase 
(x)S   Somite (x) 
S1P   Sphingosine-1-phosphate 
S1PR   Sphingosine-1-phosphate receptor 
SCF   Stem cell factor 
SDF-1α  Stroma-derived factor 1α 
SH2   Src homology 2 
SHH   Sonic hedgehog 
siRNA   Silencing ribonucleic acid 
SIRT2   Sirtuin 2 
SIV   Sub-intestinal vein 
  19 
Slp2a/4a  Synaptotagmin-like protein 2a/4a 
SNX18  Sorting nexin 18 
SPIM   Single plan illumination microscopy 
TALEN  Transcription activator-like effector nuclease 
TGF-β   Transforming growth factor β 
TIAM1  T-cell lymphoma invasion and metastasis 1 
Tnnt2a   Troponin 2a 
TPA   12-O-tetradecanoyl-phorbol-13-acetate 
VE-Cadherin  Vascular endothelial cadherin 
VEGF   Vascular endothelial growth factor 
VEGFR  Vascular endothelial growth factor receptor 
vISV   Venous intersegmental vessel 
vSMC   Vascular smooth muscle cell 
WT    Wild-type 
ZO-1    Zona occludens 1 
 
Chapter 1 Introduction 
 20 
Chapter 1. Introduction 
 
1.1 The cardiovascular system: structure, development and 
associated diseases 
1.1.1 Organisation and function of the cardiovascular system 
The growth, survival and reproduction of living organisms rely on the delivery and 
recycling of metabolites to and from all cells in the body. Throughout evolution, as 
organisms grew in size and complexity, the simple diffusion of metabolites through cell 
membranes and multiple cell layers had to be complemented with the development of 
specialised transport and exchange structures. To this end, vertebrates expanded highly 
complex and hierarchised blood vascular systems (Monahan-Earley et al., 2013). 
Additionally to ensuring the delivery and recycling of respiratory gases and nutrients to 
all tissues in the body, these circuits developed as guardians of the organism’s global 
homeostasis by allowing, notably, temperature regulation, hormonal communication, 
and the circulation of immune factors and cells. 
 
From ancient Greece up until the 17th century, the cardiovascular system was thought to 
be comprised of two distinct networks of arteries and veins. It is in 1628, in his book 
Exercitatio Anatomica de Motu Cordis et Sanguinis in Animalibus, that William Harvey 
presented for the first time evidence to support the model of the circulatory system as 
we know it today (Figure 1.1). However, it was not until 1661, and the development of 
light microscopy, that capillaries, and thus the link between arteries and veins, was 
discovered by Marcello Malpighi. In further centuries, the development of animal 
models and advances in microscopy techniques allowed scientists to considerably 
increase their understanding of the formation and functioning of the cardiovascular 
system. 
 
The blood vascular system of vertebrates is organised in a closed network of collecting 
(veins and venules) and distributing (arteries and arterioles) vessels connected to a 
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central peristaltic pump known as the heart (Figure 1.1). In tissues, exchange of gases 
and metabolites takes place through networks of fine capillaries, whose organisation in 
parallel throughout the body guarantees adequate distribution of resources to all organs 
(Figure 1.1), in contrast to the perfusion of tissues in series in open circulatory systems 
such as those found in many invertebrate species (Monahan-Earley et al., 2013). 
 
The efficiency and adaptability of the vertebrates cardiovascular system lies in the 
structural specialisation and hierarchical organisation of the vessels within its network. 
Capillaries are made of a single layer of endothelial cells and are surrounded by a 
basement membrane and mesenchymal cells (pericytes) (Figure 1.2). By regulating their 
permeability at various levels through fenestration, opening of cell junctions, partial 
digestion of the basement membrane, and/or detachment from pericytes, they can 
locally adapt to the metabolic needs of the surrounding tissue. On the other hand, larger 
vessels such as arteries and veins, surrounded by multiple layers of connective tissue 
and vascular smooth muscle cells (vSMCs) (Figure 1.2), can cope with higher blood 
volumes and pressure levels and adapt their diameter to modulate flow between tissues. 
 
1.1.2 Blood vessel formation during embryonic development 
Because of its critical role in nutrient and oxygen delivery, the cardiovascular system is 
the first organ system to reach a functional state during embryonic development. In 
mouse embryos, a simple circulatory loop made of a heart, dorsal aorta, sinus venosus 
and yolk sac plexus is complete as early as embryonic day E8.0-E9.0 (Drake and 
Fleming, 2000, Walls et al., 2008). In humans, cardiac morphogenesis takes place from 
the third to the ninth week of gestation (Dhanantwari et al., 2009). Heartbeat can be 
recorded from four to five weeks of gestation. 
This primitive network of blood vessels, which ramifies into a plexus made of arteries, 
veins and a dense mesh of capillaries, forms through the migration and aggregation of 
mesoderm-derived progenitors called angioblasts. This process of de novo blood vessel 
formation is known as vasculogenesis (Figure 1.3). 
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Once established, this primitive plexus remodels and expands through a second 
mechanism of blood vessel formation known as angiogenesis. Angiogenesis refers to 
the formation of new blood vessels from pre-existing ones, and happens either through 
the sprouting, and later fusion, of vessel branches from a parent vessel (sprouting 
angiogenesis), or through the splitting of existing vessels (intussusceptive angiogenesis) 
(Figure 1.3). This second wave of blood vessel formation by angiogenesis leads to the 
formation of dense plexi of capillaries from which arteries and veins later segregate and 
mature to map a fully functional body vasculature. 
 
After birth, angiogenesis still contributes to organ growth, but reaching adulthood most 
endothelial cells become and remain quiescent. The average lifetime of quiescent 
endothelial cells varies between organs, ranging from a few months (in the liver and 
lungs) to several years (in the brain and muscle) (Alberts et al., 2002). However, 
endothelial cells keep their ability to respond to pro-angiogenic stimuli through 
proliferation and sprouting, allowing the formation of new blood vessels in case of, for 
example, physiological adaptations (e.g. physical training, obesity, menstrual cycle), or 
during wound healing following injury.  
 
1.1.3 Associated diseases and therapeutic perspectives 
Endothelial cell quiescence relies as much on intrinsic mechanisms as on a tight balance 
between pro- and anti-angiogenic signals present in the tissue microenvironment. Many 
diseases have been associated with defects in one or both of these parameters. A wide 
range of pathologies - the most prominent being cancer, but also included are ocular and 
inflammatory diseases, diabetes and multiple sclerosis - are associated with enhanced 
and abnormal angiogenesis. In the well-studied case of tumour angiogenesis, blood 
vessels organise themselves into a chaotic network with juxtaposition of highly and 
poorly vascularised regions. The architecture and functionality of the vessels are altered. 
Their diameter is uneven, their lumen often small or collapsed. Perfusion is poor and 
leakage into the microenvironment is common (Potente et al., 2011). On the other hand, 
pathologies such as ischemic heart disease, preeclampsia or neurodegeneration are 
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characterised by low angiogenic response to physiological pro-angiogenic stimuli, 
impairing re-vascularisation and healing (Carmeliet, 2005, Potente et al., 2011). 
 
While the past years have seen tremendous progress in the development and 
optimisation of pro- and anti-angiogenic drugs for use in clinics, the efficacy of these 
therapies is still limited and their effects not fully understood. In particular, it has 
become apparent that the control of vessel density alone is insufficient to normalise 
vasculatures in these pathologies, and that greater focus should be placed on the 
functionality of the affected vessels (Carmeliet, 2005, Potente et al., 2011). In light of 
these results, it appears crucial to develop our understanding of the basic cellular and 
molecular mechanisms regulating sprouting angiogenesis, with the aim of designing 
better therapies with greater impact for patients suffering from these diseases. 
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Figure 1.1. The vertebrates cardiovascular system 
The cardiovascular system of vertebrates is organised as a closed network of blood 
vessels with distributing vessels (arteries and arterioles) and collecting vessels (veins 
and venules) connected to a peristaltic pump, the heart. The separation of the heart 
allows the separation of deoxygenated and oxygenated blood. Deoxygenated blood is 
sent to the lungs, where gas exchange within a network of fine capillaries allows the 
capture of oxygen and release of carbon dioxide. Oxygenated blood comes back to the 
heart where it is propelled through arteries to all organs in the body. Gas exchange in 
tissues takes place in complex networks of fine capillaries.   
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Figure 1.2. Cross-sections of arteries, veins, and capillaries 
Arteries, veins and capillaries differ in function and structure. Arteries are surrounded 
by multiple layers of vascular smooth muscle cells (vSMCs) and connective tissue, 
while veins are only surrounded by a few layers of vSMCs and a thinner layer of 
connective tissue. Capillaries are only supported by a basement membrane and isolated 
pericytes. 
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Figure 1.3. Modes of blood vessel formation 
During embryonic development, a primary network of blood vessels forms through the 
aggregation of endothelial progenitors called angioblasts in a process known as 
vasculogenesis. New blood vessels then arise either through the sprouting of vascular 
branches from pre-existing vessels (sprouting angiogenesis), or through the splitting of 
blood vessels (intussusceptive angiogenesis). 
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1.2 Cellular and molecular mechanisms of sprouting angiogenesis 
Sprouting angiogenesis is a multi-step process resulting from the secretion of pro-
angiogenic factors by poorly oxygenated tissues. The binding of such factors to the 
surface of quiescent endothelial cells initiates a cascade of signalling events that lead to 
their reactivation and to the sprouting of new vascular branches. Through coordinated 
cell migration and proliferation, angiogenic sprouts elongate and eventually fuse to 
form new vascular loops, which later lumenise to allow perfusion (Figure 1.4). The 
maturation and specification of these new vessel connections lead to the expansion of 
functional vascular networks to allow the efficient delivery and recycling of metabolites 
to the tissues in need (Potente et al., 2011). 
The following paragraphs will present in detail the cellular and molecular mechanisms 
driving and regulating the different steps of the angiogenic process, from the secretion 
of pro-angiogenic factors to the maturation and remodelling of the newly formed 
network. 
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Figure 1.4. Sprouting angiogenesis: overview of a multistep process 
Adapted from (Potente et al., 2011).   
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1.2.1 Hypoxia and secretion of pro-angiogenic factors 
Physiologically, sprouting angiogenesis is a response of the endothelium in tissues 
experiencing poor oxygenation (hypoxia), whether because of higher demands or lower 
supplies in oxygen. At the cellular level, responses to low levels of oxygen are mediated 
by hypoxia-inducible factors (HIFs), highly conserved transcription factors that control 
the expression of numerous cell cycle, differentiation, metabolic and pro-angiogenic 
genes (Krock et al., 2011, Greer et al., 2012). HIFs are comprised of two subunits, an 
oxygen-labile α subunit and an ubiquitously-expressed β subunit (Figure 1.5). At 
normal levels of oxygen (normoxia), HIFα is hydroxylated on two proline residues by 
prolyl-hydroxylase domain-containing enzymes (PHDs) (Epstein et al., 2001, Ivan et al., 
2001, Jaakkola et al., 2001, Masson et al., 2001). When hydroxylated, HIFα is 
recognised by the von Hippel-Lindau tumour suppressor protein (pVHL), ubiquitylated 
by the pVHL E3 ubiquitin ligase complex, and targeted for degradation by the 26S 
proteasome (Maxwell et al., 1999, Ohh et al., 2000). PHDs require oxygen for their 
catalytic activity. In the case of sub-optimal levels of oxygen (hypoxia), hydroxylation, 
and therefore degradation, of HIFα is abrogated. HIFα can therefore translocate to the 
nucleus, where it dimerises and binds to the HIFβ subunit. Together, HIFα/β bind to 
hypoxia-response elements (HREs) in the promoters of HIF-responsive genes, where 
they interact with the transcriptional co-activator p300/Creb-binding protein (CBP) to 
drive the transcription of a specific subset of genes (Arany et al., 1996, Wenger et al., 
2005) (Figure 1.5). Among these are a host of pro-angiogenic genes, including but not 
limited to, vascular endothelial growth factor (VEGF), angiopoietin 1 (Ang-1), 
angiopoietin 2 (Ang-2), Tie2, platelet-derived growth factor (PDGF) and basic 
fibroblast growth factor (bFGF) (Krock et al., 2011), making HIF a central regulator of 
angiogenesis in developing as well as diseased tissues. Following their secretion, pro-
angiogenic factors diffuse through and bind to the extracellular matrix, generating a 
gradient of growth signals directly available for binding to their specific receptors at the 
surface of endothelial cells. 
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Figure 1.5. Molecular regulation of pro-angiogenic factors secretion under hypoxia 
Under normoxia, the alpha subunit of HIF (α) is hydroxylated by PHDs, 
polyubiquitylated by the pVHL E3 ligase complex, and degraded through the 26S 
proteasome. Under hypoxia, α translocates to the nucleus where it associates to the beta 
subunit of HIF (β) and binds to hypoxia-response elements (HREs) to drive the 
expression of pro-angiogenic factors. 
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1.2.2 Exit from quiescence 
The first step towards the exit from quiescence and subsequent sprouting of endothelial 
cells is the breakdown of the physical barriers present at their basal side, that is the layer 
of supporting pericytes and their secreted basal membrane (Figure 1.4). Detachment of 
pericytes is mediated through concomitant activation of VEGF signalling and binding 
of Ang-2 to the Tie-2 receptor at the surface of endothelial cells (Augustin et al., 2009). 
The degradation of the endothelial cell basement membrane, made of an array of 
collagen IV fibres, laminin, heparin-sulfated proteoglycans and entactin (Kalluri, 2003), 
is mediated by a subset of proteolytic enzymes called matrix metalloproteases (MMPs). 
Both VEGF and bFGF, but also other pro-angiogenic factors at various levels, greatly 
increase the expression, activation and secretion of MMP-2, MMP-9 and membrane 
type (MT)-MMP-1 in endothelial cells (Ghajar et al., 2008). Released in the 
extracellular matrix, these enzymes cleave the components of the endothelial basement 
membrane, removing the physical barrier to sprouting but also exposing cryptic binding 
sites that further regulate sprouting, and promoting the release of additional growth 
factors sequestered in the matrix (Arroyo and Iruela-Arispe, 2010). 
 
1.2.3 Tip and stalk cell selection 
1.2.3.1 Cellular behaviours within angiogenic sprouts 
Following the binding of pro-angiogenic factors to their respective receptors, single 
endothelial cells sprout from the parent vessel and lead the growth of multicellular 
vascular branches into the hypoxic tissue (Figure 1.4). Endothelial cells show different 
phenotypes and behaviours depending on their position along the sprouts. Cells at the 
tip, referred to as ‘tip cells’, extend long and numerous filopodia indicative of a 
migratory behaviour. In contrast, trailing cells, defined as ‘stalk cells’, show shorter and 
fewer membrane protrusions and higher proliferation rates. This dichotomy led to 
suggest a model where tip cells guide the sprout by sensing and migrating towards pro-
angiogenic cues, while stalk cells support the growth of the sprout through cell 
proliferation (Gerhardt et al., 2003). Recent work using live imaging of endothelial cell 
behaviour in three-dimensional in vitro angiogenic assays and in zebrafish embryos 
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showed that endothelial cells regularly switch between tip and stalk cell phenotypes, 
leading to constant swapping of cells within the sprout and competition for the tip 
position (Jakobsson et al., 2010, Pelton et al., 2014). 
 
1.2.3.2 Molecular regulation of endothelial cell specification 
The acquisition of a ‘tip’ or ‘stalk’ phenotype by endothelial cells is dependent on the 
levels of VEGF and Notch signalling within individual cells as well as within their 
immediate neighbours. 
 
Upon binding of VEGF-A, VEGFR-2 receptors expressed at the surface of endothelial 
cells form homo- as well as heterodimers with other VEGFRs, leading to the activation 
of their tyrosine kinase domains and their autophosphorylation. Phosphorylated 
VEGFRs then recruit Src homology 2 (SH2) domain-containing adaptors and kinases, 
inducing the activation of multiple downstream signalling pathways and transcription 
programmes regulating cell proliferation, migration and specification towards a tip cell 
phenotype (Olsson et al., 2006). 
 
Among the genes whose expression is activated upon VEGF-A stimulation, Delta-like 
ligand 4 (Dll4) has been identified as a master regulator of the acquisition of the tip cell 
phenotype by endothelial cells (Hellstrom et al., 2007, Phng and Gerhardt, 2009). Dll4 
is a transmembrane protein and the main ligand for the Notch1 receptor in endothelial 
cells (Hofmann and Iruela-Arispe, 2007). The binding of Dll4 to the extracellular 
domain of Notch1 at the surface of apposing cells triggers a series of proteolytic 
cleavages of the receptor by multiple enzymes, including ADAM metalloproteases and 
γ-secretase complexes, leading to the release in the cytoplasm of the Notch intracellular 
domain (NICD) and its translocation to the nucleus (Figure 1.6). In the absence of 
NICD, the recombination signal-binding protein for immunoglobulin-kappa J region 
(RBP-Jκ) represses the expression of Notch target genes through the recruitment of co-
repressor complexes (CoR) and histone deacetylases (HDAc) to their promoter regions. 
Upon its translocation to the nucleus, NICD displaces these co-repressors from RBP-Jκ, 
and recruits co-activators such as Mastermind-like (MAML) proteins and histone 
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acetyltransferases (p300/CBP) to form a transcriptional activator complex (Borggrefe 
and Oswald, 2009) (Figure 1.6). Notch direct and indirect target genes in endothelial 
cells are numerous; Notch direct targets include genes coding for Hairy/enhancer of 
split (Hes) and Hes-related proteins (Hey/HRT/HERP), themselves transcriptional 
repressors of further downstream genes. Importantly, the transcriptional programme 
thus activated leads to a suppression of the tip cell phenotype and the activation of 
signalling pathways specific to stalk cells (Phng and Gerhardt, 2009). 
 
A ‘salt-and-pepper’ distribution of tip and stalk cells arises along activated blood 
vessels following small stochastic differences in the levels of VEGF signalling, and 
therefore of Dll4 expression, between individual cells. Endothelial cells expressing 
higher levels of the Dll4 ligand will become tip cells, and repress this same phenotype 
in their neighbouring cells, which will adopt stalk cell characteristics. This phenomenon 
is known as lateral inhibition (Phng and Gerhardt, 2009). Multiple layers of regulation 
add complexity to the model presented here, and form the basis for the dynamic 
regulation of tip and stalk phenotypes during sprouting. Notably, VEGF and Notch 
signalling have been shown to regulate the expression of their own as well as respective 
components, reinforcing the differences established between neighbouring cells in a 
positive feedback loop mechanism (Figure 1.7). Briefly, the activation of Notch 
signalling, additionally to inducing the expression of stalk cell-related genes, down-
regulates the expression of VEGFR-2, therefore inhibiting the acquisition of a tip cell 
phenotype in the same cell. Notch also induces the expression of the decoy receptor 
VEGFR-1, which possesses high affinity for VEGF-A but lacks kinase activity, 
therefore titrating VEGF-A away from VEGFR-2 (Figure 1.7). These mechanisms, 
together with additional regulatory pathways acting at various levels of the 
VEGF/Notch signalling cascades (Phng and Gerhardt, 2009), ensure the control of tip 
and stalk cell distribution and the coordinated elongation of multiple sprouts along the 
activated vessels (Figure 1.4).   
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Figure 1.6. Notch signalling pathway 
Binding of Dll4 to its Notch receptor on a neighbouring cell triggers a series of 
proteolytic cleavages leading to the release of the Notch intracellular domain (NICD) in 
the cytoplasm of the signal-receiving cell. NICD translocates to the nucleus where it 
binds to RBP-Jκ, displacing co-repressors (CoR) and histone deacetylases (HDAc) and 
recruiting transcriptional co-activators (MAML, p300/CBP), ultimately inducing the 
expression of the transcription factors Hes and Hey. These factors then regulate the 
expression of genes associated with the stalk cell phenotype. 
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Figure 1.7. VEGF/Notch signalling positive feedback loop 
Upon VEGF signalling, Dll4 expression is up-regulated. Dll4 binds to Notch on 
neighbouring cells, stimulating in the signal-receiving cell the expression of the decoy 
receptor VEGFR-1, and down-regulating the expression of VEGFR-2, therefore 
limiting VEGF signalling and expression of Dll4 in the signal-receiving/stalk cell.  
Adapted from (Phng and Gerhardt, 2009). 
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1.2.4 Anastomosis and lumen formation 
Following the specification of multiple tip cells along their length, several sprouts 
emerge from activated vessels and grow towards the same source of pro-angiogenic 
molecules by means of cell migration and proliferation. Eventually, tip cells from 
neighbouring sprouts meet and establish cell-cell contacts, to finally undergo a process 
of vessel fusion defined as anastomosis (Figures 1.4 and 1.8). 
Studies using live imaging of blood vessel fusion in zebrafish embryos (Blum et al., 
2008, Herwig et al., 2011, Lenard et al., 2013) showed that anastomosis relies both on 
the formation and elongation of cell contacts between anastomosing cells, and on the 
expansion of apical membrane (i.e. lining the lumen) domains to obtain a fully 
lumenised connection. Briefly, upon the formation of small contacts identifiable as 
discrete spots of junctional complexes between their respective filopodia (Figure 1.8), 
tip cells from neighbouring sprouts establish stable cell junctions, which then elongate 
while cells migrate over each other. Concomitantly, lumen forms de novo at the new 
junction, while lumens invaginate from the stalk of both sprouts into the tip cells. 
Eventually, all luminal compartments connect to form a vascular tube connected to the 
main circulation. Further cell rearrangements within the newly formed connection 
finally participate in its stabilisation as a multicellular tubular structure (Figure 1.8).  
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Figure 1.8. Sequence of cellular events leading to anastomosis 
Adapted from (Herwig et al., 2011) and (Lenard et al., 2013). 
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1.2.5 Vessel maturation 
Following anastomosis and lumen formation, newly formed vessels rapidly mature into 
perfused functional segments. Mirroring the mechanisms of endothelial cell activation 
at the onset of the angiogenic process, maturation of new vascular connections involves 
the deposition of extracellular matrix and recruitment of perivascular cells (Figure 1.4). 
The deposition of extracellular matrix is crucial to provide the attachment and stiffness 
required for endothelial cells to cope with the establishment of blood circulation and the 
resulting mechanical stresses involved. On the other hand, the matrix also provides a 
plethora of signalling cues essential to maintain endothelial cell homeostasis, regulating, 
for example, proliferation and entry into or exit from quiescence (Jain, 2003, Potente et 
al., 2011). 
Perivascular cells surround endothelial cells and, similarly to the extracellular matrix, 
fulfil both structural and signalling functions. Pericytes coat the surface of capillaries 
and immature vessels, while vSMCs support arteries and veins (Figure 1.2). The 
differentiation and recruitment of mural cells rely on multiple signals originating from 
endothelial cells. The proliferation, differentiation and recruitment of pericytes require 
signalling through the PDGFB-PDGF receptor (PDGFR)-β pathway. Secretion of 
transforming growth factor (TGF)-β by endothelial cells has, on the other hand, been 
shown to promote vSMC differentiation and function and, as a consequence, their 
attachment to endothelial cells (Pardali et al., 2010). Finally, sphingosine-1-phosphate 
(S1P) and Ang-1 have been reported as two ligands whose secretion by endothelial cells 
and signalling to their respective receptors, S1P receptors (S1PRs) and Tie2, promote 
mural cell adhesion (Gaengel et al., 2009, Potente et al., 2011). 
 
1.2.6 Arterial-venous specification 
A critical step in making or expanding functional vascular networks is the specification 
and remodelling of the newly formed vessels into arteries and veins. While arteries 
transport oxygenated blood under high pressure, supported by multiple layers of 
contractile vSMCs, veins, on the other hand, carry blood under low pressure with the 
help of specialised valve structures. Although the specification of immature vessels into 
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arteries and veins was first thought to be determined by the differences in 
haemodynamics experienced by vessels depending on their position in the network, 
many studies since showed that arterial and venous identities can be found even prior to 
blood perfusion, and identified many regulatory pathways controlling this process 
(Swift and Weinstein, 2009, Potente et al., 2011). 
The first genes discovered to be differentially expressed in arteries and veins were the 
genes coding for the transmembrane protein ephrinB2 and its receptor EphB4, 
respectively (Wang et al., 1998). The complementary expression of ephrinB2 and 
EphB4 in arterial and venous endothelium is required for the proper remodelling of 
vascular networks but also for the maintenance of arterial and venous identities later 
during development (Swift and Weinstein, 2009). 
Additionally to its role in tip and stalk cell selection at the onset of sprouting, Notch 
was also identified as a major regulator of arterial-venous specification, functioning 
cell-autonomously to repress the venous fate, downstream of VEGF, itself downstream 
of sonic hedgehog (SHH) signalling (Swift and Weinstein, 2009). 
While these pathways repress venous fate and promote arterial fate acquisition, chicken 
ovalbumin upstream promoter-transcription factor II (COUP-TFII) was identified as an 
inducer of venous specification (You et al., 2005). 
Interestingly, graft experiments performed in chick embryos revealed that the identity of 
single vessels within the network remains plastic, and that arterial and venous identities 
can even be reversed (Moyon et al., 2001, Othman-Hassan et al., 2001). This also 
proved true in cases of experimental modification of blood flow patterns, additionally 
suggesting that blood flow itself is a regulator of arterial-venous specification (le Noble 
et al., 2004). 
 
1.2.7 Vascular remodelling 
Once established, vascular networks constantly remodel to adapt to local changes in 
metabolic needs and/or haemodynamics. Indeed, both low concentrations of VEGF 
(Hlushchuk et al., 2011) and local loss of perfusion (Chen et al., 2012) have been shown 
to trigger regression (also referred to as pruning) of vascular segments. 
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Two major mechanisms of vessel regression have been described to date. In the cases of 
the pupillary membrane and the hyaloid vessels, two transient vascular networks of the 
eye, vessel segments regress via apoptosis of the endothelial cells making the regressing 
segment (Meeson et al., 1999, Lobov et al., 2005). By contrast, endothelial cells in 
regressing vessels of the developing rat and mouse retinas do not undergo apoptosis 
(Hughes and Chang-Ling, 2000, Franco et al., 2015). Live imaging of regressing vessels 
in the brain, trunk and sub-intestinal vein (SIV) plexus of zebrafish embryos showed 
that vessels regress instead through the coordinated migration of endothelial cells away 
from the pruning vessel into the neighbouring branches they are connected to (Chen et 
al., 2012, Franco et al., 2015, Lenard et al., 2015). Interestingly, vascular pruning 
through endothelial cell migration follows the same steps than anastomosis (Figure 1.8) 
but in reverse order: junctions rearrange and cells slide away from each other, giving 
rise to unicellular vessel segments; lumen collapses, generating isolated lumen 
fragments; and finally, cells lose connections and the vessel segment breaks, while 
endothelial cells migrate into the neighbouring vessels (Franco et al., 2015, Lenard et al., 
2015). The signalling pathways regulating this process are only starting to be uncovered. 
In an oxygen-induced retinopathy (OIR) model of pathological angiogenesis, 
Notch/Dll4 signalling was found to promote vessel regression through the up-regulation 
of the expression of the vasoconstrictor angiotensinogen and down-regulation of the 
expression of the vasodilator adrenomedullin (Lobov et al., 2011). Interestingly, this 
study and others (Kochhan et al., 2013, Franco et al., 2015) establish a correlation 
between low perfusion and sites of regression in different vascular beds and organisms, 
suggesting the existence of robust feedback mechanisms between blood flow dynamics 
and endothelial cell behaviour at the level of single capillaries. 
 
1.2.8 Concluding remarks 
The past decades have seen tremendous advances in our understanding of the cellular 
and molecular mechanisms driving sprouting angiogenesis. The most recent 
investigations, taking advantage of time-lapse imaging of sprouting endothelial cells, 
and local and inducible genetic, chemical and mechanical manipulations, have revealed 
an extreme plasticity and adaptability of endothelial cells to varying microenvironments. 
Chapter 1 Introduction 
 41 
Basic questions however remain unanswered. The nature of the mechanisms driving 
lumen formation during sprouting angiogenesis in vivo is, for example, still subject to 
debate, and will be the focus of the present work. 
 
1.3 Working models for the study of vascular lumen formation 
Multiple models have been developed and tested over the years to allow the study of the 
cellular and molecular mechanisms that regulate blood vessel formation during both 
development and disease. The following paragraphs will focus on some of the in vitro 
and in vivo models of vasculogenesis and angiogenesis currently used in the field and 
particularly relevant for the study of lumen formation. 
 
1.3.1 In vitro models 
The complexity of the cellular behaviours observed during blood vessel formation in 
vivo called for the development of simplified yet truthful in vitro models of endothelial 
cell self-assembly and sprouting. Although many endothelial cell behaviours can be 
recapitulated and studied in 2D culture assays, the arrangement of endothelial cells into 
complex three-dimensional structures proved crucial to allow the study of 
morphogenetic events such as lumen formation, and therefore led to the development of 
3D culture assays where endothelial cells are allowed to form capillary networks within 
3D matrices. 
 
The laboratory of George Davis at the University of Missouri (USA) pioneered the use 
of such assays and developed over the years standardised protocols for generating 
lumenised capillary networks in vitro (Davis and Camarillo, 1996, Koh et al., 2008b, 
Davis et al., 2013). Briefly, endothelial cells self-assembly into vascular networks is 
obtained by including human umbilical vein endothelial cells (HUVECs) at a density of 
2.106 cells/mL in 3D matrices made exclusively of type I collagen at a final 
concentration of 3.75 mg/mL. After polymerisation of the matrix, cells are treated with 
standard culture medium supplemented with VEGF-165, FGF-2, ascorbic acid and 12-
O-tetradecanoyl-phorbol-13-acetate (TPA) (Table 1.1). Under these conditions, 
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endothelial cells self-assemble into cords and lumenise within 72 hours (Figure 1.9). 
While this assay recapitulates the morphogenetic events observed during vasculogenesis, 
a similar assay was developed to follow angiogenic sprouting, by seeding HUVECs on 
top of the polymerised collagen gel instead of including them into the gel prior to 
polymerisation. Using the same medium composition as previously described and the 
same matrix supplemented with sphingosine-1-phosphate (S1P) and stromal-derived 
factor-1α (SDF-1α) (Table 1.1), cells can be seen invading the underlying matrix, 
organising themselves into sprouts resembling closely the angiogenic sprouts observed 
in vivo (Koh et al., 2008b, Davis et al., 2013). 
In an effort to guarantee reproducible and truthful results, these assays have recently 
been modified to allow formation of capillary networks in serum-free and TPA-free 
conditions. Collagen gels are instead supplemented with FGF-2 and the hematopoietic 
stem cell cytokines SDF-1α, stem cell factor (SCF) and interleukin-3 (IL-3) (Stratman 
et al., 2011, Davis et al., 2013). 
 
While these assays have been used for most of the in vitro studies that will be 
mentioned later in this introduction, many laboratories developed similar protocols 
using endothelial cells from different species or vascular beds, and matrices of varying 
composition (Morin and Tranquillo, 2013). More complex systems also include co-
culture with pericytes (Stratman et al., 2009, Waters et al., 2013, Bowers et al., 2015, 
Kim et al., 2015), and recent development of microfluidic devices now allows perfusion 
of lumenised vessels in vitro (Zheng et al., 2012, Moya et al., 2013, Bichsel et al., 2015, 
Wang et al., 2016). 
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 Collagen Medium 
   
Medium M199 M199 
Collagen type I 3.75 mg/mL - 
Fetal calf serum (FCS) - 20 % 
Bovine brain extract - 400 µg/mL 
Bovine serum albumin (BSA) - 0.5 mg/mL 
Sodium selenite - 5 ng/mL 
Human insulin - 5 ng/mL 
Human holo-transferrin - 5 ng/mL 
Oleic acid - 4.28 µg/mL 
VEGF-165 - 40 ng/mL 
FGF-2 - 40 ng/mL 
TPA - 50 ng/mL 
   
       - Added for sprouting assay   
SDF-1α 200 ng/mL - 
S1P 1 µM - 
   
      - Added for serum-free/TPA-free assays   
SDF-1α 200 ng/mL - 
SCF 200 ng/mL - 
IL-3 200 ng/mL - 
FGF-2 200 ng/mL - 
 
Table 1.1. Composition of collagen gels and media used for in vitro models of 
vasculogenesis and sprouting angiogenesis 
According to (Koh et al., 2008b) and (Davis et al., 2013). 
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Figure 1.9. In vitro models of vasculogenesis and sprouting angiogenesis, as 
developed by Davis and colleagues 
In both assays, endothelial cells are plated into (vasculogenesis) or on top 
(angiogenesis) of type I collagen gels. After 72h of culture, endothelial cells self-
assemble into vascular cords, sprout, and lumenise. 
Adapted from (Koh et al., 2008b). 
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1.3.2 In vivo models 
1.3.2.1 Mouse retina 
One of the most widely used model of sprouting angiogenesis in vivo is the 
development of the primary inner plexus of the mouse retina (Fruttiger, 2007). This 
vascular network, which starts developing around mid-gestation in humans and around 
birth in mice, supplies oxygen and nutrients to the inner portion of the retina. Initially, 
the inner part of the eye is supported by the hyaloid vasculature, a network of arteries 
running from the optic nerve through the vitreous, and exiting through an annular 
collection vessel at the front of the eye (Figure 1.10). Around birth, the hyaloid 
vasculature regresses to be replaced by a vascular plexus growing from the optic nerve 
below the surface of the retinal tissue. This primary plexus grows radially, from the 
optic nerve to the periphery of the retina (Figures 1.10 and 1.11), during the first eight 
days of life in mice, and do so by sprouting angiogenesis following gradients of VEGF 
secreted by immature retinal astrocytes. While new sprouts arise and connect at the 
periphery of the plexus, the more central regions mature and organise themselves into 
networks of arteries, veins and capillaries (Figure 1.11). About one week after birth, a 
second wave of sprouting from veins, venules and capillaries in venous regions leads to 
the formation of the deeper plexus of the retina, starting from the centre of the retina 
and expanding towards its periphery. Vascular sprouts grow towards the inner nuclear 
layer (INL) of the retina, and change direction sideways at both its upper and lower 
limits to lead to the formation of two additional networks, parallel to the primary 
network present at the surface of the retina (Figure 1.10). 
 
The formation and maturation of the primary plexus of the mouse retina established 
itself as a robust model for the study of sprouting angiogenesis. This model first offers 
many technical advantages: it benefits from the powerful genetic tools available in 
mice; it is one of the few vasculatures developing after birth; and its development 
within one single plane at the surface of the tissue allows easy access and bears 
potential for high resolution imaging because of the limited working distance (Figure 
1.11). Most of all, from a biological point of view, the primary plexus offers the 
possibility to observe endothelial cells at different stages of the angiogenic process. At 
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post-natal day 6 (P6), endothelial cells present along the periphery of the growing 
plexus can be found undergoing, in an asynchronous manner, tip/stalk selection, 
anastomosis, or lumen formation. Concomitantly, vessels in the most central part of the 
retina undergo regression and remodel into veins and arteries (Figure 1.11). 
 
Finally, the mouse retina vasculature also offers the possibility to study pathological 
vessel growth, or neovascularisation, a common feature of blinding eye diseases such as 
diabetic retinopathy and age-related macular degeneration. A model for oxygen-induced 
retinopathy (OIR) has been developed, where mouse pups are maintained in hyperoxia 
chambers then returned to room air, leading to the formation of tuft-like structures made 
of highly tortuous and leaky vessels that resemble the structures found in human 
pathologies (Scott and Fruttiger, 2010).  
 
 
 
 
 
 
 
 
Figure 1.10. Post-natal development of the mouse retina vasculature 
Before birth, blood is supplied to the eye through hyaloid arteries originating from the 
optic nerve and drained into collecting veins (choroidal net). At birth, hyaloid vessels 
regress to be replaced by a primary inner plexus, which expands into the deeper layers 
of the retina to form the deeper plexus about a week after a birth. 
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Figure 1.11. The development of the mouse retina primary inner plexus: a model 
for high resolution imaging of sprouting angiogenesis 
Harvested at P6, mouse retinas allow the imaging of endothelial cells at all stages of the 
angiogenic process. The growth of the plexus at the surface of the tissue allows high 
resolution imaging of single endothelial cells (C). Blood vessels in A and B are 
immunostained with isolectin GS-IB4. A single endothelial cell expressing membrane-
bound GFP is shown in C.   
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1.3.2.2 Zebrafish 
Although the mouse retina model allowed the identification and in-depth 
characterisation of the key morphogenetic events and some of the major signalling 
pathways regulating sprouting angiogenesis, the plasticity and dynamics of endothelial 
cells called for the development of new models allowing live imaging of their behaviour 
in vivo. In particular, as blood flow quickly appeared as a major regulator of endothelial 
cell biology, the study of live organisms where blood flow is maintained and can be 
monitored became necessary. 
 
The zebrafish (Danio rerio), a small tropical freshwater fish, established itself as a 
model of choice for such studies. Zebrafish is a popular model organism in the field of 
developmental biology due to its small size, short life cycle, and large clutch size. Many 
genetic tools are now available to generate transgenic reporter and mutant lines. Most 
importantly, zebrafish embryos bear the advantage of remaining transparent until 2 days 
post-fertilisation (dpf), allowing non-invasive intra-vital imaging of early vertebrate 
development. 
While the injection of tracers into the circulation of zebrafish embryos allowed the 
detailed description of its vasculature at different stages of development (Isogai et al., 
2001), a major advance in the use of zebrafish as a model for blood vessel development 
was the engineering of transgenic lines expressing fluorescent proteins exclusively in 
endothelial cells. Generated through random integration into the genome of the coding 
DNA sequence (CDS) of standard fluorophores under the control of the promoter 
regions of endothelial-specific genes, such as fli1 or flk1/vegfr2, these lines allowed the 
tracking of endothelial cells and the time-lapse imaging of blood vessel formation in 
developing embryos (Lawson and Weinstein, 2002, Jin et al., 2005). 
 
Vascular development in zebrafish starts around 12-14 hours post-fertlisation (hpf) 
(Lawson and Weinstein, 2002, Jin et al., 2005, Herbert et al., 2009, Ellertsdottir et al., 
2010). Angioblasts start migrating from the lateral plate mesoderm (LPM) on both sides 
of the embryo towards the trunk midline where they coalesce to form one single 
vascular cord by 19.5 hpf. Establishment of cell junctions between angioblasts and 
subsequent lumenisation leads to the formation of the first primordial vessel, the dorsal 
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aorta (DA), by 22 hpf. Between 21 and 23 hpf, a subset of venous-fated cells sprout 
ventrally from the dorsal aorta to form the posterior cardinal vein (PCV) by 24 hpf 
(Herbert et al., 2009). These events lead to the formation of a simple circulatory loop, 
where blood starts flowing as early as 24-26 hpf. From the heart, blood leaves through 
the bulbus arteriosus and the ventral aorta to the right and left mandibular aortic arches, 
which empty into the lateral dorsal aortas (LDAs). LDAs then merge in the cranial 
trunk to form the DA. In the tail region, the DA and PCV connect as caudal artery (CA) 
and vein (CV). At this stage, the CV is an intricate mesh of vessels that merge in the 
trunk into the PCV. In the cranial trunk, the PCV splits into a pair of vessels that each 
empties across the yolk in the duct of Cuvier, which then connects to the sinus venosus 
of the heart (Figure 1.12). 
 
From this first circulatory loop, multiple vascular plexi develop through sprouting 
angiogenesis and have been used to study various stages of the angiogenic process in 
vivo. The most studied network is the trunk vasculature (Figure 1.12), which starts 
developing around 20-23 hpf (Childs et al., 2002, Isogai et al., 2003). While venous-
fated cells in the dorsal aorta migrate ventrally to participate in the formation of the 
PCV, arterial-fated cells later sprout dorsally to form the intersegmental vessels (ISVs). 
ISVs sprout from the DA on both sides of the embryo, growing as paired vessels at 
regular intervals between somites. Passing the notochord and neural tube, ISVs connect 
to their anterior and posterior counterparts on the same side of the embryo through 
anastomosis to form the dorsal longitudinal anastomotic vessels (DLAVs) (Figure 1.13). 
By 40 hpf, this primary network of ISVs and DLAVs is fully lumenised and perfused 
(Figure 1.12). Concomitantly to DLAV formation, a secondary set of angiogenic 
sprouts arises at 32 hpf from the dorsal side of the PCV and migrates towards the 
horizontal myoseptum, where sprouts either connect to ISVs or specify as parachordal 
lymphangioblasts that will later take part in the lymphatic vasculature. As connections 
between ISVs and secondary sprouts stabilise and lumenise, the connections of these 
ISVs with the dorsal aorta regress, leading to a remodelling of the ISV network into 
arterial ISVs (aISVs) and venous ISVs (vISVs) (Isogai et al., 2003) (Figure 1.13). 
Although DLAVs remain as two paired vessels in the cranial regions, many anastomotic 
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vessels form between the right and left vessels in the most posterior region of the 
embryo (Isogai et al., 2001). 
The formation of the primary network of ISVs quickly became a model of choice for 
the study of sprouting angiogenesis in vivo. In particular, reproducibility from embryo 
to embryo, as well as the fact that multiple sprouts undergo the same morphogenetic 
events along the trunk of one same embryo, made it suitable for reverse genetic studies 
aimed at identifying regulators of sprouting angiogenesis in vivo. The growth of the 
ISVs close to the surface of the embryo, and within a relatively thin volume (about 50 
µm in depth), also offered advantageous conditions for imaging. Tracing of single 
endothelial cells during ISV and DLAV formation allowed fine analysis of processes 
such as cell migration, cell proliferation, cell rearrangements and lumen formation 
during sprouting angiogenesis in vivo (Childs et al., 2002, Kamei et al., 2006, Blum et 
al., 2008, Wang et al., 2010, Herwig et al., 2011, Phng et al., 2013, Sauteur et al., 2014, 
Aydogan et al., 2015, Phng et al., 2015, Yu et al., 2015). 
 
Although the trunk vasculature has become the model of reference for the study of 
endothelial cell sprouting, other vascular plexi developing in early zebrafish embryos 
have allowed to follow various steps of the angiogenic process in vivo. The brain 
vasculature is, for example, another plexus that develops through a highly stereotypical 
sequence of morphogenetic events, with multiple vessel connections forming and 
pruning while the vasculature settles into its final pattern (Figure 1.12). Imaging of the 
brain vasculature has proved particularly suitable for the study of anastomosis (Lenard 
et al., 2013) and vessel remodelling (Chen et al., 2012, Kochhan et al., 2013). More 
recently, detailed description of the remodelling of the sub-intestinal vein plexus (SIV) 
identified it as a model for the study of vascular pruning (Lenard et al., 2015). 
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Figure 1.12. Anatomy of the zebrafish vasculature at 1.5 and 2.5 dpf 
The vasculature of 1.5 (A) and 2.5 (B) dpf zebrafish embryos was imaged by confocal 
microangiography. Pictures are from The Interactive Atlas of Zebrafish Vascular 
Anatomy (Isogai et al., 2001). AA, aortic arch; ACV, anterior cardinal vein; CA, caudal 
artery; CCV, common cardinal vein; CtA, central artery; CV, caudal vein; DA, dorsal 
aorta; DLAV, dorsal longitudinal anastomotic vessel; DLV, dorsal longitudinal vein; H, 
heart; IOC, inner optic vesicle; MCeV, middle cerebral vein; MsV, mesencephalic vein; 
NCA, nasal ciliary artery; LDA, lateral dorsal aorta; MtA, metencephalic artery; PCeV, 
posterior cerebral vein; PCV, posterior cardinal vein; PHBC, primordial hindbrain 
channel; PHS, primary head sinus; PMBC, primordial midbrain channel; PPrA, 
primitive prosencephalic artery; PrA, prosencephalic artery; Se, intersegmental vessel; 
SIV, subintestinal vein; VA, ventral aorta. 
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Figure 1.13. Formation of the trunk vasculature in the zebrafish embryo 
The sprouting of endothelial cells from the dorsal aorta (DA) leads to the formation of a 
primary network of intersegmental vessels (ISVs). Secondary sprouts growing from the 
posterior cardinal vein (PCV) either connect to ISVs to form venous ISVs after 
regression of the connection to the DA, or specify into parachordal lymphangioblasts to 
later take part into the lymphatic vasculature. 
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1.4 Lumen formation during vascular development 
The opening of a lumen is an essential step in the formation of epithelial tubes, and has 
been the focus of many studies both in vitro and in vivo. In the following paragraphs, I 
will present the general principles and main mechanisms of lumen formation identified 
to date in epithelial tissues, illustrated by key examples in both invertebrate and 
vertebrate species, to finally give a detailed review of the literature on lumen formation 
in blood vessels. 
 
1.4.1 General principles of apical-basal polarity establishment and lumen 
formation in epithelial tissues 
Biological tubes are found in organs with exchange and/or transport functions, and are 
made of one or several layers of highly polarised epithelial cells lining a central lumen. 
Epithelial cells have two distinct membrane domains: an apical domain facing the 
lumen, and a basal domain in contact with the extracellular matrix (ECM) and 
underlying cell layers. Both domains are separated by cellular junctions − tight and 
adherens junctions in vertebrates, septate junctions in invertebrates – which prevent the 
mixing of the lipid and protein components specific to each domain, and control the 
overall permeability of the epithelial barrier. Apical-basal polarity is essential for the 
function of the epithelium. The segregation of specific lipids and proteins between the 
two domains allows directed and controlled transport of molecules between the apical 
and basal sides of the cells. 
The coordinated acquisition of apical-basal polarity within groups of cells is necessary 
for the opening of a lumen during the formation of epithelial tissues. Mechanisms 
driving apical-basal polarity establishment and lumen formation are diverse. Careful 
analysis and review of these mechanisms in various models of epithelial morphogenesis 
led to their classification in the following categories: wrapping and budding, where 
epithelial sheets deform to give rise to epithelial tubes; cavitation, where cells present at 
the center of a cord die by apoptosis to leave an empty space behind; cord hollowing, 
driven by the separation of apposing membranes at cell junctions; cell hollowing, with 
the generation and fusion of large vacuoles within single cells; and finally, membrane 
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invagination, where lumen expands through the invagination of plasma membrane 
within single cells (Lubarsky and Krasnow, 2003, Sigurbjornsdottir et al., 2014) (Figure 
1.14). It is interesting to note that in the case of wrapping and budding, lumens form 
from already polarised epithelia, while all other mechanisms require establishment of 
apical-basal polarity de novo. The cellular and molecular basis of these mechanisms is 
detailed below. 
 
1.4.2 Mechanisms of apical-basal polarity establishment and lumen formation in 
epithelial tissues 
1.4.2.1 Lumen formation from already polarised tissues 
1.4.2.1.1 Wrapping 
The most common example of lumen formation by wrapping is the formation of the 
neural tube, or primary neurulation, in vertebrates (Andrew and Ewald, 2010). During 
embryonic development, a population of cells within the ectoderm germ layer 
differentiate into neuronal precursors, thus forming the neural plate. At this stage, 
neuronal precursors are already polarised, with their apical membrane facing the 
extraembryonic space, and their basal membrane in contact with the underlying 
mesoderm. Neurulation is the result of active cell shape changes driven by the 
remodelling of the microtubule and actin cytoskeletons in neuronal precursors. It starts 
with the coordinated elongation of the cells in their apical-basal axis, a process 
dependent on the microtubule cytoskeleton (Schoenwolf and Powers, 1987). 
Subsequently, apical domains constrict through actomyosin contraction and cell 
divisions maintain nuclei towards the basal side of the cells (Smith and Schoenwolf, 
1988), giving rise to wedge-shaped cells and thus allowing the folding of the neural 
plate. Eventually, the edges of the neural plate come together and fuse to lead to the 
separation of the neural tube, running parallel to the ectoderm germ layer it originated 
from (Andrew and Ewald, 2010) (Figure 1.14). 
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Figure 1.14. Mechanisms of lumen formation 
Magenta, apical membrane. Black, basolateral membrane. Adapted from (Lubarsky and 
Krasnow, 2003). 
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1.4.2.1.2 Budding 
Another mechanism of lumen formation involving the reshaping of an already polarised 
epithelium is the formation of lumens by budding. One example of such a mechanism is 
the growth of the primary branches of the trachea in Drosophila melanogaster. The 
tracheal system of Drosophila forms from twenty epidermal placodes, ten on each side 
of the embryo, from which primary tracheal branches emerge through bending of the 
tissue, generating epithelial invaginations or “buds”. Similarly to wrapping, budding is 
marked by the elongation of groups of about six cells per placode in their apical-basal 
axis, followed by actomyosin-driven constriction of their apical membrane while nuclei 
are maintained close to the basal domain, driving the change in cell shape necessary to 
bend the tissue (Brodu and Casanova, 2006, Sawyer et al., 2010) (Figure 1.14). 
 
1.4.2.1.3 Mechanisms of apical constriction 
In both wrapping and budding, lumen formation relies on the constriction of the apical 
domains of groups of polarised cells to induce the cell shape changes required for local 
bending of the tissue. Apical constriction is a common mechanism underlying tissue 
shaping during embryogenesis (Sawyer et al., 2010, Martin and Goldstein, 2014). 
Although the modalities of apical constriction show some levels of variability between 
cell types, all rely on the contraction of filamentous actin (F-actin) networks by the 
molecular motor non-muscle myosin II. In polarised cells, actomyosin networks can be 
found at the apical membrane in two locations: at junctions, forming an actomyosin belt 
made of linear actomyosin fibres; and under the apical membrane, as an actomyosin 
cortex spanning the entire surface of the apical domain. Roles in apical constriction 
have been described for both networks. Junctional actomyosin belts can drive 
contraction in a purse-string-like fashion. Dynamic contraction of actomyosin within 
the cortex can, on the other hand, generate cortical flows and drive constriction of apical 
domains. In both cases, coupling to cell junctions is critical to reduce apical surfaces 
and coordinate behaviours between cells in the tissue (Sawyer et al., 2010, Martin and 
Goldstein, 2014). 
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Additionally to the spatial control of actomyosin assembly, apical constriction relies on 
a tight temporal regulation of the contractility of apical actomyosin networks. First 
reported in Drosophila embryos during mesoderm invagination, actomyosin networks 
were found to contract in a pulsatile manner during apical constriction, with alternating 
phases of contraction and stabilisation allowing incremental reduction of the apical 
surface in a ratchet-like manner (Martin et al., 2009). The role of pulsatile contractions 
versus continuous deformation remains to be addressed, but is very likely to allow the 
generation of higher forces and greater exploration of cellular shapes through the 
stabilisation of intermediate spatial configurations (Levayer and Lecuit, 2012, Martin 
and Goldstein, 2014). 
 
In the previously described case of neural tube formation, neuroepithelial cells have 
been found to accumulate F-actin and non-muscle myosin II in an apical belt at their 
cell junctions, and major efforts have been placed on understanding how the assembly 
and contraction of this actomyosin network are spatially and temporally controlled 
during development. Shroom3, an actin-binding protein, has been identified as a major 
regulator of apical constriction during neurulation (Hildebrand and Soriano, 1999, 
Hildebrand, 2005). Apically enriched in neuronal progenitors, Shroom3 recruits Rho-
associated protein kinase (ROCK) to cell junctions, promoting the formation of 
actomyosin cables and their contraction through the phosphorylation of the regulatory 
light chain of non-muscle myosin II (Hildebrand, 2005, Kinoshita et al., 2008, 
Nishimura and Takeichi, 2008). Recently, an additional level of regulation of ROCK by 
a set of planar cell polarity (PCP) proteins, possibly through RhoA, was found to restrict 
its activation to a subset of adherens junctions, therefore allowing the anisotropic 
shortening of apical domains required for tube formation (Nishimura et al., 2012, 
Martin and Goldstein, 2014). 
Similarly, both F-actin and non-muscle myosin II are found enriched at the apical 
membrane of tracheal cells during invagination (Brodu and Casanova, 2006). In this 
system, the enrichment and contraction of actomyosin at the apical membrane is 
dependent on the expression by invaginating cells of the transcription factor Trachealess, 
a positive regulator of epidermal growth factor receptor (EGFR) signalling. In turn, 
EGFR signalling upregulates the expression of the Rho GAP Crossveinless, promoting 
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apical actin enrichment in part by enabling specific activation of Rho1 at the apical 
membrane of invaginating cells (Brodu and Casanova, 2006, Affolter and Caussinus, 
2008, Sawyer et al., 2010). 
 
Together, these models are great examples of how the specialisation of apical and basal 
domains in polarised cells allows compartmentalisation of signalling events − here tight 
regulation of actomyosin assembly and contraction − to drive the cell shape changes 
required for lumen formation in developing tissues. 
 
1.4.2.2 Lumen formation from non-polarised tissues 
1.4.2.2.1 Cavitation 
During cavitation, apoptosis within cords of cells drives the formation of a central 
luminal space (Lubarsky and Krasnow, 2003) (Figure 1.14). One example of lumen 
formation by cavitation in vivo is the development of the mouse submandibular salivary 
gland (Wells and Patel, 2010). In this system, epithelial buds first expand as compact 
clusters of cells, and later undergo lumenisation through the clearing of the cells at the 
centre of the mass. The initiation of cavitation was found to rely on the relaying of 
polarisation signals from the extracellular matrix (ECM) to the outermost layer of cells 
within the bud. Upon attachment to the ECM, these cells establish strong intercellular 
junctions, and in turn up-regulate cell survival signals. Among those, survivin, a 
member of the inhibitor of apoptosis (IAP) family of proteins, translocates into the 
nucleus of polarising cells in the mouse salivary gland, where it prevents caspase 
activity and apoptosis. Additional anti-apoptotic effectors, such as Bcl-2, NF-κB and 
receptor interacting protein (RIP), an upstream regulator of NF-κB signalling, were also 
found to be specifically expressed in the outermost cell layer (Melnick et al., 2001). In 
contrast, cells in the centre, missing attachment to the matrix and to neighbouring cells, 
express pro-apoptotic genes and undergo caspase-dependent apoptosis (Melnick and 
Jaskoll, 2000). In this sense, cavitation is therefore a good example of how the sensing 
of extracellular polarisation cues is crucial in organising cells within a developing tissue 
to drive lumen formation. 
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1.4.2.2.2 Cord hollowing 
1.4.2.2.2.1 Madin-Darby canine kidney (MDCK) cyst model 
Cord hollowing refers to the formation of a lumen at the contact between adjacent cells 
(Figure 1.14), and has been extensively studied in vitro in the MDCK cyst model, 
allowing fine and detailed analysis of the cellular and molecular mechanisms at play 
during this process (Martin-Belmonte and Mostov, 2008, Datta et al., 2011, Overeem et 
al., 2015). MDCK cells, when grown in 3D Matrigel matrices, organise themselves into 
spherical cysts made of a monolayer of epithelial cells surrounding a central lumen and 
encircled by a basement membrane (Hall et al., 1982). When treated with hepatocyte 
growth factor (HGF), cysts develop multicellular extensions that later lumenise to form 
tubular ramifications (Montesano et al., 1991b, Montesano et al., 1991a, Pollack et al., 
1998). Both initial lumen formation within the cyst, and subsequent formation of 
lumens within tubules, happen through cord hollowing. 
Upon embedding in 3D matrices, MDCK cells randomly distribute apical and basal 
markers around their plasma membrane (Figure 1.15). Segregation of apical and basal 
components happens only upon the entry of the cells into their first division. Basolateral 
markers such as E-cadherin segregate at the nascent junction between the two daughter 
cells, while apical markers, such as podocalyxin and Crumbs3a, are internalised in 
Rab11-positive endosomes and relocalise to the membrane facing the ECM (Schluter et 
al., 2009, Bryant et al., 2010) (Figure 1.15). There, podocalyxin associates into a 
complex with Na+/H+-exchanger regulatory factor-1 (NHERF1)/ezrin radixin moesin 
(ERM)-binding phosphoprotein 50 (EBP50) and ezrin, whose phosphorylation through 
polarised activation of RhoA and ROCK1 at the ECM-facing membrane stabilises the 
complex through coupling to the actin cytoskeleton (Bryant et al., 2014) (Figure 1.15). 
Upon completion of cell division, apical-basal polarity is established following a 
stereotyped sequence of cellular and signalling events. The first step in this process is 
the internalisation of apical determinants following binding to the ECM. Binding to the 
ECM through integrin receptors, mainly α2β1 and α6β4 dimers, activates Rac1 at the 
plasma membrane (Yu et al., 2005, Myllymaki et al., 2011). Rac1, through mechanisms 
that remain unclear, in turn promotes the secretion and assembly of laminin and thus the 
formation of a basement membrane at the surface of contact with the ECM (O'Brien et 
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al., 2001). An other major regulator of laminin assembly is Par1b, which also recruits 
laminin-binding receptors specifically to the ECM-facing membrane (Masuda-Hirata et 
al., 2009). Following laminin deposition and binding of specific receptors, downstream 
signalling, partly via focal adhesion kinase (FAK), recruits p190A-RhoGAP at the 
plasma membrane, thus limiting RhoA/ROCK signalling, inhibiting the phosphorylation 
of ezrin and destabilising the podocalyxin/NHERF1/ezrin complex. Subsequent 
phosphorylation of the complex by protein kinase C (PKC) then drives the 
internalisation of podocalyxin, and potentially other apical markers such as Crumbs3a, 
into recycling endosomes that associate to Rab11a to form apical carriers (Bryant et al., 
2014) (Figure 1.15). 
In a second step, apical carriers are targeted to a region referred to as the apical 
membrane initiation site (AMIS) at the site of cytokinesis (Bryant et al., 2010) (Figure 
1.15). Both microtubule-based and actin-based transport of Rab11a-positive apical 
carriers have been reported. During telophase, Rab11a interacts with Rab11a family-
interacting protein 5 (FIP5) and, through FIP5, to the microtubule-associated molecular 
motor Kinesin 2, allowing transport to the midbody at cytokinesis (Li et al., 2014a). 
This directional transport of Rab11-positive vesicles is controlled by the 
phosphorylation of FIP5 by glycogen synthase kinase 3β (GSK-3β). In metaphase and 
anaphase, GSK-3β phosphorylates FIP5, preventing its association to the sorting nexin 
18 (SNX18), which is necessary for the maturation of recycling endosomes into apical 
carriers. Dephosphorylation of FIP5 in late telophase allows the generation and 
transport of Rab11-positive carriers along microtubules to the AMIS (Willenborg et al., 
2011, Li et al., 2014b). Rab11a-positive vesicles also undergo actin-based trafficking. 
Association of Rab11a with the guanine nucleotide exchange factor (GEF) Rabin8 
drives the activation and binding of Rab8a to Rab11a at the surface of the vesicles. 
Rab8a/Rab11a then bind to the actin-based motor protein myosin Vb, driving their 
delivery to the AMIS. At the AMIS, Rab8a/Rab11a-positive vesicles tether to the 
membrane through interaction between components of the exocyst complex − Sec15A 
at the surface of the vesicles, and Sec8 and Sec10 within the AMIS (Bryant et al., 2010). 
At the AMIS, Rab8a/Rab11a-positive vesicles interact with Rab27a/b and Rab3b, 
allowing their binding to synaptotagmin-like protein 2a (Slp2a) and 4a (Slp4a), whose 
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interaction with syntaxin-3 drives membrane fusion and integration of the apical 
determinants into the membrane (Galvez-Santisteban et al., 2012) (Figure 1.15). 
How the AMIS is defined in the first place is still not fully understood. The earliest 
determinants of the AMIS identified to date are the phosphoinositide 
phosphatidylinositol (4,5)-biphosphate (PIP2), the phosphatase and tensin homolog 
PTEN, and the Par polarity complex protein Par3 (Datta et al., 2011). Segregation of 
phosphoinositides is one of the earliest symmetry-breaking events occuring during 
apical-basal polarity establishment. While PIP2 gets enriched at the apical membrane, 
phosphatidylinositol (3,4,5)-trisphosphate (PIP3) is found exclusively at the basal 
membrane. Both have scaffolding roles and respectively recruit apical and basal 
determinants through specific phosphoinositide-binding motifs (Martin-Belmonte and 
Mostov, 2007). Elegant manipulations show that ectopic insertion of PIP2 into the basal 
membrane leads to the recruitment of apical markers, while the ectopic insertion of PIP3 
on the apical side of the cell recruits basal markers, thus showing the central role of 
PIP2 and PIP3 in identifying and organising the apical and basal domains (Gassama-
Diagne et al., 2006, Martin-Belmonte et al., 2007). The segregation of PIP2 and PIP3 
between the two domains relies on the presence of PTEN at the apical membrane, where 
it drives the conversion of PIP3 into PIP2, therefore excluding PIP3 from the apical 
membrane (Martin-Belmonte et al., 2007). What recruits PTEN to the AMIS is still not 
fully understood. Interaction between PTEN and Par3 has been reported, and presence 
of either of these two proteins at the AMIS is required for the proper localisation of the 
other (von Stein et al., 2005, Feng et al., 2008). Par3 also binds to PIP2, which could 
explain its early recruitment to the AMIS (Wu et al., 2007, Krahn et al., 2010). Since 
PIP2 is also involved in cytokinesis, it could be that its concentration at the nascent 
junction between the two daughter cells is the first signal directing recruitment of Par3, 
and therefore PTEN, to the AMIS, but this remains to be investigated. 
An important role for PIP2 in orchestrating the targeting of apical carriers to the AMIS 
is to recruit Annexin 2 (Anx2), which in turn targets the small GTPase Cdc42 to the 
AMIS (Martin-Belmonte et al., 2007). At the AMIS, Cdc42 associates with Par6 and 
recruits atypical PKC (aPKC) to form the Par complex together with Par3. There, 
Cdc42 plays an essential role in allowing the exocytosis of apical carriers through 
interactions with Rab11a/Rab8a (Martin-Belmonte et al., 2007, Bryant et al., 2010) 
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(Figure 1.15). It is also believed to be involved in the remodelling of the actin 
cytoskeleton, in part through the recruitment of the inverted formin INF2 (Madrid et al., 
2010). 
Upon delivery of apical determinants, the AMIS matures into a pre-apical patch (PAP), 
where apical membranes are defined but no luminal space is present between them 
(Figure 1.15). The transition from the AMIS to the PAP is marked by the exclusion of 
Par3/aPKC complexes from the apical membrane, and their relocation to tight junctions, 
along with junctional proteins and the exocyst complex proteins Sec8 and Sec10 
(Bryant et al., 2010). Although it has not been confirmed in this model, extensive work 
in Drosophila suggests that exclusion of Par3/aPKC could be the result of an 
antagonism with Crumbs3a, delivered by apical carriers to the AMIS (Datta et al., 2011). 
Eventually, lumen expands between PAPs, a step for which podocalyxin has been 
identified as a major regulator. Podocalyxin is a member of the CD34 family of 
transmembrane sialomucins (Nielsen and McNagny, 2008). Through extensive O-
glycosylation and syalylation of their extracellular domain, podocalyxin molecules 
accumulate negative charges at their surface, conferring anti-adhesive properties 
responsible for the repulsion of apposing membranes and inhibition of cell-cell contacts 
(Takeda et al., 2000). Because of the presence in their intracellular domains of binding 
sites for ERM proteins, podocalyxin and Crumbs3a are also thought to act as bridges to 
the actin cytoskeleton and allow the separation of luminal membranes through its 
remodelling (Nielsen and McNagny, 2008, Bulgakova and Knust, 2009, Datta et al., 
2011). Detailed analysis of actin organisation during the different steps of lumen 
formation is however still missing. Finally, fluids are secreted into the lumen through 
the action of ion pumps and channels. Among those, the Na+/K+-ATPase and the cyclic 
AMP (cAMP)-dependent chloride channel cystic fibrosis transmembrane conductance 
regulator (CFTR) have been found to promote fluid secretion into the lumen (Datta et 
al., 2011). A role for claudin-15 has also been demonstrated in generating paracellular 
pores further regulating these fluxes (Bagnat et al., 2007). 
The findings mentioned here established a robust model for the establishment of apical-
basal polarity at cell junctions in vitro. Current and future work will have to address 
whether these mechanisms are conserved in vivo and how they adapt to specific cellular 
and tissue contexts during development.   
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Figure 1.15. Mechanism of lumen formation by cord hollowing in MDCK cysts 
Adapted from (Bryant et al., 2010, Galvez-Santisteban et al., 2012, Bryant et al., 2014). 
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1.4.2.2.2.2 Drosophila fusion cells 
One example of cord hollowing in vivo is the formation of lumens between fusion cells 
during trachea development in Drosophila. Following the formation of primary 
branches by budding (see 1.4.2.1.2), tracheal branches elongate and connect in 
stereotyped positions to form a continuous tubular network. Fusion of tracheal branches 
involves specialised cells at the tip of branches called fusion cells. Similarly to tip cells 
during blood vessel formation (Figure 1.8), tracheal fusion cells anastomose after 
establishing a stable cell-cell contact. During anastomosis, fusion cells expand lumens 
de novo at their nascent junction. Concomitantly, lumens expand from their respective 
stalk cell neighbours, and fusion of all three luminal compartments eventually leads to 
the full lumenisation of the new connection (Figure 1.16). 
Similarly to what has been described for MDCK cells, the site of contact between 
fusion cells accumulates apical markers as it expands. While aPKC and Crumbs 
accumulate along the entire contact, forming a structure comparable to the PAP found 
in MDCK cysts, Par3 localises with Drosophila epithelial cadherin (DE-Cadherin) in a 
junctional ring around the PAP periphery (Gervais et al., 2012). Subsequently, fusion 
cells extensively remodel their actin and microtubule cytoskeletons to form a track 
spanning the entire length of the cells and bridging their two apical domains (Lee and 
Kolodziej, 2002, Gervais et al., 2012). Additionally to its potential role in adapting the 
shape of fusion cells to allow the expansion of luminal compartments, the cytoskeletal 
track is thought to serve as a scaffold for the directed transport of vesicles to apical 
membranes. Although vesicular trafficking remains challenging to follow in vivo, Sec5, 
a component of the exocyst complex, and the small GTPase Arl-like 3 were found 
enriched in apical membranes of fusion cells, and co-localised with Rab11-positive 
vesicles along the cytoskeletal track and at close proximity to the apical membranes 
(Jiang et al., 2007, Kakihara et al., 2008). Importantly, both Sec5 and Arl-like 3 are 
required to form lumens in fusion cells (Jiang et al., 2007, Kakihara et al., 2008), 
suggesting that vesicle fusion might also take part in the formation of lumens in tracheal 
fusion cells, similarly to what was described in MDCK cysts. Finer analysis would 
however be needed to fully differentiate mechanisms responsible for de novo lumen 
formation at the site of fusion from the mechanisms regulating expansion of the lumens 
coming from the stalks.  
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1.4.2.2.3 Cell hollowing 
Certain cells possess the ability of generating lumens de novo through the generation 
and fusion of vacuolar compartments within their cytoplasm, generating an intracellular 
luminal space (Figure 1.14). One such example is the excretory cell of Caenorhabditis 
elegans. The excretory organ of C.elegans, responsible for maintaining the osmotic 
homeostasis of the organism, is formed by four distinct cell types: one pore cell, one 
duct cell, one excretory cell, and a pair of fused gland cells. The excretory cell, shaped 
as an H, extends four lumenised canals that span the entire length of the worm, and 
drain liquids towards the duct and pore cells. The formation of the lumen within the 
excretory cell happens through the generation of intracellular vesicles/vacuoles, whose 
alignment and fusion in the center of the cell and canals lead to the formation, and later 
expansion, of a central luminal space de novo. Genetic screens have identified multiple 
genes involved in tube formation, extension and maintenance, and their characterisation 
is still under way (Buechner et al., 1999, Buechner, 2002). Among those, βH-spectrin, 
the intermediate filament IFB-1, and the ezrin homolog ERM-1, were all found to line 
the apical membrane of the canals and to be required for lumen formation and/or 
maintenance, highlighting a key role for the cytoskeleton in this process. βH-spectrin is 
thought to link the apical membrane to the actin cytoskeleton. Its loss leads to swollen 
lumens in larvae and short and dilated cysts in adults, suggesting it is required to 
maintain lumen diameter throughout the canals (Buechner, 2002). Similarly, loss of 
IFB-1 leads to the formation of dilated cysts or, even, to the total collapse of the lumen, 
highlighting a similar function for IFB-1 in maintaining lumen integrity (Kolotuev et al., 
2013). Finally, another study identified a crucial role for ERM-1 in regulating vacuole 
alignment and fusion in the middle of the cell body, possibly by linking the actin 
cytoskeleton lining the apical and vacuole membranes together during these processes 
(Khan et al., 2013). Interestingly, this same study identified an interaction between 
ERM-1 and a water channel, aquaporin 8 (AQP-8), during phases of lumen expansion, 
and found that water transport through AQP-8 is required for intracellular lumen 
expansion, thus suggesting a tight cooperation between pressure-building mechanisms 
and actin-based support in expanding apical membranes in these cells (Khan et al., 
2013). 
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1.4.2.2.4 Membrane invagination 
A fourth and last mechanism of de novo lumen formation, membrane invagination, was 
recently defined in light of studies both during trachea development in Drosophila and, 
as will be detailed later, during blood vessel formation in vertebrates. In this case, 
lumen expands through the invagination of the lumen from an already lumenised cell 
into its neighbour (Figure 1.14). Although the definition of membrane invagination as 
an additional mechanism of de novo lumen formation distinct from cell hollowing could 
appear debatable at first, the present work and detailed analysis of lumen formation in 
terminal and fusion cells in the Drosophila trachea called for such a distinction 
(Sigurbjornsdottir et al., 2014). 
As presented earlier, following the budding of a set of primary branches, the tracheal 
system of Drosophila develops from the elongation and fusion of these branches into an 
interconnected network of respiratory tubes. The formation of a lumen de novo at the 
junction between fusion cells during branch fusion was previously described 
(1.4.2.2.2.2). This process is tightly coupled to the invagination of lumens from stalk 
cells on both sides of the fusion site (Caviglia and Luschnig, 2014) (Figure 1.16). 
Single-cell labelling revealed that most of the lumen in fusion cells is contributed by the 
stalk cells, pushing into the fusion cells as “fingers poking into a balloon”. This 
configuration is generated by extensive cell shape changes, as stalk cells elongate and 
deform fusion cells which undergo extreme compaction. Staining for cell junctions 
revealed that, similar to what is observed between the two fusion cells, a junctional ring 
connects stalk cells to their fusion cell neighbour, beyond which a small lumen 
invagination contributed by fusion cells can be resolved (Figure 1.16). There, vesicular 
trafficking along the cytoskeletal track (previously described in 1.4.2.2.2.2) contributes 
to lumen expansion and, later, to the fusion of all three luminal compartments (Gervais 
et al., 2012, Caviglia and Luschnig, 2014). 
Another example of membrane invagination is the formation of the lumen in tracheal 
terminal cells. Terminal cells form a subset of specialised cells within the tracheal 
system of Drosophila, and are easily identifiable by the long cellular protrusions they 
extend to establish large gas exchange surfaces within the surrounding tissues. During 
development, terminal cells concomitantly undergo extensive elongation and lumen 
formation (Gervais and Casanova, 2010). Lumens growing in terminal cells are detected 
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as membrane invaginations originating from the connection of the terminal cells with 
their parent tracheal branch (Figure 1.16). Single-cell labelling shows that membrane 
invaginations are entirely generated by terminal cells, and accumulate apical markers 
(Par3 and DPatj, respectively part of the Par and Crumbs complexes). The presence of a 
track of F-actin, moesin and microtubules along and ahead of the lumen, and 
colocalisation of Rab11-positive recycling endosomes and vesicles carrying luminal 
components, strongly suggests that the formation of the invaginating membrane relies 
on membrane recycling and trafficking of apical determinants along a cytoskeletal track 
(Gervais and Casanova, 2010). Eventually, these invaginations grow in diameter, with 
secretion of chitin forming a transient apical matrix with shaping and stabilising 
functions (Tonning et al., 2005, Gervais and Casanova, 2010). 
 
1.4.2.3 Concluding remarks 
Together, these studies show how a same morphogenetic event, lumen formation, can 
be driven by a plethora of different mechanisms depending on the tissue and cellular 
contexts. A common feature of all these mechanisms is, however, the central role 
played by the actin cytoskeleton during lumen formation, through its regulation of both 
cell shape and membrane trafficking between membrane domains. In wrapping and 
budding, apical constriction is entirely dependent on the assembly and contraction of 
actomyosin at the apical side of the cells; during cord hollowing, the actin cytoskeleton 
is essential in driving apposing membranes apart and shaping the nascent lumen; finally, 
membrane invaginations arise from extensive cell shape changes. On the other hand, the 
actin cytoskeleton also plays a major role in organising apical and basal domains, by 
allowing the targeted trafficking of apical and basal determinants and membrane 
material. How these findings relate to the formation of lumens in the blood vascular 
system is the focus of the present study. 
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Figure 1.16. Lumen formation by membrane invagination during trachea 
formation in Drosophila 
Adapted from (Sigurbjornsdottir et al., 2014). 
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1.4.3 Vascular lumen formation 
1.4.3.1 Lumen formation during blood vessel formation in vitro 
1.4.3.1.1 Cellular mechanisms 
Vascular lumen formation was first observed in vitro by angiogenesis pioneer Judah 
Folkman. In a 1980 study, he found that both bovine and human capillary cells 
extracted from various healthy and tumor tissues grow complex vascular networks and 
undergo lumen formation when cultured on gelatin-coated plates. Imaging of these cells 
by electron microscopy revealed the presence of large vacuoles in the cytoplasm of 
endothelial cells as they lumenise, suggesting for the first time that endothelial cells 
may form lumens through a mechanism of cell hollowing in vitro (Folkman and 
Haudenschild, 1980). 
This model was confirmed more than fifteen years later with studies using models of 
endothelial cell assembly and tubulogenesis in 3D collagen and fibrin matrices (as 
described in 1.3.1). In this system, endothelial cells were found to lumenise through the 
generation and fusion of large vacuoles in their cytoplasm. The addition of fluorescent 
tracers in the culture medium, or labelling of the plasma membrane, showed that these 
vacuoles arise from the engulfing of culture medium at the ECM-facing membrane, in a 
process resembling macropinocytosis (Davis and Camarillo, 1996). When cultured at 
low density, cells are thus able to form unicellular (also referred to as seamless) tubes. 
On the other hand, cells in contact or in close proximity to each other form multicellular 
lumens through the generation and fusion of vacuoles at their shared junction (Figure 
1.17). Although vacuole formation is systemically associated with lumen formation, it is 
possible that a mechanism similar to cord hollowing also participates in the opening of a 
luminal space at cell junctions prior/concomitantly to vacuole fusion, but this remains to 
be investigated. 
 
1.4.3.1.2 Molecular mechanisms 
The development of robust and reproducible assays of in vitro vascular lumen formation 
enabled researchers to investigate the molecular mechanisms at play during this process 
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(Davis et al., 2011, Sacharidou et al., 2012) (Figure 1.18). Similarly to what was 
described for epithelial cells, signalling from both cell-ECM and cell-cell interfaces was 
found to regulate lumen formation in endothelial cells in vitro. Binding and signalling 
through α2β1 integrin is required for lumen formation in collagen matrices (Davis and 
Camarillo, 1996), while α5β1 and αVβ3 integrins mediate lumen formation in fibrin 
matrices (Bayless et al., 2000). Pericytes also influence lumen maintenance by 
promoting basement membrane deposition, thus stabilising endothelial tubes through 
their attachment to components of the basement membrane via α5β1, α3β1, α6β1 and α1β1 
integrins (Stratman et al., 2009). On the other hand, expression of both adherens and 
tight junction proteins – vascular endothelial cadherin (VE-Cadherin) and cerebral 
cavernous malformation protein 1 (CCM1), and JamB and JamC respectively − was 
found to be required for lumen formation. VE-Cadherin and CCM1 associate at cell 
junctions in a complex that is required for the proper localisation of Par3, PKCζ, and the 
Rho GTPase regulator Tiam1. VE-Cadherin additionally regulates phosphorylation of 
PKCζ (Lampugnani et al., 2010). JamB and JamC also bind to Par3 (Ebnet et al., 2003), 
and are required for its recruitment at cell junctions and subsequent lumen formation 
(Sacharidou et al., 2010). 
 
Rho GTPases play a central role in relaying signalling from the ECM and cell junctions 
to establish apical-basal polarity in endothelial cells in vitro. Both Cdc42 and Rac1 are 
found at the surface of vacuoles, and have been identified as master regulators of lumen 
formation (Bayless and Davis, 2002, Koh et al., 2008a). In contrast, RhoA is 
dispensable for lumen formation, and instead promotes lumen collapse, an effect 
mediated by ROCK (Bayless and Davis, 2002). During lumen formation, Cdc42 and 
Rac1 antagonise RhoA activity through the activation of Src and Erk1/2 (Mavria et al., 
2006, Im and Kazlauskas, 2007). 
Extensive biochemical interaction studies identified the association of Cdc42 and Rac1 
with α2β1 integrin, JamB, JamC, Par3, Par6a, Par6b, and the matrix metalloproteinase 
MT1-MMP in a master regulatory complex (Sacharidou et al., 2010). All individual 
components of this complex are required for lumen formation in vitro, and their 
recruitment within the complex is dependent on the presence of its other constituents, as 
loss of any of these proteins leads to its disruption. A number of target kinases were 
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found downstream of this complex and mediate its effects on lumen formation in vitro. 
These include Pak2, Pak4, Mek1, Erk1/2, Src, Yes, C-Raf, B-Raf, PKCε and aPKC 
(Sacharidou et al., 2010). 
Recently, additional small GTPases (kRas, Rac2, Rap1b), as well as upstream 
regulators of Rho GTPases (Arhgap31 (inhibitor of Cdc42 and Rac), Arhgap29 
(inhibitor of RhoA), Rasa1 (inhibitor of kRas)) and multiple downstream effectors 
(IQGAP1 and MRCKβ (Cdc42 effectors), beta-Pix and GIT1 (Pak2 binding partners), 
Rasip1 (Ras and Rap effector)) were further identified and complement the signalling 
network characterised to date (Norden et al., 2016) (Figure 1.18). 
 
Although the siRNA screens and biochemical interaction assays performed in these 
studies allowed the identification of key regulators of lumen formation in vitro, how 
these signals orchestrate membrane trafficking events and vacuole formation within 
endothelial cells is still poorly understood. Unlike in the MDCK cyst model, no role for 
small Rab GTPases and/or the exocyst complex have been reported, and their possible 
involvement in membrane remodelling during lumen formation in endothelial cells in 
vitro remains to be investigated. A role for the microtubule and actin cytoskeletons has 
however been demonstrated, although the distinction between their trafficking and 
structural/scaffolding functions remains to be addressed. In vitro, treatment with 
microtubule depolymerisation agents prevents lumen formation and induces the 
collapse of already formed lumens (Bayless and Davis, 2004). A number of microtubule 
modifying and capping proteins were found to regulate lumen formation in vitro. 
Tubulin acetylation and detyrosination, two marks of microtubule maturation and 
stability, accumulate during lumen formation, and the deacetylase sirtuin 2 (SIRT2) and 
histone deacetylase 6 (HDAC6) both negatively regulate lumen formation (Kim et al., 
2013). On the other hand, microtubule plus-end-binding proteins EB1, p150Glued and 
Clasp1 are required for lumen formation upstream of the Pak/Raf/Erk kinase cascade 
(Kim et al., 2013). Immunofluorescence stainings suggest that acetylated microtubules 
organise themselves as a subapical network where Cdc42, Rac, kRas and Rap1b 
GTPases concentrate during lumen formation (Kim et al., 2013, Norden et al., 2016), 
although further localisation studies will need to confirm these findings. Staining for 
phalloidin, on the other hand, shows the presence of a dense network of F-actin at the 
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basal membrane in vitro, while significantly lower amounts of F-actin are detected at 
the apical membrane (Chaki et al., 2015, Norden et al., 2016). Treatment with 
cytochalasin B, an actin polymerisation inhibitor, prevents lumen formation in vitro 
(Bayless and Davis, 2004). Recently, a role for non-catalytic regions of tyrosine kinase 
adaptor proteins 1 and 2 (Nck1/2) has been reported during lumen formation in vitro. 
Nck1/2 are adaptor proteins involved in the coupling of tyrosine kinase signalling with 
the remodelling of the actin cytoskeleton. In 3D collagen matrices, silencing of Nck1/2 
disrupts F-actin organisation and VE-Cadherin localisation at cell junctions, preventing 
the segregation of apical determinants and the fusion of vacuoles (Chaki et al., 2015). 
These results suggest a role for F-actin in polarity establishment and vacuole fusion. 
Finer analysis of actin structures and dynamics will however be required to fully 
understand the role of actin in vascular tube morphogenesis in vitro. 
 
1.4.3.1.3 Concluding remarks 
Together, these studies identified key molecular regulators of vascular lumen formation 
in vitro (Figure 1.18), some of which were also identified as such during epithelial 
morphogenesis, both in vitro and in vivo. In the future, higher resolution live imaging 
studies will hopefully allow a deeper understanding of how these proteins control 
morphogenetic events at the cellular level during lumen formation, and how vacuole 
formation and fusion is regulated during this process. 
It has to be noted that all these studies were performed in models mimicking 
vasculogenesis. In vitro models of angiogenesis, on the other hand, have only been used 
anecdotally for the study of lumen formation, presumably because of the difficulty of 
setting up and studying such systems in comparison to the ease of use of in vivo models 
such as the zebrafish. 
Finally, it is important to point out that in vitro systems differ from in vivo situations 
where endothelial tubes are exposed to high flow and blood pressure and rapidly recruit 
mural cells. Both generate strong apical and basal polarisation cues that are likely to 
affect the polarisation and lumen formation mechanisms involved in vascular 
tubulogenesis in vivo. Therefore, conservation of the signalling events identified as 
drivers of lumen formation in vitro needs to be carefully addressed.   
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Figure 1.17. Cellular mechanisms of vascular lumen formation in vitro 
 
 
 
 
Figure 1.18. Molecular mechanisms of vascular lumen formation in vitro  
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1.4.3.2 Lumen formation during vasculogenesis in vivo 
Most of our understanding of the mechanisms of lumen formation during 
vasculogenesis in vivo comes from the combination of studies in zebrafish and mouse 
embryos. While live imaging of transgenic reporter zebrafish lines allowed dynamic 
analysis of endothelial cell behaviour, the powerful genetic tools available in mice made 
possible the investigation of the genetic basis of lumen formation in vivo. In zebrafish 
embryos, the dorsal aorta forms directly through the migration and aggregation of 
angioblasts into one single vascular cord (Lawson and Weinstein, 2002, Jin et al., 2005). 
In contrast, in mouse embryos, vasculogenesis leads to the formation of a pair of 
primary dorsal aortae underneath the lateral plate mesoderm, which then migrate 
towards the midline to fuse and form a single large vessel (Drake and Fleming, 2000, 
Strilic et al., 2009). Lumen formation in the single zebrafish dorsal aorta and mouse 
aortae is however driven by similar morphogenetic events. 
 
In zebrafish embryos, angioblasts are detected within the lateral plate mesoderm around 
12 hpf, and then migrate to the midline in two consecutive waves at 14 and 16 hpf to 
aggregate as a cord dorsal to the endoderm and ventral to the hypochord. At 17 hpf, 
cells establish cell-cell-junctions and by 18 hpf a lumen starts forming by cord 
hollowing, giving rise to a vascular tube made of 4 to 6 cells in circumference (Jin et al., 
2005). This process is accompanied by drastic cell shape changes. Prior to lumen 
formation, endothelial cells show a cuboidal shape with long lateral junctions. Upon 
lumen formation, cells elongate in their anteroposterior axis and only maintain thin 
lateral junctions (Jin et al., 2005, Hultin et al., 2014). Interestingly, this process is 
independent of blood flow, as lumen formation occurs normally in the dorsal aorta of 
silent heart embryos mutant for the cardiac troponin 2a (tnnt2a) and thus lacking heart 
beat and blood circulation (Sehnert et al., 2002, Isogai et al., 2003, Hultin et al., 2014). 
In this context, endothelial cells still elongate and open a patent lumen (Hultin et al., 
2014). A similar result was recently obtained in Xenopus embryos, where the ablation 
of the cardiac region did not prevent normal formation and lumenisation of the dorsal 
aorta (Charpentier et al., 2015). Together, these studies therefore suggest that the 
formation of the aortic lumen by cord hollowing, and the observed changes in cell shape, 
are solely driven by intrinsic mechanisms within the endothelial cells.   
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Figure 1.19. Mechanisms of lumen formation in the mouse dorsal aorta 
Adapted from (Strilic et al., 2009). 
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Similar morphological events were reported during the formation of the dorsal aorta in 
mice (Strilic et al., 2009). At the one somite (1S) stage, at embryonic day 8 (E8), 
endothelial cells are found as clusters sharing extensive junctions. At the 2S stage, 
junctions are only detected laterally and by the 3S stage, a slit-like extracellular space 
can be resolved between endothelial cells. From the 3S to 5S stages, lumens larger than 
5 µm in diameter open, and enlarge beyond 20 µm at the 6-8S stages as endothelial cells 
become thinner (Figure 1.19). Together, these observations suggest that the mouse 
dorsal aorta undergoes cord hollowing following the same morphological events 
reported in zebrafish embryos. Importantly, no vacuole larger than 0.5 µm is observed 
during aortic lumen formation in mice, dismissing the hypothesis that lumen could form 
through a cell hollowing process. Instead, small vesicles are found in the cytoplasm of 
endothelial cells during the cord-to-tube transition, suggesting that significant vesicular 
membrane trafficking could participate in lumen formation in this system (Strilic et al., 
2009). 
 
Detailed structure and function analysis in mice allowed to identify some of the major 
molecular events driving lumen formation by cord hollowing in the dorsal aorta. 
Similarly to what was shown in MDCK cysts, CD34 and podocalyxin sialomucins, 
found in cytoplasmic vesicles at the 1S stage, accumulate at cell-cell contacts and are 
then found exclusively at the apical membrane by the 3S stage. Moesin, F-actin and 
non-muscle myosin II follow the same dynamics: moesin, first cytoplasmic, gets 
targeted to and phosphorylated at cell-cell contacts; F-actin and myosin II, first present 
all around the cell membrane, get enriched at junctions; all finally colocalise with 
podocalyxin at the apical membrane as cells elongate and the lumen opens (Strilic et al., 
2009) (Figure 1.19). 
Endothelial-specific deletion of VE-Cadherin, podocalyxin and moesin in mouse 
embryos all lead to failure in aortic lumen formation. In VE-Cadherin knockout 
embryos, endothelial cells form normal clusters at the 1S stage, but fail to segregate 
CD34, podocalyxin, moesin, F-actin and non-muscle myosin II at cell-cell contacts. 
Cells fail to elongate and no patent lumen can be resolved at later stages of development. 
The knockout of podocalyxin leads to a similar outcome, with diffuse presence of 
moesin in the cytoplasm and no enrichment of F-actin at junctions. Loss of moesin, or 
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inhibition of its phosphorylation using panPKC inhibitors, does not affect segregation of 
podocalyxin but impairs F-actin enrichment at cell junctions. Finally, selective 
inhibition of myosin II enrichment at junctions through VEGF-A haploinsufficiency or 
ROCK inhibition does not affect the polarisation of podocalyxin, moesin and F-actin, 
but lumens fail to form in the affected embryos (Strilic et al., 2009). 
Together, these observations suggest a similar model to the one described in MDCK 
cells, where recruitment of sialomucins at cell junctions allows the separation of 
apposing membranes through electrostatic repulsion (Strilic et al., 2010), while 
coupling of podocalyxin to the actomyosin cytoskeleton through phosphorylated moesin, 
and regulation of actomyosin contraction through VEGF-A and Rho/ROCK signalling, 
allow the cell shape changes required for the opening of a patent lumen (Strilic et al., 
2009) (Figure 1.19). 
 
Similarly to in vitro, both cell-ECM and cell-cell contacts have been identified as 
essential signalling and scaffolding platforms regulating lumen formation in the dorsal 
aorta. Endothelial-specific deletion of integrin β1 in mice leads to embryonic lethality 
between E10.5 and E14.5 from severe haemorrhages, with specific occlusion of mid-
sized arteries. In these vessels, endothelial cells remain cuboidal in shape, and fail to 
lumenise. Junctional proteins (Claudin-5, VE-Cadherin, CD99) are found all around the 
cell membrane and apical polarisation of podocalyxin is lost, suggesting that integrin β1 
is required for proper polarity establishment in the dorsal aorta (Zovein et al., 2010). 
Mislocalisation of Par3 at cell junctions, and accumulation of Rab7-coated vacuoles in 
the cytoplasm of occluding cells, further suggest conserved roles for the Par complex 
and membrane trafficking machineries in establishing polarity in vivo downstream of 
integrin signalling (Zovein et al., 2010). Endothelial-specific deletion of Rasip1, a 
RAP1 effector, additionally supports the idea that attachment to the ECM is required for 
the transition in cell shape observed during lumen formation in the aorta. In vitro, 
Rasip1 is required for the maturation of focal adhesions, possibly through the 
recruitment of Arhgap29, a negative regulator of RhoA signalling. In vivo, dorsal aortas 
in Rasip1 knockout embryos fail to lumenise. At the 3S stage, loss of adherence of the 
endothelial cells to the surrounding mesoderm generates extracellular spaces that grow 
into large cavities by the 6S stage. Although both podocalyxin and F-actin are found 
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enriched at the center of the cord, suggesting partial polarisation, junctional complexes 
and Par3 fail to relocalise laterally, and cells remain cuboidal (Xu et al., 2011). 
Together, these results suggest that the anchoring of endothelial cells to the ECM is 
essential for lumen formation in the dorsal aorta. 
Remodelling of cell-cell junctions is also critical to the successful opening of lumens 
during vasculogenesis in vivo. As previously mentioned, VE-Cadherin is required for 
lumen formation and endothelial cell polarisation in the mouse dorsal aorta (Strilic et al., 
2009). Additionally, junctions constitute scaffolds for the anchoring of actin fibres, thus 
orchestrating the cell shape changes driving lumen formation in vivo. Angiomotin-like 
protein 2 (AmotL2), a membrane-associated scaffold protein that couples VE-Cadherin 
to radial actin fibres in endothelial cells, is required for cell elongation and lumen 
formation both in zebrafish and mouse embryos. In AmotL2a/b zebrafish morphants, 
endothelial cells correctly polarise (as seen by the correct segregation of podocalyxin, 
VE-Cadherin and laminin) but fail to elongate. Interestingly, this correlates with a 
specific loss of the radial actin fibres connecting the actin cortex at cell junctions, and 
the overall phenotype is recapitulated by inhibiting actomyosin contraction with 
blebbistatin. Together with in vitro experiments showing that AmotL2 regulates tensile 
forces at junctions, this suggests a critical role for the contraction of actomyosin fibres 
anchored at junctions in driving the cell shape changes observed during lumen 
formation in the dorsal aorta (Hultin et al., 2014). Following its opening, the stability of 
the aortic lumen also relies on junctional actin dynamics. Additionally to its role as a 
regulator of endothelial cells attachment to the ECM, Rasip1 was also found to protect 
lumen integrity by promoting junction maturation: in both zebrafish and mouse 
embryos, loss of Rasip1 leads to lumen collapse and vascular leakage (Wilson et al., 
2013, Wilson and Ye, 2014). 
 
Together, these studies strongly established that lumens form through a cord hollowing 
process driven by extensive cell shape changes during vasculogenesis in vivo. Despite 
the extensive work carried out in vitro showing the ability of endothelial cells to form 
lumens through vacuole formation and fusion, none of the studies mentioned here were 
able to report the formation of such structures in vivo (Strilic et al., 2009, Xu et al., 
2011). Vacuoles were only detected in the context of integrin β1 deficiency, and their 
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extensive coating with Rab7, a marker for late endosomes and lysosomes, may rather 
suggest they arise from defective signalling and membrane trafficking downstream of 
integrins (Zovein et al., 2010). 
Interestingly, the molecular events driving lumen formation in the dorsal aorta share 
striking similarities with the mechanisms identified in the MDCK cyst model and in the 
Drosophila trachea (see 1.4.2.2.2), highlighting exceptional conservation between 
organs and species in the mechanisms driving the formation of structures of similar 
geometry. 
 
1.4.3.3 Lumen formation during sprouting angiogenesis in vivo 
The highly dynamic behaviour of endothelial cells during sprouting angiogenesis made 
the identification of the mechanisms driving lumen formation in this context 
particularly challenging to study. Several models emerged, and debate started to arise 
within the field concerning the origin of vascular lumens in angiogenic sprouts. 
 
In 2006, a first study by Weinstein and colleagues proposed the model that sprouting 
endothelial cells form lumens through vacuole formation and fusion during sprouting 
angiogenesis in vivo (Kamei et al., 2006). In this study, the authors used two-photon 
time-lapse imaging of transgenic zebrafish embryos expressing either a reporter for 
Cdc42 (Tg(fli1:EGFP-cdc42wt)y48) or RFP tagged with a membrane-targeting 
farnesylation motif (fli1:mRFP-F) to follow lumen formation in sprouting ISVs. 
Acquiring images every 3-5 minutes, they observed the presence of highly dynamic 
spherical membrane patterns within the cytoplasm of sprouting endothelial cells, and 
suggested these structures to be intracellular vacuoles (Figure 1.20). Vacuoles formed, 
disappeared, and eventually fused to open large luminal spaces, similarly to what could 
be observed in vitro in HUVECs cultured in 3D collagen matrices and expressing the 
same EGFP-Cdc42 reporter as well as a farnesylated EGFP (EGFP-F) reporter. Based 
on the idea in the field, at the time, that endothelial cells organised in a head-to-tail 
fashion in ISVs (Childs et al., 2002), the authors suggested vacuole fusion to lead to the 
formation of unicellular lumens. However, the lack of single cell labelling did not allow 
to appreciate whether these vacuoles fused intracellularly, giving rise to hollowed cells, 
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and/or whether fusion at cell junctions participated in expanding intercellular spaces. 
Injection of quantum dots into the circulation of the embryos confirmed that vacuoles 
eventually connected to the main circulation to lead to full lumenisation and perfusion 
of the newly formed vascular loops (Kamei et al., 2006). 
 
 
 
 
Figure 1.20. Endothelial tubes assemble from intracellular vacuoles in vivo 
From (Kamei et al., 2006). “Two-photon time-lapse images of EGFP-positive ventral 
endothelial cells in growing trunk intersegmental vessels in Tg(fli1:EGFP-cdc42wt)y48 
transgenic animals, showing the emergence of vacuoles and their highly dynamic fusion 
into a larger intracellular compartment.” Time is in hours:minutes. Scale bar is 20 µm. 
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Vacuoles were only observed in two other studies (Wang et al., 2010, Yu et al., 2015). 
In 2010, Essner and colleagues observed similar vacuolar structures forming in the 
cytoplasm of sprouting endothelial cells in ISVs expressing a fluorescent reporter for 
moesin1 (Tg(flk1:moesin1-egfp)). The vacuoles they observed had an average size of 
1.08 µm (s.d.: 0.29), rapidly fused with the main luminal compartment, and both 
unlabelled and labelled vacuoles were found in embryos injected intravenously with 
dextran, suggesting at least some of these structures arose de novo (Wang et al., 2010). 
Finally, a recent study by Weinstein and colleagues, using single-cell labelling with 
EGFP-F in zebrafish ISVs and imaging at a rate of one frame per minute, highlighted 
the coalescence of small membrane vesicles into larger membrane structures that could 
correspond to vacuoles forming in single sprouting cells. However, the limited duration 
of the imaging did not allow to follow fusion events and assess whether these structures 
eventually participated in the expansion of the lumen in the sprouts (Yu et al., 2015). 
 
All other studies investigating lumen formation in vivo, using various membrane and 
cytoskeleton reporters, failed to report the formation of such structures (Blum et al., 
2008, Herwig et al., 2011, Lenard et al., 2013, Phng et al., 2015), and the role of 
vacuole formation and fusion in lumen formation during sprouting angiogenesis in vivo 
is, to date, a debated topic in the field. 
 
In parallel, a consistent body of work revisited the idea that endothelial cells organise 
themselves in a head-to-tail fashion in angiogenic sprouts (Childs et al., 2002), and 
suggested major roles for cell junctions in orchestrating lumen formation during 
sprouting angiogenesis in vivo (Blum et al., 2008, Wang et al., 2010, Herwig et al., 
2011, Lenard et al., 2013). Using immunostaining for both adherens (VE-Cadherin) and 
tight (ZO-1) junctions in fixed embryos, Affolter and colleagues carefully analysed 
endothelial cell organisation within ISVs in the developing trunk of zebrafish embryos 
(Blum et al., 2008). At 48 hpf, once lumen is formed, ISVs were found to be made of 4 
to 6 endothelial cells organised such that several cells surrounded the lumen at any 
given position along the vessel. During sprouting, while tip cells connected to the stalk 
of the sprouts through ring-shaped junctions, the rest of the ISVs were found to grow as 
multicellular structures with longitudinal junctions running along the axis of the entire 
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sprout (Blum et al., 2008, Wang et al., 2010). Together, these observations started to 
suggest that the formation of unicellular lumens by vacuole formation and fusion was 
unlikely to be the sole mechanism driving lumen formation in angiogenic sprouts. Live 
imaging of transgenic reporter lines for cell junctions (Tg(fli:GAL4FF;UAS:VE-
CadherinΔC-EGFP)ubs12 and Tg(fli:GAL4FF;UAS:RFP;UAS:EGFP-ZO1)ubs5) allowed 
to carefully follow the dynamics of cell junctions (Herwig et al., 2011, Lenard et al., 
2013), and indeed provided a more complex picture of endothelial cell behaviour during 
lumen formation in vessels forming through angiogenesis. Focusing on the site of 
anastomosis between neighbouring ISVs, where the DLAV forms, Affolter and 
colleagues found that in many instances (37%) junctional rings between connecting tip 
cells, and between the tip cells and their neighbouring stalk cells, extended 
longitudinally along the axis of the DLAV prior to lumen formation, to eventually lead 
to the establishment of new connections between cells from both sides of the vessel, and 
to the splitting of the former tip cells so that the head-to-tail arrangement was lost 
(Figure 1.8). Interestingly, podocalyxin was found to accumulate at nascent junctions 
between tip cells, suggesting their specification as apical domains, and lumen rapidly 
inflated between cell junctions upon cell rearrangement at the site of anastomosis. On 
the other hand (in 63% of cases), lumen could be found to expand in single 
anastomosing cells before cells rearranged, temporarily giving rise to unicellular tubes. 
Lumen expanded in single cells through the rapid invagination of apical membrane 
from their junction with their neighbours (Figure 1.8). In all cases observed, cell 
rearrangements eventually led to the reorganisation of these unicellular lumen portions 
into multicellular tubes (Herwig et al., 2011, Lenard et al., 2013). Together, these 
studies strongly established that both uni- and multicellular lumen formation, through 
membrane invagination and cord hollowing processes respectively, participate to lumen 
formation during anastomosis. 
 
Interestingly, while the opening of the lumen in the dorsal aorta does not require blood 
flow and is solely driven by intrinsic cell shape changes (Strilic et al., 2009, Hultin et al., 
2014), blood circulation is required both for the invagination of apical membranes into 
single endothelial cells, and for the separation of membranes between apposing cells 
during anastomosis. While blood flow is required for the physical opening of the lumen, 
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cells still rearrange normally and localise podocalyxin at cell junctions in the absence of 
flow, suggesting that apical-basal polarity is not compromised (Herwig et al., 2011). 
How blood flow regulates apical membrane expansion and how endothelial cells 
accommodate blood pressure is not known. 
 
How membrane invagination and cord hollowing processes are regulated during 
angiogenesis in vivo, both at the cellular and molecular levels, still requires considerable 
investigation. Endothelial-specific deletion in newborn mice of major polarity effectors 
such as integrin β1, Par3, aPKC, Cdc42, and AmotL2 suggest that these proteins are all 
dispensable for lumen formation and maintenance during developmental angiogenesis 
in the mouse retina (Nakayama et al., 2013, Hultin et al., 2014, Barry et al., 2015, 
Yamamoto et al., 2015), although subtle phenotypes and/or altered endothelial cell 
dynamics might not be detected in this system. Single-cell labelling and manipulation 
techniques in zebrafish, combined with high resolution time-lapse imaging, constitute 
on the other hand powerful tools to build our understanding of these processes. Such 
studies already identified key roles for VE-Cadherin, moesin1, and junctional F-actin 
polymerisation through the formin-like protein 3 (FMNL3), in regulating lumen 
formation and stability during angiogenesis (Wang et al., 2010, Lenard et al., 2013, 
Sauteur et al., 2014, Phng et al., 2015). In ISVs, F-actin is found as a cortical network 
supporting the endothelial cell plasma membrane, including the apical membrane, and 
is particularly enriched at cellular junctions (Wang et al., 2010, Sauteur et al., 2014, 
Phng et al., 2015). In VE-Cadherin mutant embryos, the F-actin network shows a 
disorganised architecture, and cells fail to elongate their junctions longitudinally along 
the vessel axis. Consequently, cells fail to rearrange and mostly stand in a head-to-tail 
fashion within the sprouts. The same is obtained using a VE-Cadherin reporter lacking 
the C-terminal binding domain to β-catenin or treating embryos with the actin 
depolymerisation agent Latrunculin-B (Sauteur et al., 2014), suggesting that VE-
Cadherin and its coupling to the actin cytoskeleton are required for the cell shape 
changes occurring during lumen formation in angiogenic sprouts. Because VE-Cadherin 
mutant embryos lack blood flow (Lenard et al., 2013), the requirement for VE-Cadherin 
in lumen formation had to be addressed at the single-cell level. When transplanted into 
wild-type embryos, VE-Cadherin knockdown cells failed to lumenise (Wang et al., 
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2010), suggesting that VE-Cadherin is required for lumen formation during 
angiogenesis, possibly then through its regulation of cell shape changes in angiogenic 
sprouts (Sauteur et al., 2014). Additional support to this model comes from a study on 
FMNL3, an actin nucleator exclusively found at endothelial cell junctions during 
sprouting. Knockdown of FMNL3 in zebrafish embryos does not alter blood flow, but 
hinders lumen formation and maintenance while phenocopying the junction elongation 
and cellular rearrangement defects observed in the VE-Cadherin mutant embryos (Phng 
et al., 2015). Together, these studies therefore provide strong evidence for a role in cell 
arrangement in the opening and maintenance of stable lumens during sprouting 
angiogenesis in vivo. 
 
1.5 Objectives 
An important point of debate in the field is the question of the origin of the apical 
membrane forming the invagination observed during unicellular lumen formation in 
angiogenic sprouts in vivo. As previously mentioned, vacuoles were suggested to 
participate in the rapid expansion of the luminal compartment in sprouting endothelial 
cells in vivo. However, work by our own and other groups, focusing on various aspects 
of endothelial cell biology, and using a variety of reporters for endothelial cell 
membranes and cytoskeleton components, failed to report the presence of such 
structures in the cytoplasm of endothelial cells during phases of lumen formation. More 
importantly, the limited spatial and temporal resolution offered by the studies 
identifying intracellular vacuoles (hours and minutes) did not seem compatible with the 
kinetics characterising membrane trafficking events (seconds and milliseconds). 
 
In light of the limits of these studies, my objective was to identify the origin of the 
apical membrane expanding into single endothelial cells during lumen formation in vivo. 
Because of the need for dynamic information, and the establishment of ISV sprouting in 
zebrafish as a powerful tool for the study of lumen formation, I decided to follow apical 
membrane dynamics in this same model where membrane invaginations were 
previously observed. Following membrane dynamics in sprouting ISVs first required 
me to establish high spatial (sub-micrometre) and temporal (sub-second) resolution 
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imaging of endothelial cells. This involved generating appropriate reporters to label the 
apical membrane of endothelial cells in vivo, as well as identifying adapted imaging 
systems. Although the use of zebrafish as a model organism appeared essential to 
follow dynamic membrane remodelling events, I also wished to extend my 
investigations, as far as fixed tissues would allow, to the mouse retina model, to address 
conservation in mammals, and potentially allow future use of this system to study the 
genetic basis of the mechanisms identified as driving apical membrane invagination in 
sprouting cells. 
At the same time, I aimed at understanding the role of the actin cytoskeleton in 
regulating apical membrane expansion during angiogenesis in vivo. Because of its 
established role in forming and shaping apical membranes in all the models of lumen 
formation presented above, I planned to use high resolution imaging of its dynamics in 
vivo, and chemical and genetic manipulations, to assess its function(s) during apical 
membrane expansion in angiogenic sprouts. 
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Chapter 2. Materials & Methods 
 
2.1 Zebrafish experiments 
2.1.1 Zebrafish care and procedures 
Zebrafish (Danio rerio) were raised and staged as previously described (Kimmel et al., 
1995). Animal procedures were performed in accordance with the United Kingdom’s 
Home Office Animal Act 1986 under the authority of project license PPL 80/2391; 
animal experiments were approved by LAGeSo (Berlin, Germany) and performed under 
license number G 0117/15. 
 
2.1.2 Transgenic lines 
The following transgenic lines were used in this work: 
- Tg(kdr-l:ras-Cherry)s916 (Hogan et al., 2009); drives the expression of the 
Cherry fluorescent protein tagged with the CAAX motif of human Hras 
specifically in endothelial cells. 
-  Tg(fli1ep:PLCδ-PH-RFP) (unpublished, generated in our laboratory by Russell 
Collins); drives the expression of the pleckstrin homology (PH) domain of 
phospholipase C∂ (PLC∂) fused to RFP specifically in endothelial cells. The PH 
domain of PLC∂ interacts with phosphatidylinositol (4,5)-biphosphate (PIP2), an 
early apical determinant in epithelia. The sequence coding for the PH domain of 
PLC∂ was a gift from Banafshé Larijani (University of the Basque Country, 
Spain). 
- Tg(fli1ep:EGFP-CAAX) (unpublished, generated in our laboratory by Ilse 
Geudens); drives the expression of EGFP tagged with the CAAX motif of 
human Hras specifically in endothelial cells. 
- Tg(fli1ep:Lifeact-EGFP) (Phng et al., 2013); drives the expression of Lifeact, a 
17-amino acid peptide that binds to F-actin, fused to EGFP specifically in 
endothelial cells. 
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2.1.3 Transgenesis 
Tol2 transgenesis was used to express DNA sequences of interest in zebrafish embryos. 
The Tol2 element was first identified in the medaka fish (Oryzias latipes) as an 
autonomous transposon encoding a fully functional transposase. This system was later 
developed as a transgenesis tool to allow random integration of any DNA sequence of 
interest flanked by Tol2 cis sequences into the genome of zebrafish embryos. 
 
Briefly, DNA sequences of interest (including promoter region, coding DNA sequence 
(CDS) and, if applicable, additional regulatory elements) were cloned using the 
Multisite Gateway system (Life Technologies) into destination vectors from the Tol2Kit 
(Kwan et al., 2007) to obtain DNA constructs with the sequence of interest flanked by 
Tol2 cis sequences (Figure 2.1). On the other hand, Tol2 transposase mRNA was 
transcribed from the pCS-TP plasmid (Kawakami et al., 2004) using the SP6 
mMESSAGE mMACHINE kit (Life Technologies). Zebrafish embryos were then 
injected at the one-cell stage with 100 pg of Tol2 transposase mRNA and 40 pg of the 
DNA construct. Translation of the Tol2 transposase mRNA allowed random insertion of 
the sequence of interest into the genome of the embryos (Figure 2.1). Because of the 
random nature of the integration events, expression of the transgene was obtained only 
in single cells throughout the embryo. All experiments mentioning the analysis of 
embryos with “mosaic expression” of transgenes refer to embryos analysed right after 
transgenesis, rather than embryos obtained from stable transgenic lines. 
 
2.1.4 Cloning and constructs 
The following constructs were used for mosaic constitutive expression in zebrafish: 
pTol2-fli1ep:EGFP-CAAX (generated by Ilse Geudens; see map in Appendix), pTol2-
fli1ep:Lifeact-mCherry (generated by Li-Kun Phng; see map in Appendix). 
 
The LexOP/LexPR system (Emelyanov and Parinov, 2008) was used to generate an 
inducible reporter for myosin II. Briefly, the LexOP/LexPR system uses a hybrid 
transcription factor (LexPR transactivator) made of the DNA-binding domain of the 
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bacterial LexA repressor, a truncated ligand-binding domain of the human progesterone 
receptor, and the activation domain of the human NF-κB/p65 protein. In presence of 
mifepristone (RU-486), a synthetic steroid drug, this hybrid transactivator binds to a 
synthetic operator-promoter harbouring LexA binding sites (lexOP promoter), allowing 
expression of the downstream CDS (Figure 2.2). 
This system was implemented in our laboratory by Li-Kun Phng, who designed a 
pTol2-fli1ep:LexPR plasmid (Figure 2.2; see map in Appendix) driving the expression 
of the LexPR transactivator in endothelial cells, and therefore allowing inducible, 
endothelial-specific expression of transgenes of interest from a second plasmid using 
the lexOP promoter (unpublished; Figure 2.2; see map in Appendix). 
 
The CDS for the myosin light chain Myl9b was obtained from Source Bioscience (clone 
I0038156), cloned into a middle entry vector (pME-myl9b), and then used along a p5E-
lexOP 5’ entry vector (generated by Li-Kun Phng) and a p3E-EGFP 3’ entry vector 
(generated by Russell Collins) to generate a pTol2-lexOP:myl9b-EGFP construct (see 
map in Appendix). pTol2-fli1ep:LexPR and pTol2-lexOP:myl9b-EGFP plasmids were 
then co-injected with Tol2 transposase mRNA in one-cell stage embryos. The 
expression of the myl9b-EGFP fusion construct was induced at the onset of lumen 
formation by treating dechorionated embryos from 26 hpf with 20 µM mifepristone 
(Sigma, M8046). Green fluorescence could be observed from 3 to 4 hours after the start 
of the treatment. 
 
In order to generate a dominant-negative form of the Myl9b-EGFP reporter, targeted 
mutagenesis was performed on the pME-myl9b middle entry vector. Based on previous 
work in cultured mammalian cells (Iwasaki et al., 2001), the following base 
modifications were introduced using the QuikChange II Site-Directed Mutagenesis Kit 
(Agilent Technologies): A58G and T61G. These modifications led to the substitution of 
Alanine for Threonine 18 and Serine 19 in the Myl9b protein, hence its designation as 
Myl9bAA in this thesis. The pME-myl9bAA middle entry vector thus generated was 
then used to generate a pTol2-lexOP:myl9bAA-EGFP dominant-negative reporter 
construct as previously described.   
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Figure 2.1. Experimental procedure for live imaging of fluorescent reporters in 
single cells in zebrafish embryos 
Adapted from (Kimmel et al., 1995) and (Kawakami, 2007). 
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Figure 2.2. LexOP/LexPR inducible expression system 
Adapted from (Emelyanov and Parinov, 2008). 
LexA-DBD, LexA DNA binding domain. hPR-LBD, human progesterone receptor 
ligand binding domain. p65-AD, p65 activation domain. 
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2.1.5 Embryo preparation for imaging 
Embryos were kept in egg water (60 µg/mL Instant Ocean Sea Salts (Cat. #SS15-10) in 
dH2O) at 28.5°C until processed for imaging. 
For imaging, embryos were dechorionated using a pair of fine forceps (Fine Science 
Tools, Cat. #11254-20), selected for normal morphology, normal heartbeat and presence 
of circulating red blood cells (indicative of blood flow), and anaesthetised with 0.16 
mg/mL (1x) ethyl 3-aminobenzoate methanesulfonate (referred to as tricaine; Sigma, 
Cat. #E10521). Using a Leica M205 FA fluorescence stereomicroscope, embryos 
showing expression of the transgene of interest in endothelial cells were selected and 
transferred to a Petri dish coated with 1% UltraPure™ Agarose (Life Technologies, Cat. 
#16500-500) and filled with E3 buffer (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 
0.33 mM MgSO4) supplemented with 1x tricaine. 
Embryos were then mounted onto the bottom of 6-cm plastic dishes (Thermo Scientific, 
Cat. #130181) in single drops of 0.8% UltraPure™ Low Melting Point Agarose (Life 
Technologies, Cat. #16520-050) in E3 buffer supplemented with 1x tricaine. The 
amount of agarose used for mounting was kept to a minimum to allow the shortest 
working distance possible. Embryos were mounted on their side (Figure 2.1), and fine 
forceps were used until agarose was partially set to keep the embryos from rolling onto 
their back due to the volume of the yolk. A dozen embryos could be mounted in each 
dish. Once agarose was fully set, embryos were then covered with 10 mL of E3 buffer 
with 1x tricaine and brought to the microscope for imaging. 
 
2.1.6 Live imaging 
Live imaging of zebrafish embryos was performed at 28.5°C on: 
- an upright Carl Zeiss LSM 700 confocal microscope using a Zeiss Plan-
Apochromat 40x/1.0 NA water dipping objective 
- an inverted Andor Revolution 500 spinning disk confocal using a Nikon Plan 
Apo 60x/1.24 NA water immersion objective, whose access was kindly provided 
by Pieter Vanden Berghe (Cell Imaging Core Facility, KU Leuven, Belgium) 
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- an inverted 3i spinning disk confocal using a Zeiss C-Apochromat 63x/1.2 NA 
water immersion objective, whose access was kindly provided by Thomas 
Surrey and Nicholas Cade (Francis Crick Institute, Lincoln’s Inn Fields 
Laboratories, London, UK) 
- an upright 3i spinning disk confocal using a Zeiss Plan-Apochromat 63x/1.0 NA 
water dipping objective 
 
Depending on the system capabilities and the needs of the experiment, z-stacks 
covering the cellular structures of interest were acquired from every 5 seconds to every 
15 minutes. Pinhole size (if applicable), gain (if applicable), exposure time (if 
applicable), and laser power values, were optimised to reach the desired spatial and 
temporal resolutions while limiting photobleaching and phototoxicity. 
 
2.1.7 Laser ablations 
Laser ablations of single ISVs or of more defined cellular regions were performed on an 
upright 3i spinning disk confocal fitted with a Zeiss Plan-Apochromat 63x/1.0 NA 
water dipping objective using an Ablate™ 532 nm pulse laser, at a theoretical speed of 
100 pulses per second and a theoretical energy of 60 µJ. Ablations were performed in 
single confocal planes along lines spanning the entire thickness of the structures to be 
ablated (cell body, or membrane and underlying cortex). Laser was applied for 10 ms at 
10-20% of the maximum laser power. Ablation of the structures of interest was obtained 
by performing sequential laser cuts using increasing laser power (starting from 10% 
with 1% increments, up to 20%) at 5 to 10-second intervals. 
 
2.1.8 Image analysis 
Images were analysed using the FiJi software (Schindelin et al., 2012). Z-stacks were 
flattened by maximum intensity projection. XY drifts were corrected using the 
MultiStackReg plugin (B. Busse, NICHD). Fluorescence bleaching was corrected by 
Histogram Matching. Kymographs were generated using the MultipleKymograph 
plugin (J. Rietdorf and A. Seitz, EMBL). Contrast in all images was adjusted in Adobe 
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Photoshop CS5.1 for visualisation purposes. All images presented in this thesis are 
representative of the analysed data. 
 
2.1.9 Statistical analysis 
No statistical method was used to predetermine sample size. The experiments were not 
randomised. I was not blinded to allocation during experiment and outcome assessment. 
Statistical analysis was performed with help from Gavin Kelly (Francis Crick Institute, 
Lincoln’s Inn Fields Laboratories, London, UK). A multinomial log-linear model was 
used to test for association of bleb or cell count in the different defined phenotypic 
categories with the cell mutation status (WT or AA). The null model was that count 
variation was only due to experimental batch. 
 
2.2 Mouse experiments 
2.2.1 Mouse care and procedures 
Animal procedures were performed in accordance with the United Kingdom’s Home 
Office Animal Act 1986 under the authority of project license PPL 80/2391. 
The following mouse strains were used in this study: C57BL/6 and Lifeact-EGFP (Riedl 
et al., 2010). Lifeact-EGFP mice were genotyped by checking ear biopsies for the 
presence of bright green fluorescence. 
 
2.2.2 Retina dissection 
Pups were culled by decapitation at post-natal day 6 (P6). The skin covering the eyes 
was cut with fine scissors (Fine Science Tools, Cat. #14568-09) and the eyes collected 
using curved tweezers. 
 
Eyes were then fixed for 1 hour rocking at 4°C in a solution of 4% paraformaldehyde 
(PFA). 4% PFA solution was prepared by dissolving 40 g of PFA (Sigma, Cat. 
#441244) in 900 mL of dH2O heated to 70°C. The solution was then supplemented with 
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300 µL of NaOH 1M and, once cleared, 100 mL of 10x phosphate buffer saline (PBS; 
Sigma, Cat. #P5493). pH was adjusted to 7.3-7.4, the final solution filtered, and aliquots 
frozen and stored at -20°C. 
 
After fixation, eyes were washed once with PBS and kept in PBS on ice until further 
processing. Retina dissection (Figure 2.3) was performed under a stereomicroscope in a 
Petri dish filled with PBS. First, the retina was punctured at the limit between the 
cornea and the sclera using a 26G x 1’’ needle (B. Braun, Cat. #16010396E). With the 
help of fine forceps (Fine Science Tools, Cat. #11254-20) to hold the eye in place, a 
circular cut was then performed from the puncture hole using spring scissors (Fine 
Science Tools, Cat. #15000-00). The cornea, lens, iris, hyaloid vessels, and sclera were 
then removed in this sequence using a pair of fine forceps. Four radial incisions were 
then made on the extracted retina (Figure 2.3). Retinas were finally transferred to 2 mL 
Eppendorf tubes with PBS and stored on ice until further processing. 
 
2.2.3 Immunofluorescence staining of mouse retinas 
Retinas were blocked for 2 hours rocking at 4°C in Claudio’s blocking buffer (CBB; 
0.5% Triton X-100 (Sigma, Cat. #X-100), 1% bovine serum albumin (BSA; Fisher 
Scientific, Cat. #BP1600), 2% sheep serum (Sigma, Cat. #S2263), 0.01% sodium 
deoxycholate (Sigma, Cat. #D6750), 0.02% sodium azide (Sigma, Cat. #S2002)). 
Retinas were then incubated with primary antibodies diluted to optimised 
concentrations (Table 2.1) in 1:1 PBS:CBB shaking overnight at 4°C. Retinas were then 
washed three times for 10 minutes with PBS supplemented with 0.1% Tween-20 
(Sigma, Cat. #P2287) (PBST), and incubated for 2 hours at room temperature with 
secondary antibodies diluted to optimised concentrations (Table 2.1) in 1:1 PBS:CBB. 
Retinas were then washed three times for 10 minutes with PBST, incubated for 10 
minutes in DAPI (Invitrogen, Cat. #D1306) staining solution in PBS, washed once for 
10 minutes with PBST, and finally fixed for 10 minutes in 4% PFA solution. Retinas 
were then kept in PBS at 4°C until processed for mounting. 
When isolectin staining of blood vessels was required, retinas were incubated after post-
staining fixation for 1 hour at room temperature in PBlec buffer (1% Tween-20, 0.1 mM 
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CaCl2, 0.1 mM MgCl2, 0.1 mM MnCl2 in PBS, pH 6.8), then overnight at 4°C with 
isolectin GS-IB4 diluted to optimised concentrations (Table 2.1) in PBlec buffer. 
Retinas were then washed three times for 10 minutes with PBST, fixed for 10 minutes 
in 4% PFA solution, then processed for mounting. 
 
Retinas were flat-mounted on glass microscope slides (Thermo Scientific, Cat. #ISO 
8037/1) in Vectashield mounting medium (Vector Laboratories, Cat. #H-1000). In order 
to conserve the 3D architecture of the tissue, slides were covered with one layer of PVC 
electrical insulation tape (Advance, Cat. #BS EN 60454 Type 2), and a scalpel was used 
to cut a window where retinas were laid flat, then covered with mounting medium and a 
glass coverslip (Menzel-Gläser, Cat. #CS2250100). 
 
2.2.4 Imaging and image analysis 
Samples were imaged with an upright Carl Zeiss LSM 780 microscope using an Alpha 
Plan-Apochromat 63x/1.46 NA oil objective. Images were analysed using the FiJi 
software (Schindelin et al., 2012). Z-stacks were flattened by maximum intensity 
projection. Contrast in all images was adjusted in Adobe Photoshop CS5.1 for 
visualisation purposes. All images presented in this thesis are representative of the 
analysed data. 
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Figure 2.3. Mouse retina dissection and mounting  
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Antibody Host Dilution Reference 
Primary antibodies    
    ICAM-2 Rat 1:400 BD Biosciences, Cat. #553326 
    nmMyosin IIA Rabbit 1:100 Covance, Cat. #PRB-440P 
    pMLC2 Rabbit 1:100 Cell Signalling, Cat. #3671 
    ZO-1 Rabbit 1:400 Life Technologies, Cat. #61-7300 
Secondary antibodies    
    Anti-rabbit Alexa Fluor® 488 Goat 1:1000 Life Technologies, Cat. #A-11008 
    Anti-rat Alexa Fluor® 555 Goat 1:1000 Life Technologies, Cat. #A-21434 
Isolectin    
    Isolectin GS-IB4 Alexa Fluor® 647 - 1:400 Life Technologies, Cat. #I32450 
 
Table 2.1. List of antibodies used for immunofluorescence staining in mouse 
retinas 
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Chapter 3. Lumen does not form through vacuole 
formation and fusion during sprouting angiogenesis in vivo 
 
3.1 Introduction 
Previous studies suggested that lumens form during sprouting angiogenesis in vivo 
through the generation, and later fusion, of intracellular vacuoles in sprouting tip cells 
(Kamei et al., 2006, Wang et al., 2010, Yu et al., 2015). This process, similar to what 
has been described and since extensively studied in in vitro models of blood vessel 
formation (Davis et al., 2011, Sacharidou et al., 2012), was suggested to drive lumen 
formation independently of blood flow (Wang et al., 2010). However, subsequent 
studies (Herwig et al., 2011, Lenard et al., 2013) failed to observe such structures in a 
number of zebrafish reporter lines, and started to question the model in which 
endothelial cells expand lumens through vacuole formation and fusion in vivo. 
In order to clear this controversy and advance our understanding of the cellular 
mechanisms driving lumen formation in angiogenic sprouts, and in light of the limits 
inherent to the aforementioned studies, I decided to establish high resolution imaging of 
the apical membrane of endothelial cells in vivo to follow with high detail apical 
membrane dynamics during sprouting angiogenesis. This chapter presents the strategy I 
followed to reach this aim, and the findings I made as a result regarding the mechanisms 
driving lumen formation during sprouting angiogenesis. 
 
3.2 Establishment of high resolution imaging of the apical membrane 
in in vivo models of sprouting angiogenesis 
Previous studies suggesting a role for vacuole formation and fusion in vivo shared the 
limit of relying on both low spatial and low temporal resolution in the imaging of these 
processes. In particular, frame rates of the order of one frame every 3 to 5 minutes did 
not seem adequate to follow processes as rapid as membrane trafficking and membrane 
fusion events. Recent studies focused on other aspects of endothelial cell biology such 
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as junctional dynamics (Lenard et al., 2013, Sauteur et al., 2014, Phng et al., 2015) and 
vascular remodelling (Lenard et al., 2015) indeed highlighted the importance of 
performing high resolution imaging in order to draw definite conclusions on the 
mechanisms at play during such dynamic events. 
I decided to establish high resolution imaging of the apical membrane of endothelial 
cells in two in vivo models of sprouting angiogenesis, the post-natal mouse retina 
vasculature and the zebrafish trunk vasculature. The choice of these two models was 
based on the points detailed in 1.3. In particular, the mouse retina model offered the 
highest potential for high spatial resolution imaging, with the vasculature directly 
accessible at the surface of the tissue, while the use of zebrafish was key to provide 
temporal information. In addition, I wished to strengthen my study by comparing results 
in two different models, including a mammalian system. 
The establishment of high resolution imaging relied on 1) the selection of markers 
specific for the apical membrane, and the optimisation of the labelling techniques (as 
detailed in chapter 2) to obtain high signal-to-noise ratios during imaging, and 2) the 
choice of appropriate imaging systems. 
 
3.2.1 Choice of apical membrane markers 
In the mouse retina, my choice turned to the use of antibodies targeting the intercellular 
adhesion molecule 2 (ICAM-2), a transmembrane glycoprotein expressed at the apical 
membrane of endothelial cells that binds to lymphocyte function-associated protein 1 
(LFA-1), an adhesion molecule expressed at the surface of leukocytes. In mouse retinas 
collected at post-natal day 6 (P6), all structures staining for podocalyxin, an early apical 
determinant, were found to also stain for ICAM-2 in endothelial sprouts (Figure 3.1). 
Since podocalyxin has been identified as one of the earliest determinants recruited at the 
apical membrane in epithelial tissues (Rodriguez-Boulan and Macara, 2014), including 
the endothelium (Strilic et al., 2009, Strilic et al., 2010, Herwig et al., 2011), ICAM-2 
therefore appeared to be a reliable marker for both early and mature apical structures in 
endothelial cells. Importantly, in contrast to podocalyxin, immunostaining for ICAM-2 
offered very low background signal (Figure 3.1), allowing clear visualisation of the 
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apical membrane in endothelial sprouts, and therefore making it a marker of choice for 
the study of lumen formation in mouse retinas. 
 
In zebrafish embryos, expression through Tol2 transgenesis of fluorescent reporters for 
proteins known to localise at the apical membrane bears the risk of overexpressing 
functional proteins and thus affecting the biology of the cells. In order to circumvent 
this event, my choice turned to the use of standard bright fluorophores (EGFP and 
mCherry) tagged at their C-terminus with a CAAX motif (C standing for cysteine, A for 
aliphatic amino acid, and X for any amino acid). CAAX motifs are post-translational 
modification motifs that regulate protein localisation to cell membranes. Briefly, the 
processing of CAAX sequences through three consecutive enzymatic reactions leads to 
1) the addition of a polyisoprene lipid chain to the cysteine, 2) the cleavage of the AAX 
residues, and 3) the addition of a methyl group at the C-terminus of the protein. This 
sequence of modifications leads to the formation of a hydrophobic domain that confers 
affinity for lipid bilayers. CAAX motifs have been shown to regulate protein 
localisation and associated signalling, one well-studied example being the Ras 
superfamily of small GTPases (Wright and Philips, 2006). 
In the case of endothelial cells, the Tg(kdr-l:ras-Cherry)s916 zebrafish line (Hogan et al., 
2009) has been widely used to study the development of the vasculature, and uses the 
mCherry fluorophore fused to the C-terminus of the human HRas GTPase to label 
endothelial cell membranes. By performing high resolution imaging in Tg(kdr-l:ras-
Cherry)s916 embryos, I found that this reporter accumulates at the apical membrane and 
cell junctions of endothelial cells during lumen formation in intersegmental vessels 
(ISVs), similarly to a PLC∂-PH-RFP reporter for phosphatidylinositol (4,5)-biphosphate 
(PIP2), an early apical determinant in epithelia (Figure 3.2 a,b). The mCherry-CAAX 
reporter additionally only suffered from limited photobleaching (data not shown). 
A second zebrafish line expressing EGFP tagged with the CAAX motif from HRas 
under the control of the endothelial-specific fli1ep promoter (Tg(fli1ep:EGFP-CAAX)) 
was generated in our laboratory by Ilse Geudens (KU Leuven), and showed the same 
localisation at the apical membrane and cell junctions (Figure 3.2 c). 
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Together, these experiments established ICAM-2, and EGFP-CAAX and mCherry-
CAAX, as good reporters for the apical membrane of endothelial cells in mouse retinas 
and zebrafish ISVs, respectively. 
 
3.2.2 Choice of imaging systems 
The imaging of mouse retinas was performed using an upright Carl Zeiss LSM 780 
confocal laser scanning microscope using an Alpha Plan-Apochromat 63x/1.46 NA oil 
objective. Although the theoretical resolving power of the lens was 174 nm at a 
wavelength of 509 nm (emission maximum for EGFP), in practice the XY resolution 
achieved was estimated at 200-300 nm, due to factors such as light scattering and noise. 
Images were sampled at 0.132 µm/pixel with fields of view of 135x135 µm. Together, 
these parameters made possible the visual separation of apical and basal membranes in 
lumenised vessels (Figure 3.1) and, in theory, the observation of sub-micrometre 
structures such as membrane vesicles (not shown). Z-stacks were acquired with 1-µm 
steps. 
 
For live imaging of zebrafish embryos, additional elements needed to be taken into 
consideration. While previous studies looking at apical membrane dynamics during 
endothelial cell lumenisation used frame rates of one frame every 3 to 5 minutes (Kamei 
et al., 2006, Wang et al., 2010), my aim was to reach a temporal resolution in the order 
of seconds to follow processes as fast as vesicular trafficking. Additionally, 
photobleaching and phototoxicity had to be reduced to the minimum in order to allow 
such rapid imaging over a period of several hours. 
These considerations led me to choose spinning disk confocal microscopy for imaging 
in zebrafish. After testing and using several systems (see details in chapter 2) over the 
course of this work, the best resolution was obtained, and most of the experiments 
presented in this thesis were performed, using an upright 3i spinning disk confocal 
microscope using a Zeiss Plan-Apochromat 63x/1.0 NA water dipping objective. This 
system offered reduced photobleaching and undetectable phototoxicity. The theoretical 
resolving power of the lens was 255 nm at a wavelength of 509 nm, although in practice 
the XY resolution achieved was estimated at 300-350 nm. Images were sampled at 0.1 
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µm/pixel with fields of view of 135x135 µm. This allowed clear visualisation of the 
apical membrane in sprouting ISVs (Figure 3.2). Z-stacks were acquired with 1-µm 
steps. Importantly, both the EGFP-CAAX and mCherry-CAAX reporters could be 
imaged at a rate of up to 5 frames per second. 
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Figure 3.1. ICAM-2 is a specific marker for the apical membrane in mouse retinas 
Wild-type mouse retinas were collected at P6 and stained for podocalyxin (green), 
ICAM-2 (magenta), and isolectin IB4. Isolectin IB4 staining was used to delineate the 
outline of the cell (white dotted line). Top panels are maximum intensity projections. 
Bottom panels are single z planes. Arrows show co-localisation of podocalyxin and 
ICAM-2 at the apical membrane. Scale bars are 10 µm. 
 
 
 
 
 
Figure 3.2. mCherry-CAAX and EGFP-CAAX localise to the apical membrane 
and cell junctions in sprouting ISVs 
Tg(fli1ep:PLC∂-PH-RFP) (a), Tg(kdr-l:ras-Cherry)s916 (b) and Tg(fli1ep:EGFP-CAAX) 
(c)  zebrafish embryos were imaged between 32 and 36 hpf. Arrows show localisation 
of the reporters at the apical membrane. Arrowheads show localisation at cell junctions. 
Scale bars are 10 µm.   
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3.3 Lumen does not expand by vacuole formation and fusion in 
angiogenic sprouts in vivo 
The apical markers and imaging systems thus identified allowed to image the apical 
membrane of sprouting endothelial cells in the mouse retina and in zebrafish ISVs with 
both high spatial and high temporal resolution, and to investigate the cellular 
morphogenetic events leading to lumen expansion in angiogenic sprouts. 
In order to assess whether lumens expand through vacuole formation and fusion in vivo, 
P6 mouse retinas were stained for ICAM-2 and sprouting endothelial cells were 
screened for the presence of such cellular compartments. From n=487 sprouts analysed 
in N=9 retinas, only 8 sprouts (1.6 %) showed the presence of large disconnected lumen 
fragments (Table 3.1 and Figures 3.3 and 3.4 a), suggesting it is very unlikely that the 
generation of such structures de novo is the main mechanism driving lumen formation 
in the mouse retina vasculature. Importantly, some of these fragments were found to 
retain what seemed to be white blood cells (Figure 3.4 a, white arrowhead), suggesting 
these fragments were previously perfused and likely the result of the collapse of pre-
existing lumens. 
Imaging of Tg(kdr-l:ras-Cherry)s916 zebrafish embryos from 30 hours post-fertilisation 
(hpf) supported this hypothesis, and showed that large lumen fragments arise during 
ISV lumenisation following the collapse of already-formed lumens (Figure 3.4 b). 
Further imaging showed that these fragments later reconnect to the growing lumen 
(Figure 3.4 b), or collapse into smaller membrane fragments. More importantly, no 
vacuole was found to form de novo in any of the cells analysed in these experiments 
(n=10), nor in any of the other experiments presented in this thesis, using a range of 
reporters for endothelial cell membrane, cytoplasm, and cytoskeleton components. 
Together, these results strongly suggest that angiogenic sprouts, both in the mouse 
retina and in the zebrafish trunk vasculature, do not expand through vacuole formation 
and fusion. 
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3.4 Lumen expansion is dependent on blood pressure 
Whereas it is well established that lumens form independently of blood flow during 
dorsal aorta formation (Jin et al., 2005), previous studies suggested both flow-
independent and flow-dependent lumen formation in ISVs (Wang et al., 2010) and 
during anastomosis (Herwig et al., 2011, Lenard et al., 2013), respectively. To test 
whether lumen expansion in angiogenic sprouts requires blood perfusion, Tg(kdr-l:ras-
Cherry)s916 embryos were treated with a four-fold higher dose of tricaine 
methanesulfonate (4x tricaine) than the dose normally used for anesthesia. Under these 
conditions, embryos show lower heart rate, loss of blood flow and decreased blood 
pressure (Lenard et al., 2013). Upon the addition of 4x tricaine mid-way through ISV 
lumenisation, lumens did not expand further and eventually collapsed (Figure 3.5). 
However, when placed back in 1x tricaine at 2 days post-fertilisation (dpf), the embryos 
recovered normal heartbeat, blood flow was re-established (as assessed by the presence 
of circulating red blood cells) and lumens expanded through the ISVs. Control embryos 
kept in 1x tricaine for the whole duration of the experiment lumenised normally from 
30-35 hpf, while embryos kept in 4x tricaine remained unlumenised (Figure 3.5). 
Together, these data show that lumen expansion in endothelial sprouts is dependent on 
cardiac activity and on the presence of blood flow. 
 
3.5 Conclusions 
As described above, I was able to establish both high spatial (sub-micrometre) and high 
temporal (sub-second/minute) resolution imaging of lumen formation in two different in 
vivo models of sprouting angiogenesis, the mouse retina vasculature and the zebrafish 
trunk vasculature. Data obtained from the imaging of lumenising endothelial cells in 
both models led me to challenge the current model proposed by Weinstein and 
colleagues (Kamei et al., 2006, Yu et al., 2015) in which they suggest that lumens form 
during sprouting angiogenesis in vivo through the formation and fusion of intracellular 
vacuoles. Following in detail apical membrane dynamics in single endothelial cells, and 
using reporters bearing no biological function, I was not able to observe the formation 
de novo of any vacuole in the cytoplasm of lumenising cells, but instead found that 
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lumen fragments only occasionally arise from the collapse of pre-existing lumens. 
Additionally, in contradiction to their proposed model, I found that lumens did not 
expand in the absence of blood flow, suggesting a mechanism of lumen expansion 
driven by blood pressure in angiogenic sprouts in vivo.  
 
 
 Uni-cellular 
% of total 
unicellular 
Multi-
cellular 
% of total 
multicellular Total 
% of total 
lumens 
Expanded 33 57.9 302 70.2 335 68.8 
Constricted 17 29.8 119 27.7 136 27.9 
Disconnected 7 12.3 1 0.2 8 1.6 
Closed 0 0 8 1.9 8 1.6 
Total 57 100 430 100 487 100 
% of total 
lumens 12  88    
 
Table 3.1. Quantitative analysis of lumen conformations in endothelial sprouts in 
P6 mouse retinas 
Wild-type P6 mouse retinas (N=9) were stained for ICAM-2 and ZO-1. Endothelial 
sprouts (n=487) were screened by eye and classified into different categories according 
to the conformation of the lumen in these sprouts (expanded, constricted, disconnected, 
or closed; for representative examples see Figure 3.3), and on whether these lumens 
were observed as invaginations into single endothelial cells (unicellular) or were shared 
between several cells at the tip of the sprout (multicellular). 
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Figure 3.3. Categorisation of endothelial sprouts according to lumen conformation 
and cellularity (continued on next page) 
Wild-type P6 mouse retinas were stained for ZO-1 (green), ICAM-2 (magenta) and 
isolectin IB4. Isolectin IB4 staining was used to delineate the outline of the cells (white 
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dotted lines). Arrows, points of constriction at the apical membrane. Arrowheads, 
lumen fragments. Scale bar is 10 µm. 
 
 
 
 
Figure 3.4. Disconnected lumen fragments arise from the collapse of pre-existing 
lumens 
a) Wild-type P6 mouse retinas were stained for ICAM-2 (magenta) and DAPI (green). 
White arrows, disconnected lumen fragments. White arrowhead, trapped white blood 
cell. Top panels are maximum intensity projections. Bottom panels are single z planes. 
Scale bars are 10 µm. 
b) Embryos with mosaic expression of EGFP-CAAX (n=7) were imaged from 36 hpf. 
Black arrow, lumen fragment. Black arrowhead, local lumen collapse. Time is in 
hours:minutes:seconds. Scale bar is 10 µm. 
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Figure 3.5. Blood pressure is required for lumen expansion in angiogenic sprouts 
Tg(kdr-l:ras-Cherry)s916 embryos (n=5 for each condition) were imaged at 33 hpf (A, 
A’, A’’). Two (out of three) sets of embryos were then treated with 4x tricaine (A’-E’, 
A’’-E’’). Blood flow stopped after 20-25 minutes of treatment, as assessed by the 
absence of circulating red blood cells (not shown). Control embryos (A-E) were left in 
1x tricaine. After 14h of treatment with 4x tricaine, a first set of embryos was returned 
to 1x tricaine (A’-E’). The second set of embryos was kept in 4x tricaine (A’’-E’’). 
Arrows, lumens. Scale bar is 10 µm. 
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Chapter 4. Blood pressure drives lumen formation by 
inverse membrane blebbing during sprouting angiogenesis 
in vivo 
 
4.1 Introduction 
The results presented in the previous chapter suggested that lumens do not expand 
through de novo vacuole formation during sprouting angiogenesis in vivo, and that their 
expansion is dependent on the presence of blood flow as inhibiting heart activity 
abrogates lumen formation in sprouting ISVs in zebrafish. 
In this chapter, I present my finding that apical membrane expands in angiogenic 
sprouts in vivo through a novel mechanism of inverse membrane blebbing. 
 
4.2 Angiogenic sprouts expand both unicellular and multicellular 
lumens in vivo 
During anastomosis, lumens expand both through apical membrane invagination into 
single anastomosing cells (unicellular lumen formation), and by de novo apical 
membrane formation at their nascent junction (multicellular lumen formation) (Herwig 
et al., 2011, Lenard et al., 2013). Since the tip of endothelial sprouts can be occupied by 
either one or several cells as they compete for the tip position (Jakobsson et al., 2010, 
Pelton et al., 2014), I asked whether similar mechanisms of lumen formation apply to 
unicellular and multicellular endothelial sprouts prior to anastomosis. 
 
Using immunostainings for ICAM-2 and zona occludens-1 (ZO-1) in P6 mouse retinas, 
I was able to image respectively the apical membrane and cell junctions in sprouting tip 
cells undergoing lumen formation. By doing so, I found that lumens are present either 
as membrane invaginations into single tip cells, or between cells as they share the tip 
position (Figure 3.3), suggesting that endothelial cells undergo both unicellular and 
multicellular lumen formation in the mouse retina. Quantification showed that 88 % of 
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the sprouts at the vascular front of P6 retinas have multicellular lumens, while the 
remaining 12 % have unicellular lumens (Table 3.1), suggesting that unicellular lumen 
formation is a rare and/or short-lived event during sprouting angiogenesis in mice. 
 
Time-lapse imaging of Tg(kdr-l:ras-Cherry)s916 zebrafish embryos showed that, similar 
to what was observed in mouse retinas, lumens expand in sprouting ISVs prior to 
anastomosis, and do so by invagination of the apical membrane either into single tip 
cells (Figure 4.1 and Movie 4.1), or along cell junctions when the tip of a sprouting ISV 
is shared between several cells (Figure 4.1 and Movie 4.2). 
 
 
 
Figure 4.1. Endothelial sprouts undergo both unicellular and multicellular lumen 
formation in zebrafish ISVs (continued on next page) 
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a) Tg(kdr-l:ras-Cherry)s916 embryos (n=10) were imaged from 32 hpf. Black arrows, 
cell junction. Magenta arrows, apical membrane. Time is in hours:minutes:seconds. 
Scale bar is 10 µm. 
b) Schematic illustration of unicellular and multicellular lumen formation in angiogenic 
sprouts. 
 
4.3 Apical membranes expand by inverse membrane blebbing during 
angiogenesis 
4.3.1 Apical membranes undergo inverse blebbing during unicellular and 
multicellular lumen expansion 
In order to get a better understanding of the mechanisms responsible for apical 
membrane expansion in sprouting ISVs, I imaged with high spatial and temporal 
resolution zebrafish embryos with mosaic expression of EGFP-CAAX. By doing so, I 
discovered that apical membranes undergo rapid expansion through a process 
reminiscent of membrane blebbing (Figure 4.2 and Movie 4.3). 
 
In most eukaryotic cells, the plasma membrane is supported by a cortex of actin, myosin, 
and associated proteins. Because of its contractile properties, this cortex can generate 
tension and counteract the pressure exerted by the cytoplasm on the plasma membrane; 
it is thus actively maintaining but also adapting cell shape during processes such as cell 
division or cell migration. Membrane blebs are small (about 2-10 µm in size) plasma 
membrane protrusions caused by local rupture of the actomyosin cortex or its 
detachment from the plasma membrane (bleb initiation, Figure 4.3; and (Cunningham, 
1995, Keller and Eggli, 1998, Paluch et al., 2005, Charras et al., 2008)). Under 
cytoplasmic pressure, the membrane in such actomyosin-free regions inflates from a 
neck into a spherical protrusion (bleb expansion, Figure 4.3). Bleb expansion is thought 
to be the result of both tearing of the membrane from the cortex and flow of lipids 
through the bleb neck, rather than of endocytosis and/or un-wrinkling of the membrane 
(Charras et al., 2008). Depending on the context, blebs are eventually resolved either by 
detachment (as seen in apoptosis), forward movement of the cell (during cell migration), 
or through recruitment and contraction of actomyosin on the inner side of the bleb (bleb 
retraction, as seen in cell division) (Figure 4.3 and (Charras and Paluch, 2008)). 
Chapter 4 Results 
 
 113 
In endothelial cells, blebbing was observed at the apical membrane during lumen 
expansion (Figure 4.2 a and Movie 4.3). These blebs however showed inverted polarity 
in comparison to previously described blebs, with the apical membrane protruding into 
the cell body. Hence, I propose to name this process “inverse membrane blebbing”. 
Following expansion, inverse blebs either retracted (Figure 4.2 a, panel B and black 
arrowheads in Figure 4.2 b) or persisted, in particular as larger structures, leading to an 
expansion of the luminal compartment (Figure 4.2 a, panel C and white arrowheads in 
Figure 4.2 b). Interestingly, persisting blebs were only found at the tip of the growing 
lumen, therefore restricting lumen expansion to this region of the cell. In contrast, blebs 
arising on the lateral sides of the lumen always retracted. Finally, no bleb was found to 
detach from the apical membrane (not shown). 
Quantitative morphometric analysis of inverse blebs showed that their size, expansion 
time and speed, as well as retraction time and speed, are of the same order of magnitude 
as those of classical blebs (Figure 4.4, Table 4.1 and (Cunningham, 1995, Charras et al., 
2008)). 
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Figure 4.2. Apical membrane undergoes inverse membrane blebbing during lumen 
expansion in sprouting ISVs 
Embryos with mosaic expression of EGFP-CAAX (n=7) were imaged from 36 hpf. 
a) Arrow in B, retracting bleb. Arrowheads in C, bleb necks. Time is in 
hours:minutes:seconds. Scale bars are 10 µm (A,C) and 5 µm (B). 
b) A kymograph was generated along the magenta line in a, panel A. X axis, time (t) in 
minutes. Y axis, distance (d) in µm. Black arrowheads, retracting blebs. White 
arrowheads, non-retracting blebs. 
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Figure 4.3. Membrane blebbing: cellular and molecular mechanisms 
Schematic representation of membrane blebbing during cell migration, apoptosis and 
cell division. Blebs expand following local breakage of the cortex or its detachment 
from the membrane. When occurring, bleb retraction is driven by actomyosin 
contraction. 
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Figure 4.4. Measurement of expansion time, retraction time, expansion speed, and 
retraction speed of inverse blebs 
Tg(kdr-l:ras-Cherry)s916 embryos with mosaic expression of Lifeact-EGFP were used to 
measure expansion time (a), retraction time (b), expansion speed (c) and retraction 
speed (d) in relation to bleb size (n=31 blebs, N=3 cells). 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.1. Comparison of properties of classical and inverse blebs  
Tg(kdr-l:ras-Cherry)s916 embryos with mosaic expression of Lifeact-EGFP were used to 
measure bleb size, expansion time, retraction time, expansion speed and retraction 
speed. Values for inverse blebs correspond to mean and standard deviation calculated 
from n=31 blebs (N=3 cells). Values for classical blebs come from (Charras et al., 
2008). 
 Inverse blebs Classical blebs 
Bleb size (µm) 3.4 ± 4 2 
Expansion time (s) 55 ± 78 30 
Expansion speed (µm/s) 0.08 ± 0.04 0.25 
Retraction time (s) 90 ± 34 120 
Retraction speed (µm/s) 0.03 ± 0.01 0.03 
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Inverse blebs were observed at the apical membrane of both unicellular (Figure 4.2 and 
Movie 4.3) and multicellular (Figure 4.5 and Movie 4.4) sprouts during lumen 
expansion. However, because endothelial cell junctions are highly dynamic (Jakobsson 
et al., 2010, Sauteur et al., 2014, Phng et al., 2015) and accumulate apical markers 
during lumenisation (Herwig et al., 2011), I chose for clarity to focus the rest of my 
analysis on unicellular lumens where non-junctional apical membrane can clearly be 
distinguished. 
 
 
 
 
Figure 4.5. Lumens expanding in multicellular sprouts undergo inverse membrane 
blebbing 
Tg(kdr-l:ras-Cherry)s916 embryos with mosaic expression of EGFP-CAAX (n=4) were 
imaged from 32 hpf. Arrowheads, inverse blebs. Dashed line, cell junction. Time is in 
hours:minutes:seconds. Scale bar is 10 µm. 
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4.3.2 Inverse blebbing is driven by blood pressure 
Because the expansion of classical blebs is driven by cytoplasmic pressure, and because 
I found that lumen expansion in sprouting ISVs requires blood flow (see chapter 3), I 
asked whether the growth of inverse blebs at the apical membrane of endothelial cells is 
driven by blood pressure. 
 
The knockdown or mutation of troponin 2a (tnnt2a) has been the standard method used 
to stop heartbeat, and thus inhibit blood flow, in zebrafish embryos. In accordance with 
my own experiments using tricaine (Figure 3.5), lumens do not expand in ISVs of 
mutant embryos (own observations and (Herwig et al., 2011)). Additionally, Herwig 
and colleagues showed that although cell junctions accumulate apical markers in mutant 
embryos, unicellular regions lack apical domains. Therefore, this method did not seem 
suitable to address the relationship between blood flow and apical membrane blebbing. 
Instead, I chose to induce blood pressure drops at the time of lumen expansion, and did 
so following two different strategies. 
 
I established a first method to stop blood flow in single ISVs by laser ablating the 
connection of the sprouts to the dorsal aorta in Tg(fli1ep:EGFP-CAAX) embryos 
(Figure 4.6 and Movie 4.5). With this technique, blood flow could be interrupted 
immediately and irreversibly in single sprouts. Although the cells at the base of the 
sprouts were lost during ablation, cells at the tip remained viable and did not show any 
sign of damage; these cells still expanded and retracted multiple filopodia (Figure 4.6 
and Movie 4.5). However, following ablation and loss of blood flow, their apical 
membrane stopped blebbing and the lumen gradually regressed (Figure 4.6 and Movie 
4.5), strongly suggesting that inverse blebbing in endothelial cells is indeed driven by 
blood pressure. 
In order to further support this result, I took a second approach where I inhibited then 
re-started blood flow using high doses of tricaine (Figure 4.7 and Movie 4.6). Following 
15-20 minutes of treatment with 4x tricaine, blood flow stopped (as assessed by the 
absence of circulating red blood cells) and blebs could no longer be observed at the 
apical membrane of lumenising cells (Figure 4.7, panel B and kymograph). When 
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returned to 1x tricaine, embryos recovered blood flow and re-expanded lumens by 
inverse blebbing (Figure 4.7, panel E and kymograph). 
Together, these experiments show that the generation of inverse blebs depends on the 
positive pressure difference existing between the luminal and the cytoplasmic sides of 
the apical membrane. 
 
Interestingly, treating embryos for a short time with 4x tricaine recapitulated the lumen 
collapse and re-growth events observed during normal lumen formation (Figure 3.4). In 
these experiments, stopping blood flow systematically led to the following sequence of 
events: 1) cessation of apical blebbing (Figure 4.7, panel B), 2) collapse of the lumen 
(Figure 4.7, panel C), 3) fragmentation of the apical membrane into small vesicles 
(Figure 4.7, panel D), and, after washout 4) re-growth of the lumen by inverse blebbing 
(Figure 4.7, panel E). Although no method is currently available to measure in real-time 
local variations of blood pressure, thus preventing us from establishing a correlation 
with apical membrane dynamics during normal lumen development, this set of 
experiments strongly suggests that local lumen collapse and re-growth events occur 
during normal development following variations in blood pressure. 
 
4.3.3 Apical membrane shows constricted patterns in mouse retinas suggestive of 
lumen expansion by inverse blebbing 
In the mouse retina, stainings for ICAM-2 revealed the presence of two major lumen 
conformations where the apical membrane appeared either expanded or constricted 
(Figure 3.3 and Table 3.1). This observation suggests that a similar mechanism of apical 
membrane blebbing might take place during sprouting angiogenesis in mice. 
 
4.4 Conclusions 
By performing high resolution imaging of apical membrane dynamics in sprouting ISVs, 
I found that lumens expand during angiogenesis through a previously undescribed 
mechanism of inverse membrane blebbing. I show that inverse blebs share the same 
morphology and expansion and retraction rates than classical blebs, and that their 
Chapter 4 Results 
 
 120 
expansion is driven by blood pressure, therefore generating the inverted polarity 
observed in this system. Finally, imaging in mouse retinas suggests that a similar 
mechanism might be driving lumen expansion in angiogenic sprouts in mice. 
 
 
 
 
Figure 4.6. Ablation of the connection of ISVs to the dorsal aorta abrogates inverse 
blebbing at the apical membrane of lumenising cells 
Tg(fli1ep:EGFP-CAAX) embryos (n=6) were imaged from 33 hpf. Ablation was 
performed at the base of the ISV to stop blood flow in the sprout (double-headed arrow, 
ablated region). A kymograph was generated along the magenta line in A to follow 
apical membrane dynamics before and after ablation. X axis, time (t) in minutes. Y axis, 
distance (d) in µm. Arrowheads, inverse blebs. Scale bars are 10 µm. 
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Figure 4.7. Transient treatment with 4x tricaine leads to transient loss of inverse 
blebs at the apical membrane of lumenising cells 
Tg(kdr-l:ras-Cherry)s916 embryos (n=5) were imaged from 32 hpf in 1x tricaine, and 
then treated with 4x tricaine. Blood flow stopped approximately 15 minutes after the 
start of the treatment. After 30 minutes of treatment, embryos were washed with E3 
buffer and placed back in 1x tricaine. A kymograph was generated along the magenta 
line in A to follow apical membrane dynamics. X axis, time (t) in minutes. Y axis, 
distance (d) in µm. Arrowheads, inverse blebs. Arrows, remnants of apical membrane. 
Scale bar is 10 µm. 
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Chapter 5. Endothelial cells regulate inverse blebbing 
and lumen expansion by local and transient recruitment 
and contraction of actomyosin 
 
5.1 Introduction 
In the previous chapter, I showed that the growth and persistence of inverse blebs at the 
tip of the lumen lead to the expansion of the apical membrane in sprouting endothelial 
cells. However, all blebs growing on the sides of the lumen, as well as a number of 
blebs growing at its tip, were found to retract, and did so following similar membrane 
dynamics as classical blebs. Since retraction of classical blebs, when not by detachment 
or forward movement of the cell, involves the recruitment and contraction of 
actomyosin on the inner surface of the bleb (Figure 4.3 and (Charras and Paluch, 2008)), 
and since initiation of classical blebbing itself is dependent on the properties of the 
actomyosin cortex (Charras et al., 2008), I decided to investigate if and how actomyosin 
assembly and contraction regulates inverse membrane blebbing during lumen formation 
in endothelial cells. 
 
5.2 Endothelial cells retract inverse blebs by recruiting and 
contracting actomyosin at the apical membrane 
5.2.1 F-actin polymerises around inverse blebs during phases of retraction 
In order to follow F-actin dynamics during lumenisation in sprouting ISVs, I imaged 
zebrafish embryos expressing an endothelial-specific Lifeact-EGFP reporter for F-actin 
(Tg(fli1ep:Lifeact-EGFP) generated in our laboratory by Li-Kun Phng (Phng et al., 
2013)). Lifeact is a 17-amino acid peptide that binds to F-actin and offers a reliable 
system for the labelling of actin structures in eukaryotic cells, both in vitro and in vivo 
(Riedl et al., 2008, Riedl et al., 2010, Fraccaroli et al., 2012, Phng et al., 2013). 
Although it may affect stability of F-actin at high concentrations (Courtemanche et al., 
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2016), Lifeact has been shown to bind to F-actin filaments without interfering with their 
structure and dynamics in multiple cellular systems (Riedl et al., 2008). By imaging 
embryos expressing both mCherry-CAAX and Lifeact-EGFP reporters (Tg(kdr-l:ras-
Cherrys916;fli1ep:Lifeact-EGFP)), I was able to correlate apical membrane and actin 
dynamics in endothelial cells during sprouting angiogenesis. Although it was difficult to 
optically resolve the presence of an actin cortex at the apical membrane of endothelial 
cells during sprouting, a cortex was clearly visible at the apical membrane at 2 dpf 
(Figure 5.1), once vessels were fully lumenised and likely experiencing higher levels of 
blood pressure. 
When imaged during phases of lumen expansion, strong polymerisation of F-actin was 
however observed all around the surface of inverse blebs, from the initiation of 
retraction until its completion (Figure 5.2 and Movie 5.1). In contrast, blebs that did not 
retract did not show any polymerisation of F-actin at their surface. These observations 
therefore suggest that retraction of inverse blebs, similarly to the retraction of classical 
blebs, involves the recruitment and contraction of actomyosin at the surface of the bleb. 
 
5.2.2 Myosin II is recruited around inverse blebs during phases of retraction 
In order to assess whether myosin II is also recruited to the apical membrane during 
bleb retraction, I generated an endothelial-specific reporter for the regulatory light chain 
of non-muscle myosin II (Myl9b) (Figure 5.3). In order to overcome potential side 
effects of the overexpression of Myl9b in endothelial cells, the LexPR/LexOP system 
(see chapter 2) was used to induce the expression of the reporter only from the onset of 
lumen formation. Additionally, analysis was restricted to cells showing low levels of 
expression of the reporter. At 2 dpf, cells expressing Myl9b-EGFP showed normal 
morphology, and Myl9b-EGFP co-localised with a Lifeact-mCherry reporter for F-actin 
at endothelial cell junctions, at the base of filopodia, and at the apical membrane (Figure 
5.1). Together, these observations suggest that this reporter constitutes a reliable tool to 
image myosin II localisation in endothelial cells, and that myosin II, together with F-
actin, forms an actomyosin cortex that supports the apical membrane in lumenised 
vessels. 
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In order to follow myosin II dynamics during lumenisation, Tg(kdr-l:ras-Cherry)s916 
embryos with mosaic expression of Myl9b-EGFP were imaged from 35 hpf. Myosin II, 
similarly to F-actin, was recruited transiently to the surface of inverse blebs during 
phases of bleb retraction (Figure 5.4). In order to analyse with more detail the timing of 
assembly of actomyosin at the surface of inverse blebs, Myl9b-EGFP and Lifeact-
mCherry reporters were co-expressed in wild-type embryos and imaged at high 
temporal resolution. Similarly to what has been reported during classical blebbing, F-
actin polymerisation preceded the recruitment of myosin II at the surface of inverse 
blebs (Figures 5.5 and 5.9 and Movie 5.2). 
 
5.2.3 Bleb retraction requires actomyosin contraction 
In order to address whether the retraction of inverse blebs is driven by the contraction of 
the actomyosin cortex recruited at their surface, I chose to inhibit actomyosin 
contraction in endothelial cells and determine the impact of this manipulation on the 
ability of the cells to retract inverse blebs growing at the apical membrane. 
 
Actomyosin filaments are formed by the association of myosin II molecules in an anti-
parallel fashion through their rod domains, and by their attachment to F-actin filaments 
through the globular heads of their heavy chains (Figure 5.3). The contraction of these 
actomyosin filaments is dependent on the ATPase activity of the myosin II molecules. 
Following hydrolysis of ATP, the neck region of myosin II undergoes a conformational 
change allowing the sliding of the attached F-actin filaments in respect to one another 
(Figure 5.3). 
Non-muscle myosin II is formed by the association of two heavy chains, two regulatory 
light chains (RLCs), and two essential light chains (ELCs) (Figure 5.3). At the 
molecular level, actomyosin contractility and assembly are regulated by the 
phosphorylation of the light and heavy chains of myosin II, respectively. The 
phosphorylation of the RLCs on Thr18 and Ser19 by a wide range of kinases, including 
MLCK, ROCK and PKC, has been shown in many cell types to greatly increase the 
ATPase activity of myosin II in the presence of actin, and to promote filament assembly 
by allowing the unfolding of the heavy chains otherwise locked in a closed 
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conformation through a head-to-tail interaction. Phosphorylation of the heavy chains at 
their C-terminus is also suggested to regulate filament assembly (Vicente-Manzanares 
et al., 2009). 
 
A common strategy to experimentally inhibit actomyosin contraction is to use 
blebbistatin, a small molecule inhibitor found to bind the myosin-ADP-Pi complex with 
high affinity, preventing the release of phosphate and blocking myosin in a state with 
low affinity for actin (Kovacs et al., 2004). Blebbistatin efficiently inhibits striated 
muscle myosins, but also, at significantly lower concentrations, non-muscle myosins. 
On the other hand, smooth muscle myosins were found to be only poorly affected by 
blebbistatin treatment (Limouze et al., 2004). Blebbistatin therefore appeared as a 
suitable approach to inhibit actomyosin contraction in endothelial cells in vivo, and has 
since been used successfully to study other aspects of endothelial cell biology in 
zebrafish (Sauteur et al., 2014). 
However, treatment of 30-35 hpf zebrafish embryos with blebbistatin, even at low 
concentrations of the drug (2.5-10 µM) and for short periods of time (one hour), was 
found to affect heartbeat and thus perturb blood flow, as assessed by the speed of 
circulation of red blood cells in the dorsal aorta and posterior cardinal vein (data not 
shown). Because inverse blebbing is a response of the apical membrane to blood 
pressure, and because no tool currently allows to measure blood pressure levels in 
zebrafish embryos, I decided this approach was not suitable to address whether 
actomyosin contraction in endothelial cells regulates inverse blebbing. 
 
In vitro, a form of the myosin II RLC mutated for its two phosphorylation sites 
(T18A/S19A) has been shown to act as a dominant-negative protein and its expression 
impaired both stress fibre formation in interphase cells and contractile ring formation in 
dividing cells (Iwasaki et al., 2001). Therefore, I decided to generate a non-
phosphorylatable form of the myosin regulatory light chain Myl9b (Myl9bAA) and to 
express it mosaically in Tg(kdr-l:ras-Cherry)s916 embryos, thus affecting actomyosin 
contraction in single endothelial cells in the embryo. Importantly, in order to circumvent 
any general and potentially deleterious effects during earlier development, the mutant 
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reporter (Myl9bAA-EGFP) was put under the control of the LexOP/LexPR expression 
system, and its expression was induced only from the onset of lumen formation. 
This strategy allowed me to successfully inhibit actomyosin contraction in single 
endothelial cells at the time of lumen formation (Figure 5.6). Upon expression of 
Myl9bAA-EGFP, I observed a significant difference in the frequency of bleb retraction 
compared to control cells expressing the wild-type form of Myl9b (Myl9b-EGFP), with 
larger proportions of blebs showing no or partial retraction (Figure 5.6). These data 
therefore indicate that bleb retraction is driven by the contraction of the actomyosin 
recruited at the surface of inverse blebs during lumen expansion. 
 
5.2.4 A contractile actomyosin cortex underlines the apical membrane in 
angiogenic sprouts in mouse retinas 
Immunostainings for ICAM-2 in mouse retinas suggested that a similar mechanism of 
apical membrane blebbing occurs during sprouting angiogenesis in mice (see 4.3.3). In 
order to address whether actomyosin contraction could also regulate apical membrane 
expansion in this system, I stained retinas from Lifeact-EGFP+/wt P6 mice for ICAM-2, 
and retinas from wild-type P6 mice for non-muscle myosin IIA and ICAM-2. By doing 
so, I found that the apical membrane in sprouting cells undergoing lumen formation is 
underlined by a cortex of F-actin and non-muscle myosin IIA in mouse retinas (Figure 
5.7). The apical membrane of lumenising cells additionally stained for the 
phosphorylated form of myosin light chain 2 (pMLC2) (Figure 5.7), strongly suggesting 
that a similar mechanism of regulation of apical membrane expansion through 
actomyosin contraction could be taking place in sprouting cells in mice. 
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Figure 5.1. F-actin and myosin II reporters co-localise at cell junctions, at the 
apical membrane, and at the base of filopodia in zebrafish ISVs 
Embryos with mosaic expression of Myl9b-EGFP and Lifeact-mCherry (n=6) were 
imaged at 2 dpf. Arrowheads show co-localisation of F-actin and myosin II at cell 
junctions (A), at the apical membrane (B), and at the base of filopodia (C). Scale bars 
are 10 µm. 
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Figure 5.2. F-actin polymerises at the surface of inverse blebs during phases of 
retraction 
a) Tg(kdr-l:ras-Cherry)s916 embryos with mosaic expression of Lifeact-EGFP (n=5) 
were imaged from 35 hpf. Dotted line, apical membrane. Arrow, expanding apical 
membrane. Arrowhead, onset of F-actin polymerisation. C, cytoplasm. L, lumen. Time 
is in hours:minutes:seconds. Scale bar is 5 µm. 
b) Kymograph generated along the magenta line in a. X axis, time (t) in seconds. Y axis, 
distance (d) in µm. Dotted line, apical membrane.  
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Figure 5.3. Structure and regulation of actomyosin filament assembly and 
contraction 
Non-muscle myosin II is formed by the association of two heavy chains, two regulatory 
light chains (RLCs), and two essential light chains (ELCs). The actin-binding and 
ATPase activity domains of myosin II are carried by the globular heads of the heavy 
chains. Non-muscle myosin II becomes assembly-competent following the double 
phosphorylation of its RLCs on Thr18 and Ser19. Association to actin filaments is 
allowed through the phosphorylation of the heavy chains at their C-terminus. ATP 
hydrolysis triggers the bending of the neck region of myosin II, leading to the sliding of 
the actin filaments in respect to one another. Adapted from (Vicente-Manzanares et al., 
2009). 
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Figure 5.4. Myosin II is recruited at the surface of inverse blebs during phases of 
retraction 
a) Tg(kdr-l:ras-Cherry)s916 embryos with mosaic expression of Myl9b-EGFP (n=3) 
were imaged from 34 hpf. Dotted line, apical membrane. Arrow, expanding apical 
membrane. Arrowhead, onset of myosin II recruitment. C, cytoplasm. E, extracellular 
space. L, lumen. Time is in hours:minutes:seconds. Scale bar is 5 µm. 
b) Kymograph generated along the magenta line in a. X axis, time (t) in seconds. Y axis, 
distance (d) in µm.  
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Figure 5.5. F-actin polymerisation precedes myosin II recruitment at the surface of 
inverse blebs 
a) Embryos with mosaic expression of Myl9b-EGFP and Lifeact-mCherry (n=5) were 
imaged from 35 hpf. Arrow, onset of F-actin polymerisation. Arrowhead, onset of 
myosin II recruitment. C, cytoplasm. E, extracellular space. L, lumen. Time is in 
hours:minutes:seconds. Scale bar is 5 µm. 
b) Kymograph generated along the magenta line in a. X axis, time (t) in seconds. Y axis, 
distance (d) in µm.  
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Figure 5.6. Actomyosin contraction drives bleb retraction 
Embryos with mosaic expression of Myl9b-EGFP or Myl9bAA-EGFP and Lifeact-
mCherry were imaged from 34 hpf. Blebs growing on the lateral sides of expanding 
lumens were assessed for their ability to retract within the maximum time necessary for 
expansion and retraction (approximately 10 minutes, see Figure 4.4). A multinomial 
log-linear model was used to test for association of bleb count in the different categories 
with the mutation status (WT: n=102 blebs, N=5 cells; AA: n=161 blebs, N=5 cells; 
data pooled from three independent experiments; p=2.1e-13; ****, p<0.0001). 
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Figure 5.7. The apical membrane of angiogenic sprouts is lined with a contractile 
actomyosin cortex in mouse retinas 
Retinas from Lifeact-EGFP+/wt (a) or wild-type (b,c) mice were harvested at P6 and 
stained for ICAM-2 (a-c), non-muscle myosin IIA (nmMyosin IIA; b), and 
phosphorylated myosin light chain 2 (pMLC2; c). Arrows show localisation of F-actin, 
nmMyosin IIA and pMLC2 at the apical membrane. Images correspond to single 
confocal planes. Scale bar is 10 µm. 
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5.3 Weakening of the actomyosin cortex at the apical membrane 
triggers inverse blebbing 
In most eukaryotic cells, the actomyosin cortex provides the tension necessary to 
counteract the pressure exerted by the cytoplasm on the plasma membrane, and 
blebbing has been shown to be the natural response of the membrane to local 
detachment or rupture of the cortex (Cunningham, 1995, Keller and Eggli, 1998, Paluch 
et al., 2005, Charras et al., 2008). 
In order to understand whether the actomyosin cortex underlying the apical membrane 
of sprouting endothelial cells also counteracts blood pressure by generating tension at 
the membrane, and to assess whether its local weakening could be the event behind the 
initiation of inverse blebs, I decided to perform local ablations of the cortex at the tip of 
the lumen in sprouting endothelial cells. This technique has been successfully used in 
previous studies to induce blebbing in mouse fibroblasts (Tinevez et al., 2009). 
By performing ablations along lines spanning the entire thickness of the apical 
membrane and its underlying cortex in Tg(kdr-l:ras-Cherrys916;fli1ep:Lifeact-EGFP) 
embryos, I could induce the expansion of inverse blebs at the site of ablation (Figure 5.8 
and Movie 5.3). Similarly to inverse blebs growing at the apical membrane during 
normal lumen formation, the growth of these artificially induced blebs was followed 
shortly by F-actin polymerisation and bleb retraction (Figure 5.8 and Movie 5.3). These 
experiments therefore suggest that the actomyosin cortex present at the apical 
membrane of sprouting cells generates tension to counteract blood pressure in “resting” 
conditions, and that its local weakening during lumen formation might be the event at 
the origin of inverse blebbing (Figure 5.9). 
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Figure 5.8. Local ablation of the cortex at the apical membrane of sprouting cells 
induces inverse blebbing 
Tg(kdr-l:ras-Cherrys916;fli1ep:Lifeact-EGFP) embryos were imaged from 33 hpf. Laser 
ablation was performed along a line spanning the entire thickness of the apical 
membrane and its underlying cortex, at the tip of the growing lumen. In 5 out of 18 cells, 
ablation resulted in the expansion of an inverse bleb at the apical membrane. Arrowhead, 
site of ablation. Arrow, inverse bleb. C, cytoplasm. E, extracellular space. L, lumen. 
Scale bars are 5 µm. 
 
 
 
 
 
 
 
 
Figure 5.9. Inverse blebbing: molecular mechanisms 
Schematic representation of inverse blebbing at the apical membrane of endothelial 
cells. Under blood pressure, and probably following local weakening of the cortex or its 
detachment from the membrane, blebs expand devoid of any F-actin or myosin II. 
Retraction occurs following 1) F-actin polymerisation, 2) myosin II recruitment, and 3) 
contraction of this actomyosin cortex all around the surface of the bleb. 
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5.4 Apical membrane contractility is required for lumen formation 
and maintenance 
In order to assess whether apical membrane contractility is required for proper 
lumenisation in sprouting ISVs, I induced the expression of the dominant-negative 
Myl9bAA-EGFP reporter in single endothelial cells in Tg(kdr-l:ras-Cherry)s916 
embryos, from the onset of lumen formation, and checked ISVs made of EGFP-labelled 
cells for the presence of a lumen at 2 dpf. Quantification of ISVs with Myl9bAA 
expression revealed a significant difference compared to control ISVs expressing the 
wild-type form of Myl9b, with a decrease in the proportion of cells showing normal 
lumens (Figure 5.10). Abnormal ISVs were found to be unlumenised or displayed 
dilated lumens (Figure 5.10 and 5.11), suggesting that endothelial cell contractility is 
required for lumen formation and/or maintenance in sprouting ISVs. 
 
In order to determine whether unlumenised ISVs were the result of a failure to expand 
lumens, or of the collapse of successfully formed lumens, I performed live imaging of 
Myl9bAA-expressing cells from 30 to 48 hpf. By doing so, I found that cells lacking 
lumens at 2 dpf were unable to expand their apical membrane during the time window 
when lumenisation normally occurs in sprouting ISVs (Figure 5.12 and Movie 5.4). 
 
In order to get a deeper mechanistic understanding of the effects of Myl9bAA 
expression on apical membrane dynamics, I performed fast imaging of both 
unlumenised and dilated cells at 2 dpf. In both cases, the dynamics of the apical 
membrane was visibly affected by the expression of Myl9bAA. In unlumenised vessels, 
lumens initially expanded into Myl9bAA-expressing cells but the apical membrane 
showed excessive and uncoordinated blebbing. Failure to retract blebs led to new blebs 
growing on unretracted blebs and occasional disconnection of blebs from the membrane 
(Figure 5.11 and Movie 5.5), preventing lumen expansion as described above. On the 
other hand, dilated and partially lumenised cells were also unable to fully retract blebs 
growing on the lateral sides of the lumen, leading to the expansion in diameter of the 
lumen and the formation of side lumen branches (Figure 5.11 and Movie 5.6). 
 
Chapter 5. Results 
 
 137 
The occurrence of the phenotypes presented here depended on the levels of expression 
of the dominant-negative Myl9bAA reporter (Figure 5.10). The proportion of cells with 
no or abnormal lumens increased with the level of expression of Myl9bAA. Within this 
population, dilated lumens were observed in higher proportions in cells with moderate 
expression of Myl9bAA, while the absence of lumens at 2 dpf was more prominent in 
cells with strong expression of the reporter (Figure 5.10). These observations could 
suggest that dilated lumens arise in cells that are still able to contract actomyosin at the 
apical membrane at sufficient levels to allow partial lumen expansion. Variability in 
phenotypes may however also be due to some differences within the cell population in 
the time separating the onset of expression of the transgenes and the onset of lumen 
expansion. 
 
Together, these data show that sprouting cells require actomyosin contraction at the 
apical membrane to counteract membrane deformations and thus ensure single, 
unidirectional lumen expansion in response to blood pressure. 
 
5.5 Conclusions 
In this chapter, I showed that endothelial cells actively respond to inverse blebbing by 
transiently and locally polymerising F-actin and recruiting myosin II to the apical 
membrane. The contraction of actomyosin filaments assembled at the surface of inverse 
blebs allows their successful retraction, and enables endothelial cells to control the 
deformations of the apical membrane generated by blood pressure and, ultimately, to 
control lumen expansion. Impairing the ability of endothelial cells to contract leads to 
severe lumen defects, and shows that apical contractility is required for lumen 
formation in sprouting ISVs. Finally, the presence of a contractile actomyosin cortex at 
the apical membrane of lumenising sprouts in mouse retinas further suggests that this 
mechanism could be conserved in mammals. 
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Figure 5.10. Expression of Myl9bAA from 30 hpf leads to lumen defects in ISVs at 
2 dpf 
Tg(kdr-l:ras-Cherry)s916 embryos with mosaic expression of Myl9b-EGFP or 
Myl9bAA-EGFP were analysed at 2 dpf. EGFP-positive ISVs were classified by eye 
into three categories according to their level of EGFP expression (low, moderate, 
strong) and screened for the presence of a lumen. A multinomial log-linear model was 
used to test for association of cell count in the different categories with the mutation 
status (WT: n=55 ISVs, N=24 embryos; AA: n=31 ISVs, N=9 embryos; data pooled 
from three independent experiments; p=0.30 (low), p=0.11 (moderate), p=0.0002 (high), 
p=0.00024 (total); **, p<0.01). EGFP-positive cells where the presence or absence of a 
lumen could not be appreciated were referenced as undetermined. 
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Figure 5.11. ISVs expressing Myl9bAA show dilated or no lumen at 2 dpf 
Tg(kdr-l:ras-Cherry)s916 embryos with mosaic expression of Myl9b-EGFP or 
Myl9bAA-EGFP (n=3) were imaged at 2 dpf. Arrowhead, disconnected lumen fragment. 
Arrow, side lumen branch. Scale bars are 10 µm. 
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Figure 5.12. Myl9bAA-expressing endothelial cells lacking lumens at 2 dpf fail to 
expand lumens 
Tg(kdr-l:ras-Cherry)s916 embryos with mosaic expression of Myl9bAA-EGFP (n=3) 
were imaged from 35 hpf. Arrowheads, lumen. Time is in hours:minutes:seconds. Scale 
bar is 10 µm. 
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Chapter 6. Discussion 
6.1 Summary of the findings 
In the present work, I used high spatial and temporal resolution imaging of lumen 
formation in angiogenic sprouts, both in the zebrafish trunk vasculature and in the 
mouse retina inner vascular plexus, to dissect the cellular mechanisms of lumen 
formation during sprouting angiogenesis in vivo. Using this approach, I discovered that 
lumens expand into angiogenic sprouts through a previously undescribed mechanism of 
inverse membrane blebbing driven by blood pressure. If multiple cells share the tip of a 
sprout, lumen expands at their junction. In the case of single tip cells, lumen expands as 
a membrane invagination, thus generating unicellular lumens, as previously reported 
during anastomosis (Herwig et al., 2011). In both cases, inverse blebs grow at the apical 
membrane of lumenising cells, leading to the expansion of the luminal compartment 
between or within single cells. When blood flow is stopped experimentally by laser 
ablation of the base of the vessel or by tricaine-induced decrease of blood pressure, 
inverse blebbing ceases and the lumen stops expanding and eventually collapses. 
In addition, I found that, similarly to what is observed for classical blebbing in other 
cell and organism models (Charras and Paluch, 2008), endothelial cells have the ability 
to retract inverse blebs growing at their apical membrane by recruiting and contracting 
actomyosin around the bleb membrane. This mechanism allows selective bleb retraction 
along the apical membrane. When the ability of the cell to contract is altered through 
the expression of a dominant-negative form of the regulatory light chain of non-muscle 
myosin II, endothelial cells fail to retract blebs, leading to excessive and uncoordinated 
deformation of the apical membrane. The affected cells fail to expand lumens and, if 
partially lumenised, show unresolved blebs and side lumen branches. 
Together, this work shows that a tight equilibrium between the forces exerted by the 
blood on the apical membrane of endothelial cells, and the endogenous contractile 
responses from the endothelial cells, drives and controls lumen expansion in angiogenic 
sprouts in vivo (Figure 6.1). Immunostainings for the apical membrane and actomyosin 
in mouse retinas, although only providing static information, suggest that this 
mechanism might be conserved in mammals, and constitutes a general mechanism of 
pressure-driven lumen formation in perfused blood vessels.   
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Figure 6.1. Model of lumen formation by inverse membrane blebbing during 
sprouting angiogenesis in vivo  
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6.2 Cellular mechanisms of vascular lumen formation 
6.2.1 Revisiting previous models of lumen formation during sprouting 
angiogenesis in vivo 
This work challenges the previous model proposed by Weinstein and colleagues (Kamei 
et al., 2006) that lumens form in angiogenic sprouts in vivo through the formation and 
fusion of intracellular vacuoles in the cytoplasm of sprouting cells. Using reporters for 
the apical membrane, F-actin and non-muscle myosin II, and fast time-lapse imaging 
allowing tracking of membrane dynamics within seconds, I could not observe any de 
novo formation of vacuoles in the cytoplasm of lumenising cells. Large isolated lumen 
fragments were observed, but these structures always derived from the collapse of 
growing lumens in sprouting ISVs (Figure 3.4). The observation of only a very low 
number of such fragments in angiogenic sprouts in mouse retinas (1.6% of total sprouts, 
see Table 3.1) also suggests that vacuole formation and fusion is very unlikely to be the 
main mechanism of lumen formation in this model. 
Several reasons can be advanced to explain the difference between the model of lumen 
expansion by inverse membrane blebbing that I propose in this work, and the model 
described by Weinstein and colleagues. First and foremost, their microscopy data 
suffered from low spatial and temporal resolution and, supported by their finding that 
endothelial cells form vacuoles in vitro, probably led them to mistake inverse blebs for 
vacuoles in close proximity with the growing lumen. The interval between the 
acquisition of each frame of their time-lapse series (3 to 5 minutes) is longer than the 
average time I report for the expansion and retraction of inverse blebs (see Figure 4.4), 
and therefore did not allow them to follow single blebbing events. Secondly, the main 
reporter used in their study (EGFP-Cdc42) did not allow clear labelling of the apical 
membrane, and high fluorescence signal in the cytoplasm of labelled cells contributed 
to the lack of resolution of the presented time-lapse series. Finally, although viability 
and normal development of the Tg(fli1:EGFP-cdc42wt)y48 zebrafish line was confirmed, 
increased levels of Cdc42 in the cells may have affected membrane dynamics. In vitro, 
it has been reported that expression of exogenous reporters for Cdc42, kRas, and Rap1b 
significantly enhances tubulogenesis in endothelial cells cultured in 3D collagen 
matrices (Norden et al., 2016). Overexpression of the wild-type Myl9b-EGFP reporter 
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was also seen to occasionally affect membrane dynamics and lumen formation in some 
endothelial cells when expressed at very high levels (not shown). Therefore, expression 
of exogenous reporters should be kept at the lowest level and carefully controlled to 
allow the drawing of reliable conclusions. This is the reason why I turned, in the present 
study, to the use of reporters bearing no biological function (EGFP-CAAX and 
mCherry-CAAX). 
The fact that lumen expansion immediately stops after ablation of the connection of 
single ISVs to the dorsal aorta strongly suggests a vacuole-independent mechanism of 
lumen formation. However, the existence of vacuoles and their participation to lumen 
expansion cannot be completely dismissed. Although the EGFP- and mCherry-CAAX 
reporters should, in theory, label vacuolar membranes, it is still possible that such 
structures remained unlabeled, and were therefore missed, in the course of this study. 
Identification of vacuole-specific markers, or the design of reporters for early apical 
markers, could further strengthen our current hypothesis of a flow-dependent, vacuole-
independent mechanism of lumen formation during sprouting angiogenesis in vivo. 
 
6.2.2 Relevance of in vitro models of vascular lumen formation 
This work also more generally raises the question of the relevance of in vitro models of 
tubulogenesis in endothelial cells, as the mechanism at play (vacuole formation and 
fusion) differs from all mechanisms identified in vivo – cord hollowing during 
vasculogenesis, and cord hollowing and membrane invagination during sprouting 
angiogenesis. The assay used in most of the in vitro studies presented in the 
introduction to this work (and detailed in 1.3.1) allows lumen formation between 
endothelial cells coalescing in 3D collagen matrices, in a context resembling the 
formation of the primary vessels by vasculogenesis. The success of this method is 
highly dependent on culture conditions (Koh et al., 2008b, Davis et al., 2013), and the 
first and most extensively used version of this assay relied on the use of phorbol ester, 
an activator of PKC, to drive vacuole formation in vitro. Phorbol ester is a potent 
inducer of endo- and pinocytosis in many cell types (Swanson et al., 1985, Nilsson et al., 
1989, Keller, 1990, Aballay et al., 1999), which raises the question of the relevance of 
the vacuoles observed using this assay for the more general context of physiological 
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endothelial lumen formation. The recent switch to a phorbol ester-free cytokine-based 
assay (Stratman et al., 2011, Davis et al., 2013), where results from previous studies 
could be confirmed, may provide a better basis for further investigations, although 
relevance of vacuole-based models of lumen formation for the general understanding of 
lumen formation during vascular development remains debatable. 
In vitro models of vascular lumen formation remain an area in need for further 
development, since such models would allow to easily assess the contribution of 
individual signalling pathways, as well as of external stimuli such as matrix 
composition and stiffness, interaction with pericytes, or even perfusion, on 
tubulogenesis. Considerable efforts currently invest in the development of devices in 
which endothelial cells are allowed to organise themselves into lumenised networks that 
are later perfused using pump or reservoir systems (Zheng et al., 2012, Moya et al., 
2013, Bichsel et al., 2015, Wang et al., 2016). While such devices will offer important 
insights into the role of haemodynamics in various aspects of blood vessel formation 
and remodelling, they could also be considered for the study of lumen formation under 
flow, if design modifications can be brought to induce sprouting in these systems. 
Although the field of sprouting angiogenesis benefits from in vitro sprouting models 
from embryonic stem cell aggregates or from beads coated with endothelial cells, none 
of these systems allows perfusion, therefore lacking what I describe here as a major 
driver of lumen formation in angiogenic sprouts. These systems could however still 
provide insights into flow-independent mechanisms of lumen formation, such as, for 
example, those driving the segregation of apical determinants at cell junctions, since 
these mechanisms appear to work independently of blood flow (Herwig et al., 2011). 
Although the development of such in vitro systems would, in principle, allow easy 
manipulation and fine dissection of the cellular and molecular mechanisms of lumen 
formation, their setup is challenging. On the other hand, zebrafish established itself as a 
powerful model for the study of blood vessel formation in vivo, and recent technical and 
technological advances open the door to the fine analysis of endothelial cell behaviour 
at the single-cell level in specific genetic contexts. TALEN- and CRISPR/Cas9-
mediated gene editing techniques, for example, are being developed in many research 
groups and bear great potential for efficient gene knockout and knockin in zebrafish 
embryos (Huang et al., 2011, Sander et al., 2011, Hwang et al., 2013b, Hwang et al., 
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2013a, Auer et al., 2014, Auer and Del Bene, 2014). Generation of zebrafish lines 
mutant for potential polarity effectors using these techniques will allow to assess the 
requirement for these proteins during vascular development. In the event of global 
effects on the organism and/or to highlight cell-autonomous phenotypes, transplantation 
of mutant cells into wild-type embryos could allow finer assessment of the role of these 
proteins at the single-cell level. Additionally, the development of advanced imaging 
techniques such as spinning disk microscopy (used in this work), single plan 
illumination microscopy (SPIM), and super resolution microscopy, will offer the 
opportunity to follow membrane trafficking events and the structure and dynamics of 
protein complexes during polarity establishment and lumen formation at the subcellular 
level. Together, these considerations make zebrafish a model of choice for the study of 
lumen formation during sprouting angiogenesis. 
 
6.2.3 Lumen formation during vasculogenesis and angiogenesis in vivo: different 
contexts call for specific mechanisms 
Both previous work in the field (Herwig et al., 2011, Lenard et al., 2013) and the 
present study show that blood flow is required for lumen formation in angiogenic 
sprouts in vivo, by allowing separation of apposing membranes at cell junctions and 
invagination into single endothelial cells through inverse membrane blebbing. In 
comparison, the primary vessels that form by vasculogenesis develop and lumenise 
prior to the establishment of blood circulation, and therefore do so through blood 
pressure-independent mechanisms involving extensive cell shape changes mediated by 
the contraction of apically enriched actomyosin (Strilic et al., 2009). It is interesting to 
note how vessels developing in different physiological contexts have adopted different 
mechanisms of lumen formation, although both require extensive cell shape changes 
under the control of the actin cytoskeleton and involve, to some extent for angiogenesis, 
cord hollowing mechanisms. 
It will be important to extend the present study to different vascular beds, organisms, 
and to adult angiogenesis. In particular, it will be interesting to address the differences 
that may exist between physiological and pathological contexts, especially those 
presenting altered blood perfusion and/or pressure, such as cancer and diabetes (Potente 
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et al., 2011). Other vascular beds in zebrafish embryos, such as the brain vasculature or 
the subintestinal vascular plexus, could provide further insights into the variability 
existing in the mechanisms of lumen formation. Some of these vessels might 
additionally prove useful to dissect in more detail the molecular mechanisms at play 
during membrane invagination. In fact, while the arrangement of endothelial cells in 
ISVs is relatively heterogeneous, vessels in the brain vasculature have been identified as 
highly stereotypic. The palatocerebral artery, for example, always lumenises first 
through apical membrane invagination into the anastomosing tip cells, before cells 
rearrange to lead to the establishment of a multicellular tube (Lenard et al., 2013). The 
fin regeneration model in adult zebrafish could also be considered for the study of 
lumen formation in the adult and in the context of wound healing (Xu et al., 2014). 
Finally, many mouse models of pathological angiogenesis are available. While the 
study of fixed tissues would provide only limited information on apical membrane 
dynamics, dynamic data could be obtained using intravital imaging of angiogenesis in 
live animals, for example in the brain using cranial windows (Kienast et al., 2010). 
 
6.3 Molecular mechanisms of vascular lumen formation 
6.3.1 Establishment of apical-basal polarity 
Studies in MDCK cysts built a detailed model for the segregation of apical and basal 
determinants during lumen formation between contacting cells. Work carried in in vitro 
models of vascular lumen formation suggests that many of the identified regulators of 
apical-basal polarity establishment in MDCK cysts are also required in endothelial cells, 
although these findings mostly rely on siRNA and biochemical interaction studies, and 
would benefit from more extensive analysis by time-lapse imaging of protein 
localisation and dynamics. 
Some of these mechanisms have already been shown to be conserved in vivo during the 
formation of the dorsal aorta. Podocalyxin, moesin, F-actin and non-muscle myosin II 
were all identified as essential regulators of apical domain specification and cell shape 
changes during lumen formation in the mouse dorsal aorta (Strilic et al., 2009). 
Attachment to the ECM through integrin β1 (Zovein et al., 2010) and integrity of cell 
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junctions (Strilic et al., 2009, Wilson et al., 2013) have also both been reported as 
polarisation cues required for lumen formation during vasculogenesis. How signalling 
from cell-ECM and cell-cell interfaces leads to the segregation of the identified apical 
determinants remains to be addressed. 
During sprouting angiogenesis, podocalyxin is found at the apical membrane of 
lumenising ISVs of zebrafish embryos, and accumulates at the new cell junction 
forming between anastomosing cells (Herwig et al., 2011). VE-cadherin and moesin1 
have also been identified as regulators of lumen formation in sprouting ISVs (Wang et 
al., 2010). However, post-natal endothelial-specific deletion of integrin β1, Par3, aPKC, 
and Cdc42 in mice suggests that these proteins are all dispensable for lumen formation 
in the mouse retina inner plexus (Nakayama et al., 2013, Barry et al., 2015, Yamamoto 
et al., 2015), and therefore raises the question of whether these mechanisms also 
regulate lumen formation during sprouting angiogenesis. 
It would be interesting to address whether, and if so to what extent, ECM-cell and cell-
cell signalling, polarity complexes, Rho GTPases, and Rab-mediated membrane 
trafficking regulate lumen formation during sprouting angiogenesis in vivo. These 
questions will benefit from high resolution single-cell studies in zebrafish embryos, 
where the localisation and dynamics of such polarity effectors could be investigated, 
along with their requirement for lumen formation, taking advantage of the technical 
advances previously mentioned. 
 
6.3.2 The role of the actin cytoskeleton during vascular lumen formation 
6.3.2.1 Cell shape changes during lumen formation 
Several studies and the present work have identified and described in detail multiple 
roles for actin in regulating vascular lumen formation in vivo. Drastic cell shape 
changes are observed both during vasculogenesis and angiogenesis, and are required for 
lumen formation and maintenance (Strilic et al., 2009, Herwig et al., 2011). 
Interestingly, cell elongation is observed in both contexts and happens independently of 
blood flow in both cases, since inhibition of blood flow in zebrafish embryos does not 
affect cell elongation in angiogenic sprouts (Herwig et al., 2011). However, while cell 
shape changes drive the opening of lumens during vasculogenesis, the cell elongation 
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observed during angiogenesis is not sufficient in this context to induce the separation of 
apposing membranes, a process that requires blood flow. 
In the case of vasculogenic lumen formation, although current studies only refer to cell 
elongation, the topology of lumenised vessels suggests that the apical membrane must 
also bend and adopt a concave morphology to allow the formation of a tubular structure. 
Distinction between mechanisms of cell elongation and, if existing, apical membrane 
bending, has not been addressed yet. Recruitment of F-actin and non-muscle myosin II 
at the apical membrane, and phosphorylation of myosin II through VEGF-A and ROCK, 
are required for tubulogenesis in the mouse dorsal aorta, suggesting that the contraction 
of an apically-enriched actomyosin network drive the cell shape changes observed 
during lumen formation in this model (Strilic et al., 2009). In zebrafish, AmotL2 is 
required for the anchoring of radial actin fibres to cell junctions, which are, in turn, 
required for cell elongation in the dorsal aorta (Hultin et al., 2014). Together, these 
studies therefore suggest a model where contraction of an apically-enriched actin cortex 
and, if distinct, of actin fibres connecting cell junctions, drive cell morphology changes 
during vasculogenesis, through cell elongation and/or apical membrane bending. 
During sprouting angiogenesis, cell elongation is also dependent on the coupling of F-
actin to VE-Cadherin at cell junctions, and on F-actin polymerisation, partly through 
FMNL3, but treatment with the myosin II inhibitor blebbistatin suggests that this 
process does not involve actomyosin contraction (Sauteur et al., 2014, Phng et al., 2015). 
This difference with the mechanisms described during vasculogenesis might account for 
the difference observed in the morphogenesis of blood vessels in these two contexts, 
and could suggest that actomyosin contraction at the apical membrane of aortic 
endothelial cells is what drives membrane separation and lumen opening, although this 
remains entirely hypothetical. 
Together, the studies carried on the role of actin suggest that different actin structures 
and/or dynamics might regulate endothelial cell shape changes during vasculogenic and 
angiogenic lumen formation in vivo. In this context, it would be interesting to describe 
with high detail the subcellular organisation and dynamics of the actin cytoskeleton 
during lumen formation, and assess the individual contribution that specific networks 
might have in regulating different cellular processes at different locations in the cell – 
apical membrane, basal membrane, and cell junctions. 
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6.3.2.2 Regulation of inverse blebbing at the apical membrane 
Here, I describe a novel role for actin at the apical membrane of sprouting endothelial 
cells during phases of lumen formation. I show that upon blood pressure-induced 
membrane deformation, F-actin polymerises locally at the apical membrane, forming 
transient actin networks whose contraction upon non-muscle myosin II recruitment and 
activation allows retraction of inverse blebs and control over apical membrane 
deformation. 
 
What drives actin polymerisation and actomyosin contraction at the apical membrane of 
endothelial cells remains unknown. During classical blebbing, as shown in 
constitutively blebbing M2 melanoma cells in vitro, an actomyosin cortex assembles at 
the membrane of expanding blebs through the action of a variety of actin nucleators and 
linkers. Early recruitment of membrane-actin linkers of the ERM family, such as ezrin 
and moesin, allows the anchoring of F-actin filaments at the bleb membrane (Charras et 
al., 2006). F-actin polymerisation itself is regulated by several nucleators. While the 
formin mDia1 and the Arp2/3 complex have been identified as the major nucleators 
involved (Bovellan et al., 2014), roles for the formins mDia2, FHOD1, FMNL2, and 
DIAPH3 have also been reported (Eisenmann et al., 2007, Hannemann et al., 2008, 
Kitzing et al., 2010, Stastna et al., 2012, Wyse et al., 2012). F-actin polymerisation is 
then followed by the recruitment of non-muscle myosin II in foci along the newly 
formed cortex. Phosphorylation of myosin II finally drives contraction of the newly 
assembled cortex, leading to membrane crumpling and bleb retraction. RhoA is a major 
regulator of actomyosin contraction, and regulates both actin polymerisation through 
formins and myosin phosphorylation via ROCK (Sit and Manser, 2011). RhoA was 
found to regulate blebbing in vitro, although the exact mechanism by which it does so 
remains to be identified (Charras et al., 2006).  
It would be of high interest to determine whether the same mechanisms are regulating 
actomyosin assembly and contraction at the membrane of inverse blebs in endothelial 
cells. Moesin is required for lumen formation in sprouting ISVs (Wang et al., 2010). 
Whether the lack of lumen in cells knocked down for moesin results from impaired 
attachment of the actin cortex to the membrane of expanding blebs is an obvious 
question. Inducible single-cell loss-of-function approaches such as the one used in this 
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work to inhibit myosin function could target this question. Preliminary work carried out 
in our laboratory also suggests a role for RhoA in regulating lumen formation in 
zebrafish ISVs. Upon inducible expression of dominant-negative or constitutively-
active forms of RhoA from 30 hpf, lumen defects are observed at 2 dpf (Li-Kun Phng, 
unpublished data). Preliminary live imaging experiments however suggest that the 
whole cortex of endothelial cells is affected by the expression of these constructs, and 
specific contribution of RhoA in regulating actin assembly and myosin phosphorylation 
at the apical membrane might be hard to address with the tools that are currently 
available. The expression of a fluorescence resonance energy transfer (FRET) biosensor 
for RhoA should hopefully indicate whether activation of RhoA is detected at the apical 
membrane during phases of lumen expansion (ongoing work). On the other hand, 
dominant-negative and constitutively-active forms of ROCK and MLCK reporters were 
generated to address the requirement for both kinases in the regulation of myosin II 
phosphorylation with hopefully, if involved in this process, narrower effects on the 
overall cell morphology in comparison to RhoA manipulations. 
 
An important consideration when comparing classical and inverse blebbing is the 
polarity of these two mechanisms. In classical blebbing, the plasma membrane blebs 
outwards following the positive pressure difference existing between its cytoplasmic 
and extracellular sides. In contrast, during inverse blebbing, pressure is higher outside 
the cell, driving the membrane to bleb inwards. In this case, the membrane has to break 
through the actin cortex underlying the apical membrane, which might involve more 
extensive alterations of the actomyosin cortex than in the case of classical blebbing, 
where the membrane only detaches from it. A second consequence of the difference in 
bleb polarity is the location of the actomyosin cortex in relation to the bleb membrane. 
In classical blebbing, an actomyosin cortex assembles on the inner surface of the bleb, 
and contraction of actomyosin fibres leads to the crumpling of the membrane that is 
pulled back in its original position. However, during inverse blebbing, the cortex 
assembles on the outer surface of the bleb, which suggests a pushing, rather than a 
pulling, of the bleb membrane against the pressure direction during retraction. Whether 
this means different actin cortex organisation and dynamics are involved in these two 
processes is an interesting point to consider. 
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The mechanisms of bleb initiation also deserve further investigation. In classical 
blebbing, both local breakage of the actin cortex and local detachment of the cortex 
from the membrane have been reported as mechanisms driving bleb initiation 
(Cunningham, 1995, Keller and Eggli, 1998, Paluch et al., 2005, Charras et al., 2008). 
In endothelial cells, local weakening of the cortex by laser ablation induces the 
formation of inverse blebs at the apical membrane of sprouting cells, and therefore 
suggests that inverse blebs may arise as well from the local breakage or detachment of 
the cortex from the apical membrane. An hypothesis could be that inverse blebbing then 
occurs stochastically within a relatively plastic actin cortex weakened by the pushing 
forces exerted by the blood on the apical membrane. 
In this work, I show that a pressure differential between the luminal and cytoplasmic 
sides of the apical membrane is required for the initiation of inverse blebbing. When 
ISVs are severed through ablation of their connection to the dorsal aorta, local breakage 
of the endothelial barrier leads to the leakage of blood into the microenvironment, and 
presumably to an instant drop in blood pressure leading to immediate stop of inverse 
blebbing. However, the values for luminal and cytoplasmic pressures - and therefore the 
amplitude of the pressure differential - involved in this process are not known. Aortic 
blood pressure has been successfully measured in zebrafish embryos from 2.5-3 dpf 
using a servo-null micro-pressure system (Pelster and Burggren, 1996, Hu et al., 2000, 
Kopp et al., 2005). Kopp and colleagues reported a blood pressure of 0.37 ±	 0.04 
mmHg (equivalent to 49.33 ±	 5.33 Pa) in the ventral aorta of 2.5-3 dpf zebrafish 
embryos. Blood pressure in single ISVs is likely to show similar values, although local 
variations, especially as the distance to the heart increases, might be observed. In vitro, 
similar servo-null micro-pressure systems have been used successfully to measure 
intracellular pressure in primary human fibroblasts (Petrie et al., 2014). In vitro, 
intracellular pressure has been reported to vary between 100 to several 1,000 Pa. Both 
bodies of literature therefore suggest that blood pressure in zebrafish embryos would be 
10 to 100 times lower than intracellular pressure as recorded in vitro, which would 
suggest a pressure differential in the opposite direction to the one reported to drive 
inverse blebbing in this study. One has to note that intracellular pressure may show 
highly different values in cells in vivo, in comparison to cells cultured in vitro on stiff 
substrates. Additionally, it could be that blood pressure in single ISVs is greater than the 
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pressure reported in the ventral and dorsal aortae. Addressing these questions will 
require precise measurement of both luminal and cytoplasmic pressures in ISVs 
undergoing lumen formation. Although it may prove technically challenging, the use of 
servo-null micro-pressure systems fitted with glass micropipettes of small diameter (0.5
μm in (Petrie et al., 2014)) seems an attractive approach to measure both pressures in 
live zebrafish embryos. 
Why inverse blebbing ceases when the system becomes perfused remains unknown. 
Theoretically, the connection of ISVs to neighbouring vessels and the establishment of 
perfusion are likely to lead to a drop in pressure within the single ISVs. This drop in 
pressure could then lead to a reduction, or even loss or inversion, of the pressure 
differential required for the initiation of inverse blebbing. Changes in cell arrangement 
within the vessels and/or in cell architecture - in particular in regards to the structure 
and dynamics of the cytoskeleton – may also affect the physical properties of the apical 
membrane of endothelial cells at that stage, and participate in the cessation of inverse 
blebbing. 
 
One of the most intriguing questions is what drives the selectivity in the occurrence of 
bleb retraction in endothelial cells, thus allowing expansion of the lumen only in the 
direction of the growing vessel. Several hypothesis can be advanced. First, the 
properties of the membrane and/or of its underlying cortex may differ between the tip of 
the lumen and its sides. An obvious difference is already observable in the topology of 
the membrane; the high membrane curvature at the tip of the lumen might recruit 
different molecular machineries through membrane curvature-sensing domains, such as 
BAR domains and ALPS motifs (Antonny, 2011). A second hypothesis could be that 
the tip and sides of the lumen experience difference haemodynamic forces related to its 
topology, although the pressure experienced by the membrane should theoretically be 
the same along its entire length. In both cases, a resulting heterogeneity in membrane 
tension could be sensed by tension sensors and relay different signals within the cell. 
Piezo1, a cation channel activated upon mechanical stress, has, for example, recently 
been identified as a regulator of endothelial cell elongation in response to shear stress, 
and is required for blood vessel morphogenesis during embryonic development (Li et al., 
2014c, Ranade et al., 2014). Whether Piezo1 or other mechanically-activated ion 
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channels could regulate signalling at the subcellular level during lumen formation 
remains to be addressed. 
 
A last consideration relates to the extreme and rapid increase in apical membrane 
surface area observed during lumen expansion by inverse blebbing. Where does the new 
apical membrane come from, and which mechanisms regulate its rapid increase? A first 
step will be to address whether the total surface of the plasma membrane of lumenising 
endothelial cells increases during lumen formation, or if the apical membrane surface 
area increases at the expense of other membrane domains, such as the basal membrane. 
The speed at which the apical membrane is sometimes seen expanding (several 
micrometres within seconds/minutes) would strongly favour the hypothesis that the 
apical membrane expands at the expense of the basal domain through a basal shift of 
junctional complexes. Single-cell labelling with EGFP/mCherry-CAAX and junctional 
reporters should allow to address this point. Other mechanisms may however contribute 
to the increase in surface area of the apical membrane. Rapid increase in surface area 
could be due in part to stretching of the lipid bilayer, although this could only contribute 
to a 2-3% increase in surface area (Hamill and Martinac, 2001). The membrane of 
endothelial cells is also known to contain large numbers of caveolae, which are small 
membrane invaginations 50-100 nm in size (Sowa, 2012). Caveolae have been shown to 
unfold in reaction to osmotic stress and mechanical stretching in lung endothelial cells 
in vitro and thus buffer membrane tension (Sinha et al., 2011). However, this 
mechanism would also induce only minor increases in cell surface area (0.1-0.3%). 
Another, but slower, mechanism could involve the recycling through vesicular 
trafficking of membrane material from other membrane domains in the cell towards the 
apical surface. Imaging of the mCherry-CAAX line revealed the presence of 
cytoplasmic spots moving within the cells during lumen formation. While the exact 
nature of these spots was not investigated, it is likely they could correspond to vesicles 
carrying membrane material, and potentially apical determinants, to the expanding 
apical membrane during lumen formation. Higher time resolution imaging would be 
necessary to determine the exact origin, destination, and trajectory of these spots, and 
thus hypothesise on their putative function(s). 
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Testing these different hypotheses in vivo will be challenging, but could be performed 
following the identification of specific markers for the different membrane domains in 
the cell, single-cell labelling, and the development of extremely high spatial and 
temporal resolution imaging. 
 
6.4 Conclusion 
Together, the present work identifies a novel mechanism of lumen expansion driven by 
blood pressure during sprouting angiogenesis in vivo, and provides an alternative model 
to the previous debated hypothesis that endothelial cells form lumens through vacuole 
formation and fusion in vivo. It additionally identifies inverse membrane blebbing as a 
reaction of plasma membranes to high external pressure, and suggests that the process 
of membrane blebbing, best described in cell division, cell migration and apoptosis, 
does not require a specific polarity, and more generally occurs in situations where 
membrane tension and stability of the actin cortex are challenged by internal or external 
mechanical stresses. In the case of endothelial cells, I find that blebbing bears a 
morphogenetic role and drives the cell shape changes required for the opening of patent 
lumens in vivo. 
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Chapter 7. Appendix 
7.1 Movie legends 
Movie 4.1. Lumens expand as membrane invaginations into single tip cells (related 
to Figure 4.1) 
Time-lapse series of an endothelial sprout expressing mCherry-CAAX imaged from 32 
hpf. Arrows point at the invagination of the apical membrane into one single tip cell. 
Time is in hours:minutes:seconds. 
 
Movie 4.2. Lumens expand along cell junctions when the tip of the sprout is shared 
between several cells (related to Figure 4.1) 
Time-lapse series of an endothelial sprout expressing mCherry-CAAX imaged from 32 
hpf. Arrows point at the expansion of the lumen along the cell junction between the two 
cells making the tip of the sprout. Time is in hours:minutes:seconds. 
 
Movie 4.3. Apical membrane undergoes inverse blebbing during lumen expansion 
(related to Figure 4.2) 
Time-lapse series of an endothelial sprout with mosaic expression of EGFP-CAAX 
imaged from 36 hpf. The apical membrane shows inverse blebs as the lumen expands 
into the sprout (black arrow). The red arrow shows a disconnected lumen fragment 
originating from the collapse of the lumen. Time is in hours:minutes:seconds. 
 
Movie 4.4. Inverse membrane blebbing drives multicellular lumen expansion 
(related to Figure 4.5) 
Time-lapse series of an endothelial sprout with mosaic expression of EGFP-CAAX (left 
panel, green) and expression of mCherry-CAAX (right panel, magenta) imaged from 32 
hpf. Inverse blebbing occurs simultaneously in both cells forming the ISV as the lumen 
expands (white arrows). Time is in hours:minutes:seconds. 
 
Movie 4.5. Interruption of blood flow by laser ablation inhibits inverse blebbing at 
the apical membrane of angiogenic sprouts (related to Figure 4.6) 
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Time-lapse series of an endothelial sprout expressing EGFP-CAAX imaged from 33 hpf. 
Laser ablation was performed along a line spanning the entire thickness of the vessel at 
the place indicated by the red arrow, and at the time indicated. Ablation led to an 
immediate loss of the inverse blebs at the apical membrane and to gradual regression of 
the lumen (black arrow). Time is in hours:minutes:seconds. 
 
Movie 4.6. Interruption of blood flow by tricaine treatment inhibits inverse 
blebbing at the apical membrane of angiogenic sprouts (related to Figure 4.7) 
Time-lapse series of an endothelial sprout expressing mCherry-CAAX imaged from 34 
hpf, before, during and after treatment with 4x tricaine. Blood flow stops about 15-20 
minutes after addition of 4x tricaine (data not shown), leading to a loss of the inverse 
blebs at the apical membrane. Black arrows show expansion of the apical membrane by 
inverse blebbing before treatment with 4x tricaine and after washout. Time is in 
hours:minutes:seconds. 
 
Movie 5.1. F-actin polymerises around inverse blebs as they retract (related to 
Figure 5.2) 
Time-lapse series of an endothelial sprout with mosaic expression of Lifeact-EGFP (left 
panel, green) and mCherry-CAAX (right panel, magenta) imaged from 35 hpf. F-actin 
polymerises around inverse blebs as they retract. Time is in hours:minutes:seconds. 
 
Movie 5.2. Myosin II is recruited around inverse blebs following F-actin 
polymerisation (related to Figure 5.5) 
Time-lapse series of an endothelial sprout with mosaic expression of Myl9b-EGFP (left 
panel, green) and Lifeact-mCherry (right panel, magenta) imaged from 35 hpf. Myosin 
II is recruited at the apical membrane around inverse blebs shortly after F-actin 
polymerisation. Time is in hours:minutes:seconds. 
 
Movie 5.3. Laser ablation of the actomyosin cortex at the apical membrane of 
growing lumens leads to the expansion of inverse blebs (related to Figure 5.8) 
Time-lapse series of an endothelial sprout expressing Lifeact-EGFP (left panel, green) 
and mCherry-CAAX (right panel, magenta) imaged from 33 hpf. Laser ablation of the 
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cell cortex was performed along the indicated black/white line and led to the expansion 
of a bleb that later retracted (white arrow). Time is in hours:minutes:seconds. 
 
Movie 5.4. Apical contractility is required for lumen expansion (related to Figure 
5.12) 
Time-lapse series of an endothelial sprout with mosaic expression of Myl9bAA-EGFP 
(left panel, green) and mCherry-CAAX (right panel, magenta) imaged from 35 hpf. The 
cell expressing Myl9bAA fails to lumenise from the ventral part of the ISV. Lumen 
pushes into the cell from the dorsal longitudinal anastomotic vessel (DLAV) but fails to 
expand (white arrows). Time is in hours:minutes:seconds. 
 
Movie 5.5. Endothelial cells with decreased apical contractility are unable to 
retract blebs and fail to expand lumens (related to Figure 5.11) 
Time-lapse series of an endothelial sprout with mosaic expression of Myl9bAA-EGFP 
(left panel, green) and mCherry-CAAX (right panel, magenta) imaged from 48 hpf. The 
apical membrane undergoes excessive and uncoordinated blebbing and fails to expand. 
Time is in hours:minutes:seconds. 
 
Movie 5.6. Partially lumenised endothelial cells with decreased apical contractility 
are dilated and show side lumen branches (related to Figure 5.11) 
Time-lapse series of an endothelial sprout with mosaic expression of Myl9bAA-EGFP 
(left panel, green) and mCherry-CAAX (right panel, magenta) imaged from 52 hpf. The 
ISV is dilated and shows side lumen branches that fail to retract (white arrows). Time is 
in hours:minutes:seconds. 
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7.2 Plasmid maps 
 
 
 
Figure 7.1. Map of the pTol2-fli1ep:EGFP-CAAX plasmid 
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Figure 7.2. Map of the pTol2-fli1ep:Lifeact-mCherry plasmid 
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Figure 7.3. Map of the pTol2-fli1ep:LexPR plasmid 
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Figure 7.4. Map of the pTol2-lexOP:myl9b-EGFP plasmid 
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